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Abstract 
Encapsulation is a technique to entrap a material of interest within a carrier material, and 
it has been used in a wide range of industries such as biopharmaceutical and 
biotechnological companies. Among biopolymers used for the carrier material, alginate 
has been widely used due to its attractive properties of biodegradability, biocompatibility 
and ease of gelation under mild conditions. In this study, a novel hybrid micro- or milli-
sphere composed of functionalised polyhydroxyalkanoate (PHA) beads and alginate was 
fabricated through ionotropic gelation methods. The selected functional proteins 
displayed on PHA beads were the IgG binding domain (ZZ) of Protein A from 
Staphylococcus aureus, and organophosphate hydrolase (OpdA). The effect of alginate 
encapsulation on their functionality was assessed. In addition, alginate millispheres 
encapsulating PHA beads were assessed for their ability to remove lipophilic compounds 
from an aqueous solution. This utilised the hydrophobic polyester core of the PHA beads 
and was assessed by using the lipophilic dye, Nile red, as the reporter.  
The results of IgG binding assays using PHA beads encapsulated in alginate microspheres 
showed no significant difference compared with negative controls, and no elution of 
bound IgG was observed. However, the alginate encapsulation enhanced IgG binding to 
the PhaC derived proteins on PHA beads within alginate microspheres. In contrast, 
alginate encapsulation limited the activity of PHA beads displaying OpdA when 
compared to free PHA beads. The qualitative data obtained from phase contrast and 
fluorescence microscopy suggested that the enzyme displayed on PHA beads was active 
within alginate microspheres. The lipophilic dye removal by PHA beads encapsulated in 
alginate millispheres was influenced by different parameters used in the millisphere 
preparation. The adsorption kinetics aligned with a pseudo second-order kinetic model, 
and the equilibrium adsorption data was in agreement with the Freundlich isotherm model. 
This study has provided preliminary data for fabrication of a hybrid material of 
functionalised PHA beads with alginate. The development of combinations of highly 
functional PHA beads with other biomaterials is expected to expand the application field 
of PHA beads. 
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1 
 
Chapter 1: Introduction 
1.1 Encapsulation in polymers 
Encapsulation is a technology of packaging solids, liquids, or gaseous materials within a 
natural or synthetic polymeric matrix (Desai & Park, 2005). This technology has been 
used in numerous applications in a wide range of industrial areas, such as the 
pharmaceutical, agricultural, medical, and food industries (Leong et al., 2016). The 
encapsulation techniques have been used to (1) immobilise materials within the polymer 
matrix, (2) separate the encapsulated material from the external environment to avoid 
possible incompatibilities while the semi-permeable membrane allows the transport of 
low molecular weight compounds, and (3) extend the viability, or shelf life, of the 
encapsulated material (Singh et al., 2010; Gasperini et al., 2014; Dragostin et al., 2017). 
Particularly in the drug delivery field, there have been extensive studies on the controlled 
release of the encapsulated material at the target destination (Singh et al., 2010). 
Moreover, in the tissue-engineering field, polymer matrices have been used to provide a 
three-dimensional scaffold for the encapsulated cells (Nicodemus & Bryant, 2008; Elabd 
et al., 2016; Bryant & Vernerey, 2018). Various types of polymers have been investigated 
for use in encapsulation applications including natural polymers such as alginate, chitosan, 
and agarose (Gasperini et al., 2014; Rehm et al., 2016) and synthetic polymers such as 
silica, polyacrylate, and polyethylene glycerol (PEG) (Gill & Ballesteros, 2000; Olabisi, 
2015; Rehm et al., 2016). Amongst the various available polymers, alginate is widely 
used in the encapsulation process due to its outstanding physical properties. Alginate has 
the properties of biocompatibility, biodegradability, low toxicity, as well as easily 
forming gels using divalent cations under mild and safe conditions (Lee & Mooney, 2012; 
Gasperini et al., 2014; Paques, 2015). 
1.2 Alginate 
1.2.1 Chemical structure 
Alginate is a naturally occurring anionic and hydrophilic polysaccharide that is composed 
of β-D-mannuronic acid (M) and α-L-guluronic acid (G) monomer residues linked via the 
β-1,4-glycosidic bond (Figure 1). The monomers are linked in highly variable distribution 
patterns, and the proportions of M and G-residues give different properties to the alginate 
polymer. The arrangement of monomer blocks can be homopolymeric (GG and MM) and 
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heteropolymeric (MG) (Donati & Paoletti, 2009; Ching et al., 2017). The main source of 
alginate is brown algae (Gasperini et al., 2014), but some bacteria also produce alginate 
(Remminghorst & Rehm, 2006). The different species produce different proportions and 
distributions of the monomers that affects the molecular weight and physical properties 
of the alginate. In most cases, alginate is available as the sodium, potassium or ammonium 
salts (Ching et al., 2017).  
 
Figure 1: Chemical structure of alginate. A: Chemical structure of alginate monomers; M, 
mannuronic acid; G, guluronic acid. B: Sequences of an alginate polymer; M-block, G-block, and 
MG-block linked via a β-1,4-glycosidic bond. 
 
1.2.2 Alginate gel matrix (Hydrogels)  
Alginate hydrogels are hydrophilic three-dimensional polymer networks, which can be 
formed through physiological and chemical cross-linkage of the polymers (Lee & 
Mooney, 2012). The physical properties of an alginate hydrogel are largely influenced by 
the chemical composition, the distribution and ratio of G and M residues, and the 
concentration of alginate in the preparation (Donati & Paoletti, 2009; Lee & Mooney, 
2012; Paques, 2015). The advantage of using alginate for the encapsulation process, 
especially for sensitive materials, is that alginate gelation can occur under mild conditions 
and uses nontoxic compounds during the preparation (Paques, 2015). Moreover, in 
comparison to other polysaccharide-based hydrogels, such as gelatin or agar, alginate gel 
formation is less dependent on temperature (Draget & Skja˚k-Bræk, 2011). Therefore, 
alginate is an ideal option for encapsulating sensitive materials. There have been a number 
of methods developed to prepare alginate hydrogels, including ionic cross-linking, 
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thermal gelation, cell-cross-linking, free radical polymerisation, and the click reaction 
(Sun & Tan, 2013). The most common gelling method used in the preparation of alginate 
spheres is the ionic cross-linking method (Ching et al., 2017). Alginate hydrogel prepared 
with the ionic cross-linking gelation is described below. 
1.2.2.1 Ionic gelation 
Ionic cross-linking with various divalent cations is the most commonly used gelation 
method in alginate hydrogel preparation. The binding of multivalent cations to alginate is 
a highly selective process as it depends on the composition of the alginate, such as the 
presence of G blocks, and the binding affinity of the divalent cations used (Draget & 
Skja˚k-Bræk, 2011; Paques, 2015; Ching et al., 2017). The binding affinity of various 
cations in increasing order is as follows: Mg2+<Mn2+<Zn2+<Ni2+<Co2+<Ca2+<Sr2+ 
<Ba2+<Cd2+<Cu2+<Pb2+ (Donati & Paoletti, 2009; Ching et al., 2017), and the affinity 
directly influences the strength of the gel matrix as a higher binding affinity produces a 
stronger hydrogel (Smidsrød, 1974; Smidsrød & Skja˚k-Bræk, 1990). Among the various 
available divalent cations, calcium is the most commonly used for the ionotropic gelation 
of alginate. This is because the calcium ion is non-toxic, readily available, and relatively 
inexpensive (Paques, 2015; Ching et al., 2017). In the presence of divalent cations, there 
is an ion exchange of the sodium ions from the G residue of the alginate polymer with the 
divalent cations, and gelation occurs by the cooperative interaction between the divalent 
cation and the oxygen atoms from the carboxyl groups of G residue block regions of the 
alginate polymers (Sun & Tan, 2013; Zia et al., 2015). Each cation binds with four G 
residues forming a characteristic “egg-box” calcium linked junctions (Figure 2) (Draget 
& Skja˚k-Bræk, 2011; Ching et al., 2017), which results in the interlinking of the alginate 
chains and forms a three-dimensional gel network.  
 
Figure 2: Alginate polymer binding with calcium ion to form an "egg-box" junction model.  
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1.2.2.1.1 External gelation 
The external gelation method is the most widely used mechanism of ionotropic gelation 
for alginate sphere preparation because of its simple one-step process. When an alginate 
droplet contacts a divalent cation-containing cross-linkage solution, the divalent cation 
instantaneously cross-link with the alginate polymer at the periphery of the droplet, 
resulting in the formation of a solid membrane surrounding the liquid droplet in the core. 
Extended immersion in the cross-linking solution allows diffusion of the divalent cations 
across the membrane and ultimately towards the centre of the droplet. Therefore, this 
method is also referred to as the “diffusion method” (Chan et al., 2006; Paques, 2015). 
As a result, this method produces a heterogeneous gelling profile with more alginate and 
cation networks formed at the peripheral regions compared with the centre of the sphere 
(Figure 3) (Chan et al., 2006). To solve the inhomogeneity, a low concentration of non-
gelling cations, such as Na+ or Mg2+ ions, added in the cross-linking solution with calcium 
ions during gelation, have been shown to produce a homogeneous alginate hydrogel 
matrix (Skjåk-Bræk et al., 1989; Donati & Paoletti, 2009). In an attempt to reduce the 
particle size of alginate spheres, an emulsification method with external gelation was 
conducted. In this method, alginate solution was added to an oil phase and dispersed to 
produce micron-sized droplets. Subsequently, the alginate droplets were externally gelled 
by adding CaCl2 solution into the emulsion. The productivity of alginate spheres 
(microspheres) increased, however, clustering of alginate microspheres occurred, and 
multiple emulsion (water-in-oil-in-water, w/o/w) formed (Poncelet et al., 1992). 
Therefore, the emulsification method predominantly uses internal gelation as later 
described. However, a recent study demonstrated that the formation of clusters and 
multiple emulsions were minimised by dispersing CaCl2 nanoparticles in the oil phase of 
the emulsion instead of adding CaCl2 solution directly to initiate gelation externally 
(Paques et al., 2013).  
1.2.2.1.2 Internal gelation 
Alginate hydrogels prepared by the internal gelation method use insoluble calcium, such 
as calcium carbonate (CaCO3), calcium citrate (Ca3(C6H5O7)2), or calcium sulfate 
(CaSO4) as the cross-linker in alginate polymers. The insoluble calcium compound is 
mixed with alginate solution, then dispersed into oil to form alginate droplets containing 
the insoluble calcium compounds. Calcium ions are then released in the alginate droplet 
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by dissolution of the insoluble calcium. This is achieved by reduction of the pH through 
acid addition, e.g. CH3COOH. The reaction occurs as follows: 
CaCO3(s)+2H+(aq)→Ca2+(aq)+H2O(l)+CO2(g). In contrast to the alginate hydrogel 
prepared by external gelation, internal gelation generates evenly distributed cations in the 
alginate hydrogel, thereby forming a more homogeneous gel network (Figure 3) (Poncelet 
et al., 1992; Reis et al., 2006; Zhao et al., 2007; Andersen et al., 2015; Paques, 2015).  
 
 
Figure 3: Schematic image of alginate hydrogels prepared by external and internal gelation. Based 
on Leong et al. (2016). 
 
1.2.3 Physical properties of alginate hydrogel  
The strength of alginate hydrogel prepared by ionic cross-linking is influenced by the G-
block content and the level of calcium ion interaction with the alginate polymer (Smidsrød, 
1974; Gombotz & Wee, 2012). Alginate with high G-block content tends to produce a 
stiff hydrogel while alginate with high M-block content produces a soft hydrogel. 
However, from the mechanical property point of view, the alginate hydrogel prepared 
with high G-block content is brittle while high M-block content is elastic (Thu et al., 
1996; Gombotz & Wee, 2012; Ching et al., 2017). Higher concentrations of calcium ion 
give a greater extent of interaction with alginate polymer, influencing the gel strength as 
denser gel network will be formed (Draget et al., 1993). In addition, the type of divalent 
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cation chosen in the ionic cross-linkage also influences the gel strength. For instance, 
barium ion has higher affinity for alginate than calcium ion, and binds to both M and G-
blocks, while calcium ion does not bind to M-block (Mørch et al., 2006). Moreover, the 
molecular weight of alginate also contributes to the mechanical strength of alginate 
hydrogel when calcium ion concentration is low. At low concentrations of calcium ion, 
higher molecular weight alginate contributes to stronger mechanical strength in which the 
intra-molecular covalent bonds of alginate polymer backbone are stronger than the inter-
molecular ionic bonds formed by calcium ion cross-linking (Kuo & Ma, 2001; Draget et 
al., 2005; Lee & Mooney, 2012). However, by increasing the concentration of calcium 
ion, there will be more interactions between calcium ions and alginate polymer making 
this a more significant contributor to the mechanical strength than molecular weight (Qiu 
et al., 2011). Meanwhile, in the presence of excess calcium ions, it has been shown that 
contribution of molecular weight to the mechanical strength occurs up to 150 kDa. With 
alginate molecular weight higher than 150 kDa, there was only a slight increase in 
mechanical strength when the calcium ion and alginate polymer interaction was saturated 
(Draget et al., 1993). The gelation rate controls the uniformity and strength of hydrogel 
as slower gelation produces hydrogel with more uniform structure and greater mechanical 
integrity (Kuo & Ma, 2001). For instance, gelation at low temperature reduces the rate of 
gelation, in turn, the mechanical strength of the hydrogel is enhanced (Augst et al., 2006). 
The alginate hydrogel preparation method, either internal or external gelation, 
significantly influences the porosity and permeability of the alginate hydrogel in the 
resulting alginate spheres (Chan et al., 2006). The porous structure is a significant feature 
of alginate hydrogel as it allows substrates to diffuse in and out of the hydrogel (Smidsrød 
& Skja˚k-Bræk, 1990; Holte et al., 2006). Studies using various analytical methods such 
as electron microscopy, size extrusion, diffusion studies, and gel chromatography have 
shown that alginate gel pore size ranges from 5-200 nm (Klein et al., 1983; Stewart & 
Swaisgood, 1993; Simpliciano et al., 2013). However, these values are highly variable, 
and gel pore size can be modulated by several factors. The concentrations and monomer 
composition of alginate influences porosity of the hydrogel. An increase of alginate 
concentration in the preparation reduces pore size of alginate hydrogel (Tanaka et al., 
1984). Alginate with a high G-block content creates a more open structure by interaction 
with calcium ions, creating larger pore sizes (Martinsen et al., 1991). The concentration 
of calcium ion is also important to control the pore size, hence influencing the 
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permeability of the hydrogel. A higher concentration of calcium ion influence alginate 
polymer gelling to a greater extent. Therefore, it produces a higher gel density, creating 
smaller pore sizes, which in turn reducing the gel permeability (Ching et al., 2017). The 
type of gelation mechanism influences the pore size of the gel matrix. As described above, 
the alginate spheres prepared by external gelation results in an inhomogeneous 
distribution of calcium ions with a denser gel at the surface than the interior of the sphere 
(Figure 3). Meanwhile, the alginate spheres prepared by internal gelation results in a 
homogeneous distribution of calcium ion in the spheres (Andersen et al., 2015; Paques, 
2015). This leads to an alginate hydrogel prepared by external gelation having a smaller 
pore size at the surface, resulting in higher resistance to diffusion of the substrate 
compared to internal gelation (Liu et al., 2002). There have been a number of molecules 
tested for diffusability into alginate hydrogel. Small molecules such as glucose, ethanol, 
ammonia, or vitamin B12 can diffuse across the alginate membrane regardless of the 
molecular weight of alginate (Martinsen et al., 1991; Gautier et al., 2011). Meanwhile, 
the transfer of large molecules, such as albumin, is hindered by the porous structure. 
However, several proteins, including immunoglobulin G (IgG), fibrinogen, haemoglobin 
and insulin have been reported to transfer through the porous structure of alginate (Tanaka 
et al., 1984; Liu et al., 2002; Mørch et al., 2006; Gombotz & Wee, 2012). 
Syneresis and swelling are physical characteristics that can occur with alginate hydrogels. 
Syneresis is the shrinkage of alginate hydrogels resulting from the loss of water molecules 
from the hydrogel (Donati & Paoletti, 2009). In an alginate hydrogel, water molecules are 
entrapped within the alginate hydrogel through hydrogen bonding. Upon an increase in 
the level of ionic cross-linking, an external force is applied that contracts the hydrogel, 
and the release of water molecules from the hydrogel is induced. As a result, there is a 
decrease in dimensions of the alginate hydrogel (Donati & Paoletti, 2009; Helgerud et al., 
2009). The composition and sequence of alginate polymer significantly influence the 
degree of syneresis. Long G-blocks contribute to a decrease in syneresis as it forms 
stronger irreversible junctions than shorter G-blocks, meanwhile alternating MG-blocks 
give flexible elastic properties to alginate hydrogel, leading to a higher degree of syneresis 
(Martinsen et al., 1989). In addition to this, the length of alternating MG-blocks has been 
shown to determine the extent of collapse of the hydrogel, leading to syneresis, by 
forming MG/MG junction upon an increase in calcium ion concentration (Donati et al., 
2005). Moreover, the degree of syneresis increases with increasing concentration of 
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calcium ion, gelation time, and alginate molecular weight. (Martinsen et al., 1989; Draget 
et al., 2001; Donati & Paoletti, 2009). Swelling of an alginate hydrogel occurs under 
different external stimuli. It has been demonstrated that alginate hydrogels shrink in low 
pH and swell at close to neutral pH and above (Han et al., 2007; Matyash et al., 2014; 
Ching et al., 2017). In addition, ionic concentrations in a buffer also influence the degree 
of swelling of the alginate hydrogel (Matyash et al., 2014). By dispersing alginate spheres 
in physiological solution, such as saline and PBS, the cross-linked calcium ion will be 
replaced with sodium ions, which have no cross-linking property. This phenomenon, 
namely “ion exchange”, results in the destabilisation of the hydrogel networks, which in 
turn leads to water influx (Mørch et al., 2007; Wu et al., 2010). The mechanism of 
hydrogel shrinkage in low pH is still unclear (Ching et al., 2017). It is known that low pH 
induces proton catalysed hydrolysis of alginate polymer, leading to a lower molecular 
weight of alginate (Haug et al., 1963). However, it has also been shown that the low pH 
condition suppresses the disassociation of the carboxyl group of the alginate polymer 
(Yotsuyanagi et al., 1990; Wu et al., 2010). Therefore, it is suggested that the protonated 
carboxyl group at low pH forms a thick gel matrix due to reduced electrostatic repulsion 
(You et al., 2001). In term of alginate hydrogel preparation, it has been reported that 
swelling capacity of alginate hydrogel can be reduced with an increase in calcium 
concentration, as well as increased amounts of G-block in the alginate polymer (Gao et 
al., 2009). In addition, the type of divalent cations used to cross link the alginate polymer 
influences the swelling capacity, for instance, barium ions significantly reduced the 
swelling capacity compared with calcium ion (Smidsrød & Skja˚k-Bræk, 1990). 
1.2.4 Preparation methods for alginate spheres 
To select the appropriate alginate sphere preparation method for a particular application, 
it is important to consider the particle size of the alginate spheres required (Leong et al., 
2016). In this section, two methods of alginate sphere preparations widely used to produce 
micron- and macro-sized alginate spheres are reviewed. 
1.2.4.1 Simple extrusion dripping method 
The simple extrusion dripping method is the most widely used method to prepare alginate 
spheres because of its simple procedure. In general, this method involves an alginate 
solution loaded in a syringe, and alginate droplets are added dropwise into the cross-
linking solution. This method is usually used together with the external gelation method 
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(Sun & Tan, 2013; Ching et al., 2017). Alginate spheres produced by the simple dripping 
method are generally in the 1-2 mm size range (Ching et al., 2017), these are similar in 
size to those made from gelatin and called gelatin millispheres (Yamashita et al., 2009), 
hence will be called alginate millispheres here. The alginate viscosity, diameter of the 
needle tip opening, flow rate of alginate solution, and the height of needle tip from the 
cross-linking solution may all influence the particle size of the millispheres (Lee et al., 
2013). The distance between needle tip and the cross-linking solution affects the particle 
sphericity as when alginate viscosity and its droplet surface tension are not able to 
overcome the surface tension exerted by the cross-linking solution, the droplet may be 
deformed from a perfect sphere (Chan et al., 2009). To overcome this, surface-active 
compounds, such as methanol, may be added to reduce the surface tension of the cross-
linking solution (Skjermo et al., 1995; Thu et al., 1996). The advantage of the simple 
extrusion dripping method is its simplicity. The drawback of this method is that alginate 
spheres are large and there is low process productivity (in term of sphere number per unit 
time) (Ching et al., 2017). In addition, even though gelation occurs as soon as droplets 
are added into the cross-linking solution, diffusion of cations into the interior of the 
droplet takes a longer time, eventually creating a gradient of the gel network (Paques, 
2015). To overcome these shortcomings, several modified techniques, which aimed to 
produce smaller alginate droplets using mechanical apparatus, have been developed 
(Ching et al., 2017). These include: Electrostatic atomisation (Huang et al., 2011), 
vibration method (Zhou et al., 2009), jet cutting method (Paulo et al., 2017), spinning 
disk/nozzle method (Nagata et al., 2001), spraying method (Tritz et al., 2010), and 
impinging aerosol method (Hariyadi et al., 2010). 
1.2.4.2 Emulsification 
In the emulsification method, alginate solution is dispersed in an oil phase and 
homogenised to produce a water-in-oil (w/o) emulsion. Subsequently, gelation is slowly 
initiated by addition of either cross-linking solution (CaCl2) (external gelation, Section 
1.2.2.1.1) or acid (internal gelation, Section 1.2.2.1.2) (Paques et al., 2013; Paques et al., 
2014b; Paques, 2015). However, as described above (Section 1.2.2.1), the emulsification 
method is often used together with the internal gelation method as the external gelation 
method may result in microspheres clustering and double emulsion formation. The 
particle size of alginate spheres prepared with the emulsification method is generally in 
the range of 100-1,000 µm in diameter (microspheres) (Ching et al., 2017), or even 
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smaller particle sizes may be obtained (Paques, 2015). The particle size distribution of 
the alginate microspheres is influenced by various factors involved in the preparation, 
including alginate property and its concentration, water to oil ratio in the emulsion, 
emulsifier type and its concentration, homogeniser shear force, as well as environmental 
factors . The advantage of using this method is that it increases the productivity of alginate 
spheres in comparison to the simple dripping method (Reis et al., 2006; Zuidam & 
Shimoni, 2010). However, there are some drawbacks using the emulsification method. 
They are: (1) random alginate droplet coalescence may occur during emulsification that 
leads to a wider particle size distribution; (2) high shear force and heat generated in the 
method may affect the encapsulated material; and (3) collection of alginate microspheres 
from the emulsion usually requires centrifugation followed by extensive washing 
procedures to remove oil, in some cases using organic solvents (Zhao et al., 2007; Nagpal 
et al., 2012; Ching et al., 2017).  
1.2.5 Applications of alginate 
Owing to its attractive properties, alginate has been employed in a wide range of 
applications. The most common application is found in the food industry as a viscosifying, 
stabilising, emulsifying and gelling agent as well as a moisture retainer in products 
(Donati & Paoletti, 2009). The properties of alginate meet the requirements for use in the 
high-value niche of biomedical and pharmaceutical applications. It has been used in the 
production of wound dressings, dental impressions, and formulation with bicarbonate for 
gastric reflux prevention (Donati & Paoletti, 2009). Moreover, applications of alginate in 
hydrogel form to encapsulate a material of interest within the three-dimensional hydrogel 
have been demonstrated. For example, it has been used in various fields such as controlled 
drug delivery (Shelke et al., 2014), cell encapsulation (Gasperini et al., 2014), and tissue 
engineering for regenerative therapy (Rinaudo, 2014). 
1.2.5.1 Alginate encapsulation 
Due to its properties of biocompatibility, biodegradability, and its ability to easily form 
gels by addition of divalent cations under mild and safe conditions, alginate has been used 
to produce hydrogel (i.e. micro-/milli-spheres) to encapsulate various materials. These 
materials include proteins, enzymes, volatile compounds, cells, DNA, and various drugs 
(Chan et al., 2000; Nicodemus & Bryant, 2008; Al-Mayah, 2012; Gombotz & Wee, 2012). 
The encapsulation in alginate hydrogel provides various advantages to the encapsulated 
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materials. These are: (1) providing a relatively inert environment within the gel matrix; 
(2) forming gels in mild conditions without harmful organic solvents; (3) enhancing the 
stability and function of the encapsulated material; (4) allowing diffusion of small and 
large molecules through the porous gel structure; (5) being able to control the porous 
structure by simple coating procedures; and (6) dissolving and degrading under normal 
physiological conditions (Raj & Sharma, 2003; Holte et al., 2006; Gombotz & Wee, 
2012). For instance, in particular, (1) to (4) are important factors for cell encapsulation 
and (1) to (6) are important factors for drug delivery systems. In the encapsulation of 
enzymes into alginate hydrogel, the encapsulated enzymes typically improve their 
mechanical and thermal stability (Rehman et al., 2013), and alginate encapsulation may 
create the ideal physio-chemical microenvironment for the enzyme (Mohamad et al., 
2015). However, the practical use of enzyme-encapsulated alginate hydrogel is rather 
limited, as the hydrogel matrix tends to incur limitations in mass transfer of the substrate 
to the active site of the enzyme. In addition, leakage of the encapsulated enzyme through 
the porous gel structure may occur during the process (Blandino et al., 2001; Mohamad 
et al., 2015). Recently, Zhao and co-workers have shown that hybrid beads composed of 
chemically reduced graphene oxide and alginate effectively prevented the leakage of the 
encapsulated enzyme (Zhao et al., 2015).  
Alginate has shown to be an effective adsorbent for the removal of heavy metal ions, such 
as Cd2+, Cu2+, Cr6+, Pb2+, and Zn2+ from aqueous solution utilising its chelating property 
(Lim & Chen, 2007; Pandey et al., 2007; Deze et al., 2012). Recently, it has also been 
used as a support polymer material to prepare active material/alginate composite hydrogel 
for more efficient removal of diverse water pollutants (Jiao et al., 2016; Jung et al., 2017; 
Huang & Wang, 2018). For example, Asthana and co-workers prepared silver 
nanoparticles encapsulated in alginate beads for removal of Fe2+ from aqueous solution 
(Asthana et al., 2016). Moreover, the encapsulation of graphene oxide within alginate 
hydrogel has been widely demonstrated as an efficient adsorbent for water treatment 
applications. It has been shown that it successfully removed heavy metal ions such as 
Cu2+, Pb2+, Cr6+, and As5+ (Jiao et al., 2016; Vu et al., 2017), and organic pollutants such 
as methylene blue, phenol, tetracycline, and bisphenol A (BPA) (Wu et al., 2014; Feng 
et al., 2017; Gan et al., 2018) from aqueous solution. Similar to this, activated carbon 
encapsulated in alginate hydrogel demonstrated the ability to remove organic pollutants 
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as well as heavy metal ions from aqueous solution (Lin et al., 2005; Park et al., 2007; 
Cataldo et al., 2016).  
1.2.5.2 Protein purification 
Alginate has been shown to be useful in protein purification (Jain et al., 2006). For 
example, in affinity precipitation using a polymer, the polymer is often conjugated with 
an affinity ligand. When the ligand conjugated polymer is added to a crude mixture of 
proteins, it selectively forms a complex with the target proteins. The polymer-protein 
complex is then precipitated by an appropriate stimulus, in the case of alginate, the 
addition of calcium ions. Subsequently, the precipitated complex is collected by low 
speed centrifugation, and the target protein can be obtained by a suitable dissociation step 
(Roy & Gupta, 2000; Jain et al., 2006). Somers and co-workers observed that alginate 
beads bind pectinase, and the bound enzyme could be eluted off with a moderate 
concentration of sodium chloride (Somers et al., 1989). Based on this observation, 
pectinase was purified from Aspergillus niger by affinity precipitation (Gupta et al., 1993). 
Moreover, pre-treatment of alginate by microwaves enhanced the selectivity of alginate 
for pectinase and resulted in higher purification of the enzyme (Mondal et al., 2004). 
These affinity precipitations were conducted without conjugating an affinity ligand to 
alginate, giving an advantage for alginate in protein purification as a simple and an 
economical procedure, as well as motivating further investigations to look for other 
enzymes to be selectively purified by alginate. Several proteins have been shown to be 
selectively purified by alginate, such as α-amylase (Sharma et al., 2000a), β-amylase 
(Teotia et al., 2001a), glucoamylase (Teotia et al., 2001b), lipase (Sharma & Gupta, 2001), 
phospholipase D (Sharma et al., 2000b), and α-galactosidase (Celem et al., 2009). In 
addition, alginate in bead form used in expanded bed affinity chromatography also 
purified several proteins listed above without an affinity ligand conjugated on the alginate 
bead (Roy et al., 2004; Jain et al., 2006).  
Alginate has also been used as immobilised metal ion affinity chromatography resin, 
similar to commercially available agarose resin charged with metal ions (Jain et al., 2006). 
Gupta and co-workers produced zinc chelated alginate (Zn-alginate) beads for purifying 
soybean trypsin inhibitor from a crude extract of soybean flour. The Zn-alginate beads 
successfully purified the protein, however, 6 mM metal ion was needed throughout the 
procedure to maintain the integrity of the bead, and the metal ion caused the precipitation 
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of other proteins (Gupta et al., 2002; Jain et al., 2006). To overcome this problem, alginate 
beads were cross-linked with epichlorohydrin, in which the hydroxyl groups of alginate 
reacted with epichlorohydrin while carboxyl groups were left free for coordinating to 
metal ions (Jain et al., 2006). The epichlorohydrin cross-linked alginate bead charged 
with Cu2+ ion was used to purify goat IgG in a packed bed, resulting in high purification 
and recovery of IgG from goat serum (Jain & Gupta, 2004).  
1.3 Polyhydroxyalkanoate beads 
As described above (Section 1.2.5), alginate has been employed for applications in 
various industries owing to its unique and valuable properties. This study focused on the 
alginate encapsulation application. The material of interest to encapsulate within the 
alginate hydrogel in this study was polyhydroxyalkanoate (PHA) beads. PHAs are natural 
biopolyesters of hydrophobic nature that are produced by a wide range of microorganisms 
as spherical inclusion bodies for their carbon and energy storage (Grage et al., 2009). 
Recently, genetic engineering of bead-associated proteins allowed display of various 
functional protein at the beads’ surface, producing functionalised nano-beads (Parlane et 
al., 2017). Below provides a brief summary of PHAs, bead-associated proteins, and bead 
formation. In addition, protein immobilisation on PHA beads and their current 
applications are described. 
1.3.1 Polyhydroxyalkanoate 
Polyhydroxyalkanoates (PHAs) are natural biopolymers that are produced by a wide 
range of bacteria, some archaea, as well as some yeast cells (Rehm, 2007; Priji et al., 
2016). PHAs are synthesised and deposited in the cytoplasm of bacterial cell as spherical 
water insoluble inclusion bodies, also known as PHA beads (Rehm, 2010). PHA beads 
are formed in unbalanced nutrient conditions in which carbon source is available in excess 
while the other nutrients, such as nitrogen, oxygen, and phosphorus, are depleted 
(Steinbüchel & Valentin, 1995; Muhammadi et al., 2015). The primary function of the 
bead is to serve as the carbon and energy source by depolymerising the PHA in conditions 
of carbon starvation (Steinbüchel et al., 1992). The particle size of PHA beads ranges 
between 50-500 nm in diameter (Rehm, 2007; Grage et al., 2009). In general, bacteria 
accumulate 5-10 PHA beads per cell, and are capable of accumulating more than 80% of 
their cellular dry weight as beads (Figure 4A) (Grage et al., 2009; Tan et al., 2014; 
Muhammadi et al., 2015). In naturally synthesised (native) PHA beads, an amorphous 
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hydrophobic polyester core is surrounded by attached or embedded proteins on its surface 
that are involved in structural and regulatory functions. The surface proteins include PHA 
synthase (PhaC) that catalyses the polymerisation of PHA and remains covalently 
attached to the polyester core, as well as PHA depolymerase (PhaZ), structural proteins 
(Phasins), and regulatory proteins (PhaR) bound to the polyester core by hydrophobic 
interactions (Figure 4B) (Rehm, 2007; Parlane et al., 2017). However, it has been 
demonstrated that apart from the PHA biosynthesis genes the other bead-associated 
proteins are not necessary to produce PHA beads in recombinant (non-native) PHA 
producing cells or plants (Poirier et al., 1992; Wang et al., 1999; Parlane et al., 2017). 
 
 
Figure 4: PHA bead inclusions. A, Transmission electron microscopic image of PHA inclusions 
in recombinant E. coli; B, Schematic view of a native PHA bead. TEM image (A) from K. Ogura 
taken by the Manawatu Microscopy and Imaging Centre (Palmerston North, New Zealand) 
 
The most commonly found form of PHA in bacteria is poly(3-hydroxybutyric acid) 
(PHB), which is synthesised from 3-hydroxybutyrate (3-HB) monomers. This was the 
first bacterial PHA polymer identified and was found in the cytoplasm of Bacillus 
megaterium in 1926 (Maestro & Sanz, 2017). Currently, over 150 different (R)-3-hydroxy 
fatty acids as PHA constituents have been reported and the number is growing 
(Steinbüchel & Valentin, 1995; Parlane et al., 2017). Many factors may influence the 
monomer content in the resulting PHA polymer. This includes strains, cultivation 
conditions and carbon sources (Park et al., 2012; Jia et al., 2016). In addition, genetic or 
metabolic engineering of PHA-producing strains have been explored to produce tailor-
made monomers or monomer precursors which in turn contribute to the increase in the 
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number of PHA constituents available (Madison & Huisman, 1999; Chen et al., 2015). 
Moreover, direct chemical or physical modifications to the existing PHA polymers have 
also been demonstrated (Levine et al., 2016; Wang et al., 2016). The monomer diversity 
and ability to modify PHA polymers make it possible to synthesise PHAs with different 
thermal and mechanical properties. PHAs occur as either homopolymers or copolymers 
and are classified into three major groups based on the monomer size (Rehm, 2007; 
Maestro & Sanz, 2017). These are: short chain length PHAs (PHASCL), which are 
produced by a wide range of bacteria and archaea, and consist of 3-5 carbon atoms in the 
monomer; medium chain length PHAs (PHAMCL), which are primarily produced by 
Pseudomonas species, and consist of 6-14 carbon atoms in the monomer; and long chain 
length PHAs (PHALCL) that consist of more than 14 carbon atoms but they are scarcely 
found (Rehm, 2007; Grage et al., 2009; Maestro & Sanz, 2017). From a materials property 
point of view, PHASCL is hard but brittle with a high melting point and high crystallinity. 
In contrast, PHAMCL is more elastomeric but has less tensile strength with a low melting 
point and low crystallinity (Rehm, 2007). 
PHAs have been extensively studied in various industries due to their attractive properties 
compared with synthetic plastics. PHAs are biocompatible, biodegradable, chemically 
and physically modifiable, and can be produced from renewable sources. In comparison, 
traditional synthetic plastics are produced from crude oil, are non-renewable and non-
biodegradable. Therefore, PHAs are expected to be used increasingly as alternatives to 
the petroleum-based plastics (Philip et al., 2007; Chen, 2009). However, due to 
fermentation and purification cost, it is still more expensive to produce PHA-based 
plastics compared to conventional petroleum-based plastics. Hence, the current market 
niche for PHAs is in high-value applications, especially in the biomedical field (Chen & 
Wu, 2005; Grage et al., 2009). The biocompatible property of PHA allows its use in 
biomedical materials such as sutures (Shishatskaya et al., 2004), bone scaffolds (Lim et 
al., 2017), and drug delivery systems (Francis et al., 2011). However, these biomaterials 
are based on extracted PHA polymers, thus the PHA bead loses its natural form, as do 
any bead-associated proteins. In contrast, the application of the natural form of PHAs as 
a protein-coated bead has been exploited to produce functionalised nano-beads. In this 
technology, the bead-associated proteins are genetically engineered to display functional 
proteins on the surface of the PHA beads (Rehm, 2007; Grage et al., 2009; Draper & 
Rehm, 2012; Parlane et al., 2017). 
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1.3.1.1 PHA biosynthesis 
There are three major metabolic pathways to synthesise PHA in native bacteria. The most 
well characterised pathway, namely pathway I, is utilised to synthesise short chain length 
PHAs (PHASCL) by bacteria, such as Cupriavidus necator, while pathways II and III are 
utilised by bacteria such as Pseudomonas aeruginosa, to synthesise medium chain length 
PHAs (PHAMCL) (Rehm, 2007; Grage et al., 2009; Zou et al., 2017). 
The biosynthesis of PHB (PHASCL) in C.necator requires three key enzymes: PHA 
synthase (PhaC), β-ketothiolase (PhaA), and acetoacetyl-CoA reductase (PhaB), which 
are encoded by phaC, phaA, and phaB genes, respectively. These biosynthesis genes are 
clustered in a single phaCAB operon in the bacterial genome (Rehm, 2007; Grage et al., 
2009). The precursor ((R)-3-hydroxybutyryl-CoA) is synthesised by β-ketothiolase 
(PhaA) and acetoacetyl-CoA reductase (PhaB). β-ketothiolase (PhaA) condenses two 
molecules of acetyl-CoA to form acetoacetyl-CoA, with subsequent reduction to (R)-3-
hydroxybutyryl-CoA by NADH-dependent acetoacetyl-CoA reductase (PhaB). 
Eventually, PhaC catalyses the polymerisation of (R)-3-hydroxybutyryl-CoA monomers 
into PHB with the release of CoA (Rehm, 2007; Muhammadi et al., 2015). The pathways 
II and III in P. aeruginosa for PHAMCL synthesis utilises metabolic intermediates from 
the fatty acid de novo synthesis ((R)-3-hydroxyacyl-ACP) and fatty acid β-oxidation 
(enoyl-CoA) to convert them into (R)-3-hydroxyacyl-CoA thioester monomer, which is 
subsequently polymerised into PHAMCL by PhaC (Tsuge et al., 2003; Philip et al., 2007; 
Rehm, 2007). 
1.3.1.2 PHA bead formation: self-assembly 
Although in vitro synthesis of PHAs and self-assembly into spherical beads has been 
demonstrated using purified PHA synthases and substrates (Gerngross & Martin, 1995), 
the exact molecular events of PHA bead assembly in vivo have not been fully elucidated 
(Parlane et al., 2017). Currently, three models of PHA bead assembly in vivo have been 
proposed, namely: the micelle model, the budding model (Rehm, 2007; Grage et al., 
2009), and the scaffolding model (Parlane et al., 2017). 
The micelle model is currently considered the most favoured model. In this model, soluble 
PhaC forms a dimer, and the dimerised PhaC interacts with the substrate in the cytoplasm 
to initiate the polymerisation process. During the polymerising process, the dimer remains 
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covalently attached to the growing hydrophobic polymers, forming an amphipathic 
molecule. Subsequently, several amphipathic molecules undergo self-assembly by 
aggregation via hydrophobic interactions to form a micelle-like structure (Gerngross et 
al., 1993; Grage et al., 2009). Phasin and other bead-associated proteins (PhaZ and PhaR) 
that are involved in the regulation and metabolism of PHA beads interact with the 
intracellularly formed PHA beads by hydrophobic interaction (Parlane et al., 2017). This 
model is supported by studies of the in vitro PHA bead formation, where the cytoplasmic 
membrane is absent (Gerngross & Martin, 1995; Hiraishi et al., 2005). 
In contrast to the micelle model, the membrane budding model arose from the observation 
in electron microscopic studies showing membrane-like material surrounding PHA beads 
in intact cells and isolated beads (Boatman, 1964; Lundgren et al., 1964; Dunlop & 
Robards, 1973; Mayer et al., 1996). In this model, soluble PhaC and phasin protein 
localise to the inner side of the cytoplasmic membrane, either inherently or as soon as 
PHA chains emerge from PhaC protein. The polyester chains are growing into the inter-
membrane space, forming PHA inclusions surrounded by a phospholipid monolayer with 
other bead-associated proteins attached, which then eventually bud off the membrane into 
the cytoplasm (Jendrossek et al., 2007; Thomson et al., 2010). Studies using fluorescent 
techniques support the membrane budding model. In these studies, they have shown that 
PHA beads in native and recombinant PHA bead-producing bacteria are not randomly 
distributed in the cytoplasm, but are predominantly located at, or near, the cytoplasmic 
membrane (Jendrossek, 2005; Jendrossek et al., 2007). However, recent findings have 
provided evidence against this model. For example, high-resolution images of PHA bead 
synthesis in C. necator using electron cryotomography revealed that PHA beads of 
different sizes are distributed towards the centre of the cytoplasm, and their surface was 
a discontinuous layer with no lipid monolayer present on the surface of the bead (Beeby 
et al., 2012). Further confirmation for the absence of phospholipid layer on the PHA bead 
was conducted using fluorescence microscopy (Bresan et al., 2016). In this study, 
DsRed2EC and other fluorescent proteins fused with the phospholipid-binding domain of 
lactadherin (LactC2) were tested with three native PHA bead producers (C. necator, 
Pseudomonas putida, and Manetospirillum gyphiswaldense). The fluorescence 
microscopy showed the fusion protein co-localised only with the cytoplasmic membrane, 
but not with the PHA beads (Bresan et al., 2016). This observation is not consistent with 
the membrane budding model, as it should contain phospholipid as previously described.  
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The scaffolding model was suggested by the observation of PHA bead synthesis in C. 
necator using transmission electron microscopy (Tian et al., 2005). These authors 
observed that PHA beads localised close to the dark-stained structure or “mediation 
elements” in the centre of the cell. It was undefined at the time, however, the authors 
proposed that the mediation elements serve as scaffolds to initiate bead formation (Tian 
et al., 2005). Nowadays, the mediation element is believed to be bacterial nucleoid 
(Parlane et al., 2017). A regulatory protein, PhaM, has been shown to bind not only to 
PhaC but also to DNA and nucleoid both in vitro and in vivo (Pfeiffer et al., 2011). 
Moreover, supporting evidence for the scaffolding model was demonstrated as PhaM 
mediated the binding of PHA bead with nucleoid, and overproduction of the protein 
caused the attachment of small PHA beads to the nucleoid region in C. necator (Wahl et 
al., 2012). However, phaM deletion in C. necator strain still has shown to produce PHA 
beads. Therefore, PhaM mediated scaffolding event may be unnecessary for bead 
formation (Pfeiffer et al., 2011). 
1.3.1.3 PHA synthases 
PHA synthase is the critical enzyme for PHA synthesis. The enzyme catalyses the 
polymerisation of (R)-hydroxyacyl-CoA thioester monomers into PHAs with the 
concurrent release of CoA. Currently, genome sequencing technology has identified over 
90 PHA synthase genes in a number of different bacterial species. PHA synthases are 
classified into four different classes based on their substrate specificity, subunit 
composition, and primary structure (Rehm, 2003; Rehm, 2007; Grage et al., 2009; 
Parlane et al., 2017). 
1.3.1.3.1 Classification of PHA synthase 
Class I and II PHA synthases, with representatives from C. necator and P. aeruginosa 
respectively, consist of a single PhaC subunit with a molecular weight ranging between 
61-73 kDa (Timm & Steinbüchel, 1992; Qi & Rehm, 2001; Rehm, 2003; Philip et al., 
2007). Class III and IV PHA synthases, with representatives from Allochrimatium 
vinosum and Bacillus megatrium respectively, are composed of two subunits (Parlane et 
al., 2017). In the class III PHA synthases, there are two subunits, PhaC and PhaE, of 
similar molecular weight (40 kDa), however, they show no homology based on their 
primary structure. The PhaC subunit exhibits 21-28% similarity to the class I and II PhaC 
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while PhaE has no similarity to PhaC (Qi et al., 2000; Qi & Rehm, 2001). The class IV 
PHA synthases are similar to the class III PHA synthase, except the PhaE subunit is 
replaced with PhaR subunit (20 kDa) (Tsuge et al., 2015). In term of substrate specificities, 
class I, III, and IV PHA synthases prefer to catalyse the polymerisation of short chain 
length monomers (C3-C5) to generate PHASCL, while class II PHA synthase catalyses the 
polymerisation of medium chain length monomers (C6-C14) to generate PHAMCL 
(Parlane et al., 2017). 
1.3.1.3.2 Structural features of PHA synthases 
Purified PHA synthases have been shown to exist in vitro in equilibrium as monomeric 
and dimeric forms (Zhang et al., 2003; Rehm, 2007). The presence of substrate induces 
dimerisation of PHA synthase, suggesting dimer formation is the active form of PHA 
synthase to polymerise substrates into PHAs (Rehm, 2007). Currently, the active form of 
PHA synthase is considered to be a homodimer for class I and II PHA synthases and 
heterodimers for class III and IV PHA synthases (Rehm, 2007).  
Comparing amino acid sequences of all four classes of PHA synthases from different 
bacteria have shown six conserved amino acid blocks and eight conserved amino acid 
residues in all PHA synthases (Rehm et al., 2002; Rehm, 2007). Also, a truncation study 
on class I PHA synthase from C. necator revealed that the first 100 amino acids of the N-
terminus are highly variable and dispensable (Rehm et al., 2002; Peters & Rehm, 2005). 
In contrast, the C-terminus appeared to be a highly conserved and hydrophobic feature 
among class I and II PHA synthases, suggesting a function in enzyme activity as well as 
the binding domain to facilitate the attachment of PHA synthase to the hydrophobic 
polyester core (Rehm et al., 2002; Peters & Rehm, 2005; Rehm, 2007). In class III and 
IV, their PHA synthases do not contain a hydrophobic C-terminus, instead, their 
respective second subunit, PhaE and PhaR, possess a hydrophobic C-terminus, suggesting 
it facilitates the binding to the polyester core (Rehm, 2007). In addition, the amino acid 
alignment found that PHA synthase contains conserved PhaC box sequence ([G/S]-X-C-
X-[G/A]-G) (Tsuge et al., 2015) and a conserved cysteine-histidine-aspartate catalytic 
triad in the C-terminus of all classes of PHA synthases (Rehm, 2003). These features are 
homologous to lipase, a member of the α/β-hydrolase superfamily, which forms a core 
α/β-hydrolase fold that is composed of eight β-sheets surrounded by six α-helices (Ollis 
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et al., 1992), except the serine residue in the catalytic site of lipase is replaced with a 
cysteine residue in PHA synthase (Rehm, 2003; Rehm, 2007; Tsuge et al., 2015) 
1.3.1.4 Other PHA granule-associated proteins 
PHA synthase (PhaC) is not the only protein presented on the surface of PHA beads. 
Three major types of proteins are also known to associate with PHA beads in native PHA 
producers, and these proteins play a role in PHA synthesis regulation, bead formation, 
and degradation. These are Phasin (PhaP), PHA depolymerase (PhaZ), and regulatory 
proteins, PhaR, PhaF, and PhaI (Grage et al., 2009; Parlane et al., 2017). 
1.3.1.4.1 Phasin (PhaP) 
Phasins are a group of proteins that are the most abundantly produced bead-associated 
protein and make up to 5% of the total cellular proteins. The molecular weight of the 
proteins ranges from 11 to 25 kDa, and they are non-covalently attached to PHA beads 
by hydrophobic interactions (Grage et al., 2009). In the model PHA producer, C. necator, 
seven phasins (PhaP1-PhaP7) have been identified (Pfeiffer & Jendrossek, 2012). Their 
function is considered to be in the role of regulating PHA production level, bead size and 
number in the cell, and preventing nonspecific interaction of other proteins with PHAs 
(Grage et al., 2009; Parlane et al., 2017). Studies have demonstrated that phasins are not 
essential for PHA bead production, however, the absence of phasins led to a single large 
granule formation (Hanley et al., 1999) while many small beads were produced in a cell 
with the overproduction of phasin (Pötter et al., 2002). This observation was supported 
by other studies that demonstrated phasins stabilise the PHA beads by preventing the 
coalescence of individual beads by forming an amphiphilic layer on the surface of PHA 
beads (Parlane et al., 2017). 
1.3.1.4.2 PHA depolymerase (PhaZ) 
PHA depolymerases are the main enzymes to catalyse the degradation of PHA polyesters 
by thiolysis under nutrient deficiency (Jendrossek et al., 1996; Jendrossek & Handrick, 
2002). The PHA depolymerases are classified into two groups by the location of enzyme 
activity: intracellular and extracellular PHA depolymerases. The intracellular PHA 
depolymerases are the PHA bead-associated protein that degrades the accumulated 
polyesters in the cytoplasm of bacteria (Handrick et al., 2000). The extracellular PHA 
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depolymerases are secreted by many microorganisms into the environment to utilise the 
extracellular PHA sources (Mergaert & Swings, 1996). The PHA depolymerases have the 
substrate binding site at the C-terminus that interacts with PHA core by hydrophobic and 
chemical interactions (Jendrossek & Handrick, 2002). The four crucial amino acid 
residues (arginine, cysteine, histidine and serine) in the substrate-binding site, especially 
the positively charged histidine and arginine residues have been suggested to interact with 
the carbonyl group of PHAs by electrostatic interaction (Jendrossek & Handrick, 2002; 
Park et al., 2005).  
1.3.1.4.3 Regulatory Proteins (PhaR, PhaF, and PhaI) 
PHA biosynthesis and phasin (PhaP) production are tightly regulated by the 
transcriptional repressor PhaR (Grage et al., 2009; Parlane et al., 2017). Studies in 
Ralstonia eutropha (Currently known as C. necator) and Pseudomonas denitrificans have 
shown that PhaR binds upstream of the phaP and phaR genes (Pötter et al., 2002). A 
mutagenesis study in R. eutropha provided evidence that no phasins could be detected in 
a phaC deletion strain, whereas a phaC/phaR deletion strain and phaR deletion strain both 
produced a large amount of phasin proteins (York et al., 2002). Based on these findings, 
the PhaP/PhaR autoregulation model has been proposed (Parlane et al., 2017). The 
proposed mechanism of the autoregulation is as follows. Under non-PHA synthesis 
conditions, PhaR binds to the phaP promoter region and inhibits transcription. While 
under PHA synthesis conditions, PhaR binds non-covalently to the hydrophobic surface 
of newly synthesised PHA beads, reducing the concentration of PhaR in the cytoplasm 
below a threshold level for repressing the transcription of phaP. This then leads to the 
synthesis of phasins, and these proteins immediately interact with the PHA beads’ surface. 
Once the bead reaches maximum size, the bead surface is covered by phasins, preventing 
further binding of PhaR to the bead. This results in an increase in the cytoplasmic 
concentration of PhaR, which results in binding of PhaR to the phaP promoter region 
once again and prevents transcription of phaP and phaR (Pötter et al., 2002; York et al., 
2002; Grage et al., 2009). In Pseudomonas oleovorans, it has been reported that PhaF and 
PhaI have a similar regulatory function to the PhaP/PhaR autoregulation model of R. 
eutropha (Prieto et al., 1999; Parlane et al., 2017). 
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1.3.1.5 Immobilisation of functional protein on PHA beads 
Proteins for use in various biomedical applications often require purification from a 
complex protein mixture, ideally in a manner that does not affect their biological activity 
or altering their structure (Grage et al., 2009). Affinity-based purification technologies 
have been used as protein purification methods, and these utilise the specific interaction 
of a protein of interest with its corresponding solid support (Arnau et al., 2006). This 
interaction is often mediated by a genetically engineered purification tag, such as poly-
histidine, to the protein of interest. The purification tag may provide some positive effects, 
for instance, enhanced solubility and production level of the protein (Esposito & 
Chatterjee, 2006). However, the drawbacks of the purification tag are that they may affect 
the protein’s intrinsic properties, such as solubility, net charge, and protein folding 
(Waugh, 2005; Arnau et al., 2006). Enzymatic cleavage of the purification tag may 
overcome this issue (Esposito & Chatterjee, 2006), however, the protein may revert to an 
insoluble form (Waugh, 2005). Therefore, affinity-based protein purification requires 
optimisation for purification of each protein, as well as expensive enzymatic cleavage and 
multiple separation steps, making this method costly and time-consuming (Grage et al., 
2009; Parlane et al., 2017).  
Protein immobilisation to a solid material has been shown to enhance the stability and 
activity of the protein of interest (Hanefeld et al., 2013). However, conventional 
approaches of immobilisation need a purification of both the protein of interest and the 
solid material separately and then proteins attached to the solid material by non-specific 
adsorption or chemical cross-linking (Hanefeld et al., 2009). As these multiple steps are 
costly and time-consuming, it is desirable that bacteria produce the protein of interest and 
the solid material simultaneously, with the protein directly displayed on the solid material 
in vivo. The subsequent cell disruption and centrifugation can readily purify the protein 
of interest displayed on the solid material (Steinmann et al., 2010). 
In vivo produced PHA bead-based protein immobilisation and purification strategies have 
been developed as a cost-effective approach to purify proteins by genetically engineering 
bead-associated proteins on the surface of PHA beads. Among the bead-associated 
proteins, PHA synthase (PhaC), Phasin proteins (PhaP) and regulatory protein (PhaR) 
have been used for recombinant protein production and purification. (Rehm, 2007; Grage 
et al., 2009; Parlane et al., 2017). In 2005, Banki and co-workers developed a protein 
23 
 
purification method that combined intracellular PHA synthesis and intein-mediated self-
cleaving (Figure 5A). In this method, gene constructs were made to give the protein of 
interest fused to the C-terminus of PhaP from C. necator, which acts as the affinity tag to 
bind to the PHA bead. The fusion protein and PHA beads were co-produced in E. coli 
resulting in the in vivo production of the fusion protein bound to PHA beads. Subsequent 
cell disruption and centrifugation, followed by mild washing steps and self-cleavage of 
intein allowed purification of the protein of interest. This method successfully purified 
several model proteins, including maltose binding protein (MBP), β-galactosidase (LacZ), 
chloramphenicol acetyltransferase (CAT), and NusA (Banki et al., 2005). A similar 
strategy was demonstrated in C. necator by Barnard et al. (2005), and Wang et al. (2008) 
who produced PhaP tag fused with a protein of interest in vivo, and purified the PhaP tag 
fused with the protein of interest by subsequent attachment on separately synthesised 
PHA beads in vitro (Figure 5B). 
 
Figure 5: Schematic images of functionalised PHA bead production in vivo and protein 
purification via PhaP. 
 
Genetic engineering to give the fusion of green fluorescent protein (GFP) to the N-
terminus of PHA synthase (PhaC) from C. necator was also successfully shown not to 
affect PHA bead formation (Peters & Rehm, 2005). The authors subsequently 
immobilised the enzyme β-galactosidase onto PHA beads via PHA synthase from P. 
aeruginosa and showed it was highly functional with enhanced stability in comparison to 
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free β-galactosidase (Peters & Rehm, 2006). The main advantages of making gene 
constructs to give fusion proteins with PHA synthase over other bead-associated proteins 
are: (1) PHA synthase remains covalently attached to the polyester core; and (2) it allows 
a simple recombinant production system which only needs critical PHA biosynthesis 
genes (i.e. phaC, phaA, and phaB) in the recombinant cells (Grage et al., 2011). Hence, 
the protein fusions to PHA synthase are commonly targeted for protein immobilisation 
(Figure 6). 
 
Figure 6: Schematic image of functionalised PHA bead production in vivo and protein 
immobilisation via PhaC. 
 
1.3.1.6 Applications of PHA beads as bio-beads displaying functional proteins 
The increasing knowledge of structural and biochemical properties of bead-associated 
proteins has enabled genetic engineering of these proteins to provide PHA beads with 
various functional proteins attached while retaining the primary role of the bead-
associated proteins (Rehm, 2007; Grage et al., 2009; Parlane et al., 2017). Therefore, the 
bead-associated proteins serve as a versatile platform for the display of a range of 
functional proteins on the surface of beads. Figure 7 summarises the currently 
demonstrated applications of PHA beads via PHA synthase (PhaC) in various fields, and 
the following section describes several examples of PHA beads displaying functional 
proteins. 
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Figure 7: Schematic overview of immobilised functional proteins on PHA bead via PHA synthase. 
Based on Parlane et al. (2017). 
 
1.3.1.6.1 Bioseparation 
The purification of immunoglobulin G (IgG) was demonstrated by PHA beads displaying 
immunoglobulin G binding ZZ domain of protein A from Staphylococcus aureus, which 
was fused to N-terminus of the PHA synthase (Brockelbank et al., 2006). The ZZ domain-
displaying PHA beads showed efficient IgG purification from human serum and 
performed similarly to that of commercially available protein A-Sepharose 
chromatography beads with regards to purity and yield (Brockelbank et al., 2006). Also, 
a subsequent study produced ZZ domain-displaying PHA beads in the generally 
recognised-as-safe (GRAS) and endotoxin free bacterium Lactococcus lactis and Bacillus 
megaterium for antibody purification production designed for biopharmaceutical 
applications (Mifune et al., 2009; Grage et al., 2017). Similarly, streptavidin fused to C-
terminus of PHA synthase resulted in streptavidin-displaying PHA beads that were 
capable of binding biotin (Peters & Rehm, 2008). The streptavidin-displaying PHA beads 
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were successfully applied to the purification of biotinylated antibodies and DNA, as well 
as to enzyme immobilisation and flow cytometry (Peters & Rehm, 2008). 
1.3.1.6.2 Enzyme 
Since the first enzyme (β-galactosidase) immobilisation onto the PHA beads mentioned 
above (Section 1.3.1.5) (Peters & Rehm, 2006), there have been several enzymes 
immobilised onto PHA beads. Immobilisation of α-amylase by fusion to the N-terminus 
of PHA synthase (PhaC) from C. necator showed a Michaelis-Menten constant (KM) of 
5 µM and a maximum turnover rate (Vmax) of 506 mU/mg of protein which is similar to 
the free state enzyme. Moreover, the enzyme activity remained stable up to 85 °C and 
showed the capacity of repeated use in starch liquefaction process (Rasiah & Rehm, 2009). 
The organophosphate hydrolase (OpdA) from Agrobacterium radiobacter fused to the C-
terminus of the PHA synthase showed the enzyme activity of reduced catalytic constant 
(kcat) by 16.5 fold to 139 s-1 and increased KM by 1.6 fold to 2.5×10-4 M relative to the 
free enzyme, indicating reduced enzyme activity level. However, the OpdA-displaying 
PHA beads showed increased thermal stability, and the beads were capable of degrading 
organophosphorus pesticides present in the environmental conditions of wool scour 
effluent (Blatchford et al., 2012). Moreover, immobilisation of N-ethylmaleimide 
reductase (NemA) (Robins et al., 2013) and lipase B (Jahns & Rehm, 2015) to PHA 
synthase have also been shown to enhance the stability of these enzymes. 
1.3.1.6.3 Protein purification 
Similar to a protein purification system utilising phasins (PhaP) developed by Banki et al. 
(2005), a PHA synthase (PhaC) based protein purification system has also been developed. 
Recently, PHA synthase-sortase-protein of interest system has been developed as a new 
tool to produce tagless recombinant proteins (Hay et al., 2015). In this system, the 
addition of CaCl2 and triglycine activates the sortase, and the protein of interest is released. 
This system has been shown to purify soluble proteins, including green fluorescent 
protein (GFP), maltose binding protein and the tuberculosis antigen Rv1626 (Hay et al., 
2015) as well as some therapeutic proteins such as human tumour necrosis factor (TNF-
α) and human interferon α 2b (IFN-α 2b) Du & Rehm (2017b). Moreover, the PHA 
synthase-intein-protein of interest system allowed protein purification mediated by 
cleavage of the pH-sensitive intein fused to the PHA synthase (Du & Rehm, 2017a). 
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1.3.1.6.4 Vaccine 
Development of PHA beads-based vaccines utilising the biocompatibility and 
biodegradability properties of PHA beads has attracted great interest (Parlane et al., 2017). 
Several studies have demonstrated that PHA beads displaying antigens are immunogenic 
in vivo and successfully activated the immune response (Parlane et al., 2009; Parlane et 
al., 2011; Parlane et al., 2012; Martinez-Donato et al., 2016; Reyes et al., 2016; Lee et 
al., 2017a; Lee et al., 2017b). It is critical to select an appropriate strain to produce PHA 
beads displaying the desired antigen, especially for vaccine production. This is due to the 
potential presence of endotoxin in the PHA beads produced in E. coli. Therefore, L. lactis 
or ClearcoliTM BL21 (DE3) cells are often used as alternative strains to produce the PHA 
beads for vaccine purposes due to the lack of endotoxin production in these bacterium 
(Mifune et al., 2009; Parlane et al., 2012; Reyes et al., 2016). In addition, Lee and co-
workers used the target microbe as the production host (P. aeruginosa) to make its own 
antigen-displaying PHA bead vaccine and showed that this activated cellular immunity 
in mice (Lee et al., 2017b). 
1.3.1.7 Application of PHAs 
PHA polymers have been shown to have a variety of applications. There is increased 
recognition of global environmental issues caused by synthetic non-degradable polymers, 
thus, PHA has been gaining attention as a potential substitute to replace synthetic 
polymers (Keshavarz & Roy, 2010). Currently, there has been a number of products made 
from PHAs, including bags, containers as well as coatings and packagings (Keshavarz & 
Roy, 2010; Muhammadi et al., 2015; Keskin et al., 2017). Moreover, there have been 
extensive studies to blend PHAs with other polymers to give new plastic properties. The 
blending changes the crystallinity and the crystallisation rate of the plastic, and ultimately 
changes the mechanical property of the material (Sharma & Ray, 1995; Muhammadi et 
al., 2015). For instance, the blending of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) 
(PHBV) and thermoplastic polyurethane improved the mechanical and barrier properties, 
as well as increased water vapour permeability of PHBV (Martinez-Abad et al., 2016; 
Keskin et al., 2017).  
In the medical field, PHAs have received great attention since the polymer is 
biocompatible and biodegradable. PHB is known to be present in the blood (Reddy et al., 
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2003) and the cell membrane of eukaryotes (Reusch, 2000). Thus, the biocompatible 
property allows PHAs to be used in various biomedical applications. For example, PHAs 
have been applied in wound management such as surgical sutures, implants, and swabs, 
as well as three-dimensional tissue scaffolding and drug delivery carriers (Muhammadi 
et al., 2015). However, currently, there are still some limitations in the application of 
PHAs in the medical and pharmaceutical fields. This is due to their low tensile strength, 
minimal cell interaction capacity, and slow biodegradation and high hydraulic stability in 
sterile tissues (Wang & Bakken, 1998; Muhammadi et al., 2015; Manavitehrani et al., 
2016). To overcome these issues, PHAs have been blended with other polymers, had 
inorganic compounds added, and been modified through chemical or physical 
modifications (Manavitehrani et al., 2016).  
PHAs have also been shown to have applications in water and wastewater treatment. It 
has been shown that PHAs can serve as the solid substrate, termed “solid-phase 
denitrification”, to denitrify water and wastewater (Muhammadi et al., 2015). There are 
several advantages of using PHAs in this method. They are: (1) PHAs have no potential 
risk of releasing dissolved organic carbons to cause deterioration of effluent quality; (2) 
PHAs serve as solid matrices for the development of microbial biofilms for bacterial 
denitrification; (3) the system is controlable as the biofilm is washed out  when the supply 
of PHAs are used up; and (4) PHAs are subsequently degraded by PHA-degrading 
bacteria (Hiraishi & Khan, 2003). Moreover, the hydrophobic property of PHAs has been 
shown to have applications in removal of lipophilic organic pollutants from water 
(Muhammadi et al., 2015). Zang and co-workers produced a biomimetic adsorbent, 
named PHBMA, prepared with PHB by a modified double emulsion solvent evaporation 
method, and demonstrated adsorption of a lipophilic organochlorine compound 
(chlorobenzene and o-nitrochlorobenzene) from wastewater (Zhang et al., 2010a; Zhang 
et al., 2010b). Similarly, Sudesh and co-workers developed PHA films that were excellent 
at absorbing oil, suitable for their application of the removal of lipophilic substances 
(Sudesh et al., 2007). 
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1.4 Significance of this study 
As described above,  the PHA bead technology as a versatile platform to immobilise and 
display functional proteins is an attractive new tool for protein immobilisation. Although 
several studies have shown the effectiveness of utilising the technology, the state of the 
bead in a reaction medium may influence the level of the bead functionality. In any 
suspensions that PHA beads were dispersed, the beads have often been shown to form 
undesirable aggregates. As the functionality of the beads depends on the exposure of the 
functional protein on the bead to the outer environment, the formation of  aggregates may 
limit the functionality level of the proteins. In addition, the bead would form a rigid 
precipitation in a stock medium during long time storage. A sonication and/or mechanical 
homogeniser may be applied to separate the beads from the aggregates, however, the 
protein on the surface may be damaged or degraded leading to the loss of its functionality. 
To address this, encapsulation techniques have been used to immobilise the beads within 
a polymer matrix to prevent further formation of bead aggregates. The encapsulation 
techniques have been extensively studied in drug delivery applications, however recent 
interest is to entrap and then immobilise materials of interest, such as cells, within a 
polymer matrix. As described above, the polymer matrix functions to immobilise as well 
as to form a three-dimensional scaffolding to support the materials encapsulated within. 
In addition, it also provides a controlled and supportive environment inside, with a barrier 
against several environmental factors for the encapsulated material to function effectively. 
Therefore, encapsulating PHA beads in a polymer matrix is expected to retain the 
dispersity and functionality of the  bead within the polymer matrix. 
 
PHAs have been applied to the removal of lipophilic organic pollutants from water. 
Therefore, utilising PHA in the bead from for this application has an advantage due to the 
size of the bead, which provides a higher specific surface area.  However, a single PHA 
bead is hard to control due to its small particle size. For this reason, the immobilisation 
of PHA beads in an alginate hydrogel matrix would potentially have considerable 
advantages over existing materials.  
 
The polymer material used in this study was alginate. Alginate has been shown to 
encapsulate a wide range of materials, as well as its favourable property of gelling under 
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mild conditions that should not adversely affect the activity of the protein displayed on 
the PHA beads during the hybrid material production.  
 
1.5 Aim and objectives 
The main aim of this study was to encapsulate PHA beads in an alginate hydrogel matrix 
by the ionotropic gelation method and assess the functionality of the hybrid material. To 
investigate this novel approach, this study aimed to encapsulate three different types of 
PHA beads within alginate hydrogels and assess their functionality. This study was 
divided into three distinct parts, which aimed to: 
 
1. Encapsulate PHA beads displaying IgG binding domain in alginate microspheres 
and asess the functionality of the hybrid material, focusing on the IgG binding 
ability to the binding domain displayed on the PHA beads in the alginate polymer 
matrix. 
2. Encapsulate PHA beads displaying OpdA (an organophosphate hydrolase) in 
alginate microspheres and asess the functionality of the hybrid material, focusing 
on the enzymatic activity of the fusion protein displayed on the PHA beads in the 
alginate polymer matrix. 
3. Encapsulate PHA beads in alginate millispheres as a payload for lipophilic 
substances and assess the removal of a lipophilic substance from aqueous solution.  
 
 
 
 
1.5.1 Alginate encapsulation of PHA beads displaying IgG binding domain 
To achieve the first aim, the following objectives were planned:  
• Production and purification of PHA beads:  
I. Use pPolyC (Hay et al., 2017) and pET-14b zz(-) phaC (Brockelbank et 
al., 2006) to transform a production E. coli strain, BL21 (DE3) harbouring 
pMCS69 (Amara & Rehm, 2003).  
II. Culture the transformed production strain under PHA accumulating 
conditions, and then isolate and purify the PHA beads. 
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• PHA bead characterisations and functional assessment: 
I. Characterise the morphology of E. coli cells accumulating PHA beads and 
isolated PHA beads by fluorescent microscopy, transmission electron 
microscopy (TEM), and scanning electron microscopy (SEM).  
II. Measure the particle size distribution by laser diffraction. 
III. Evaluate the fusion protein on PHA beads by sodium dodecyl sulfate 
polyacrylamide (SDS-PAGE). 
IV. Assess the IgG binding capacity of the fusion protein displayed on the 
PHA beads by IgG binding capacity assay (Brockelbank et al., 2006). 
• Production of PHA beads encapsulated in alginate microspheres: 
I. Encapsulate PHA beads in alginate microspheres using a water-in-oil 
(w/o) emulsion with internal gelation method. Subsequently, recover the 
alginate microspheres from the emulsion and further cross-link through 
exposure to a CaCl2 cross-linking solution (double gelation). 
• Characterisation of the microspheres: 
I. Assess the morphology by phase contrast microscopy, fluorescence 
microscopy and SEM, and particle size distribution by laser diffraction 
method.  
II. Assess the encapsulation efficiency of PHA beads in alginate 
microspheres by the combination of bicinchoninic acid (BCA) assay, 
SDS-PAGE, and calculate the amount of the PhaC derived protein on PHA 
beads. 
III. Assess the difference in particle size in different solutions by laser 
diffraction method. 
 
• Functional assessment of the microspheres: 
I. Assess the IgG binding capacity of the alginate encapsulated PHA beads 
by IgG binding capacity assay in batch and column conditions.  
II. Quantify the bound IgG on PhaC derived protein on PHA bead by SDS-
PAGE gel densitometry using BSA and IgG as the standard. 
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1.5.2 Alginate encapsulation of PHA beads displaying OpdA in alginate 
microspheres 
To achieve the second aim, the following objectives were planned: 
• Production and purification of PHA beads: 
I. Use pPolyC (Hay et al., 2017) and pET-14b PhaC-linker-OpdA 
(Blatchford et al., 2012) to transform a production E. coli strain, BL21 
(DE3) harbouring pMCS69 (Amara & Rehm, 2003).  
II. Culture the transformed production strain under PHA beads accumulating 
conditions, and then isolate and purify the PHA beads. 
• PHA bead characterisations 
I. Characterise morphology of E. coli cells accumulating PHA beads and 
isolated PHA beads by fluorescent microscopy, transmission electron 
microscopy (TEM), and scanning electron microscopy (SEM).  
II. Measure the particle size distribution by laser diffraction. 
III. Evaluate the fusion protein on PHA beads by sodium dodecyl sulfate 
polyacrylamide (SDS-PAGE). 
• Production of PHA beads encapsulated in alginate microspheres: 
I. Encapsulate PHA beads in alginate microspheres using a water-in-oil 
(w/o) emulsion with internal gelation method. 
• Characterisation of the microspheres: 
I. Assess the morphology by phase contrast microscopy, fluorescence 
microscopy and SEM, and particle size by laser diffraction.  
II. Assess the encapsulation efficiency of PHA beads in alginate 
microspheres by the combination of BCA assay, SDS-PAGE, and 
calculate the amount of the PhaC derived protein on PHA beads. 
• Functional assessment: 
I. Assess the enzyme activity by measuring the change in fluorescence 
caused by the liberation of enzymatic product. 
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1.5.3 Alginate encapsulation of PHA beads as a lipophilic adsorbent 
To achieve the third aim, the following objectives were planned: 
• Production of PHA beads encapsulated in alginate millispheres:  
I. Encapsulate pPolyC PHA beads obtained in the first objective of the first 
aim (Section 1.5.1) in alginate millisphere by dripping droplets of a 
mixture containing alginate and PHA beads into CaCl2 cross-linking 
solution. 
• Characterisation of the beads: 
I. Assess the morphology on appearance, diameter, and wet weight. Assess 
the proportion of PHA in the alginate millispheres by the combination of 
BCA assay, SDS-PAGE, and then calculate the amount of PhaC protein 
on PHA beads. 
• Functional assessment: 
I. Assess the adsorption capability of PHA beads in alginate millisphere to 
adsorb a lipophilic dye, Nile red, from an aqueous solution, and determine 
the residual concentration of Nile red in the solution by measuring the 
level of fluorescent intensity. Also, assess the effect of alginate 
concentrations, calcium ion concentrations, and PHA bead concentration  
used in the preparation on adsorption kinetic and isotherm of the 
millispheres. 
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Chapter 2: Materials and Methods 
Unless indicated, all reagents were purchased from Sigma-Aldrich, Ajax Finechem, or 
Merck and used without further purification.  
 
All shaking incubations at 37ºC were conducted on a Thermoline Scientific (Australia) 
model TLM-530 Chest orbital shaker. 
 
2.1 Bacterial strains and plasmids 
The bacterial strains and plasmids used in this study are listed in Table 1 and Table 2: 
Table 1: Bacterial strains used in this study. 
E.coli strains Relevant characteristics References/ Supplier 
BL21 (DE3) F- ompT hsdS(rB- mB-) dcm+ 
Tetrgal λ(DE3) endA Hte 
Stratagene 
XL1-Blue recA1 endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 lac [F´ 
proAB lacIqZ∆M15 Tn10 Tetr] 
Stratagene 
Tetr, tetracycline resistance   
 
 
 
 
 
 
 
 
 
 
 
 
35 
 
Table 2: Plasmids used in this study. 
Plasmid name Relevant characteristics References/ Supplier 
pET-14b Apr; T7 promoter; His-6tag Novagen 
pPolyC Apr; T7 promoter, pET-14b 
derivative containing phaC gene 
fragment with a C-terminal 
linker 
Hay et al. (2017) 
pET-14b zz(-)phaC Apr; T7 promoter pET-14b 
derivative containing zz gene 
fragment fused to 5’ end of phaC 
without a signal sequence 
encoding region 
Brockelbank et al. (2006) 
pET-14b phaC-linker-OpdA Apr; T7 promoter, pET-14b 
derivative containing opdA gene 
fragment fused to the 3’ end of 
phaC via a linker sequence 
Blatchford et al. (2012) 
pMCS69 Cmr; T7 promoter; pBBR1MCS 
derivative containing codon 
optimised genes phaA and phaB 
from C. necator 
Amara & Rehm (2003) 
Apr, Ampicillin resistance; Cmr, Chloramphenicol resistance 
 
2.2 Primers 
Primers used in this study are listed in Table 3 and were used to confirm the DNA 
sequence of plasmids.  
Table 3: Primers used in this study. 
Primer name Sequence from 5’ to 3’ References/ Supplier 
T7_promoter TAATACGACTCACTATAGGG Allan Wilson Centre 
T7_terminator GCTAGTTATTGCTCAGCGG Integrated DNA 
Technologies (IDT) 
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2.3 Alginate 
Medium viscosity alginic acid (sodium salt) from brown algae (A2033) was purchased 
from Sigma-Aldrich (USA). According to the manufacturer, the molecular weight of the 
alginate ranges between 80,000-120,000 Da, and the typical content of mannuronic acid 
(M) and guluronic acid (G) is approximately 61% and 39% respectively (M/G ratio of 
1.56). The viscosity is ≥2,000 cP at 2% w/v in water at 25°C. 
2.4 Media 
2.4.1 Liquid media 
Luria-Bertani (LB) medium (Neogen Corporation, USA) was prepared by adding 20 g 
per litre of distilled water and autoclaved at 121°C for 20 minutes. 
2.4.2 Solid media 
LB agar was prepared by adding agar (Neogen Corporation, USA) to 1.5 g per 100 ml 
LB medium and autoclaved at 121°C for 20 minutes. 
2.5 Antibiotic stocks and concentrations 
Antibiotics used in this study are listed below. They were sterilised by filtration using a 
0.22 µm filter and stored at -20ºC for future use. For the preparation of solid media 
supplemented with an appropriate antibiotic, autoclaved solid media (Section 2.4.2) was 
cooled to approximately 50ºC before adding the antibiotic at the concentration outlined 
below. Antibiotics were added at 1 µl stock/1 ml medium. 
 
Antibiotics Stock concentration Final concentration 
Ampicillin (Sodium salt) 100 mg/ml in Milli-Q water 100 µg/ml 
Chloramphenicol 50 mg/ml in absolute ethanol 50 µg/ml 
 
2.6 Cultivation conditions 
Cultivation of E. coli cells was performed in Erlenmeyer flasks containing sterile liquid 
LB medium supplemented with appropriate antibiotics and a carbon source. The flask 
was plugged with cotton wool plug. The culture was incubated at 37ºC with shaking at 
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200 rpm. The ratio of the flask to liquid medium volume was kept at 5:1 to maximise 
aeration. 
2.6.1 PHA bead production in E. coli 
Conditions for PHA bead production in vivo was performed as previously described 
(Hooks et al., 2013). Recombinant pET expression vectors were used to transform E. coli 
BL 21 (DE3) production strain harbouring pMCS69 and incubated (Section 2.6) to 
provide overnight pre-cultures. This overnight pre-cultures was inoculated at 2% v/v into 
1 L sterile LB medium supplemented with 1% v/v glucose, 100 µg/ml ampicillin, and 50 
µg/ml chloramphenicol. This culture was incubated at 37ºC with shaking at 200 rpm for 
approximately 2 to 3 hours until the OD600 reached 0.4-0.5. IPTG was then added to the 
culture to a final concentration of 1 mM to induce gene expression and incubation 
continued at 25ºC for 48 hours with shaking at 200 rpm (TR225, INFOS HT, Switzerland). 
 
 Stock concentration Final concentration 
IPTG 1 M in Milli-Q water 1 mM 
D-Glucose 25% w/v in Milli-Q water 1% v/v 
 
2.7 Long-term storage of bacterial strains 
E. coli cells were incubated overnight in sterile LB medium containing appropriate 
antibiotics at 37ºC with shaking at 200 rpm. 1 ml of the overnight culture was mixed with 
70 µl of filtrated dimethylsulfoxide (DMSO) in a 2 ml cryovial tube to give a final 
concentration of 6.5% v/v and stored at -80ºC for future use. 
2.8 Revival of bacterial strains 
The revival of E. coli cells was performed by removing a small chip from the frozen stock 
using a sterile pipette tip or a sterile inoculation loop, and inoculating into sterile LB 
liquid medium (Section 2.4.1) supplemented with appropriate antibiotics. The inoculated 
medium was incubated overnight at 37ºC with shaking at 200 rpm. 
2.9 Competent cells preparation 
Competent E. coli cells were prepared as described elsewhere (Hanahan, 1983). 50 ml of 
sterile LB medium (Section 2.4.1) was inoculated with 2% (1 ml) inoculum of an 
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overnight culture and incubated at 37ºC with shaking at 200 rpm until OD600 reached 
approximately 0.35. The cell culture was subsequently stored on ice for 15 minutes and 
harvested by centrifugation at 8,000×g for 15 minutes. The cell sediment was re-
suspended in 16 ml of RF1 solution and incubated on ice for a further 30 minutes. Cells 
were then harvested again by centrifugation at 8,000×g for 15 minutes and re-suspended 
in 4 ml of RF2 solution. For future use, 200 µl of competent cells were aliquoted into 
microfuge tubes and stored at -80ºC. The composition of RF1 and RF2 solutions are 
outlined below: 
 
RF1 solution:  
RbCl 100 mM 
MnCl2 50 mM 
Potassium acetate 30 mM 
CaCl2·6H2O 10 mM 
pH adjusted to pH 5.8 using acetic acid  
  
RF2 solution:  
RbCl 10 mM 
MOPS 10 mM 
CaCl2·6H2O 75 mM 
Glycerol 15 mM 
pH adjusted to pH 5.8 using NaOH  
RF 1 and RF2 were sterilised by filtration using a 0.22 µm filter. 
2.10 Plasmid isolation and DNA sequencing 
2.10.1 High Pure Plasmid isolation kit 
Plasmid isolation was performed by using the High Pure Plasmid isolation kit (Roche, 
Switzerland) according to the manufacturer’s instructions. 
2.10.2 Determination of plasmid concentration 
Plasmid concentration was measured using NanoDrop 1000 (Thermo Fisher Scientific, 
USA) according to the manufacturer’s instructions. 
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2.10.3 DNA sequencing 
DNA sequencing of the plasmids was performed by the Massey Genome Service in 
Massey University, Palmerston North, New Zealand.  
2.11 Transformation of E. coli 
The frozen E. coli competent cells were allowed to warm from storage at -80 ºC (Section 
2.9) on ice for 40 minutes. Subsequently, 3 µl of purified plasmid DNA was added and 
mixed thoroughly with the aliquot of competent cells, and then the mixture was incubated 
on ice for 20 minutes. To promote the uptake of the plasmid DNA into the cells, the 
mixture was gently mixed and heat-shocked at 42ºC for 90 seconds then immediately 
incubated on ice for 5 minutes. Cells were regenerated by adding 800 µl of sterile liquid 
LB medium (Section 2.4.1) and incubated at 37ºC for one hour. For the selection and 
isolation of transformants, 100 µl of the cell culture was spread on solid LB agar medium 
(Section 2.4.2) supplemented with appropriate antibiotics (Section 2.5). To maximise the 
yield of transformants, the remaining cells were collected by centrifugation at 6,000×g 
for 2 minutes using a Haeraeus™ Pico™ 17 (Thermo Fisher Scientific, USA), and re-
suspended in 100 µl of sterile LB medium and plated on fresh solid LB agar medium 
containing appropriate antibiotics. The plates were incubated at 37ºC overnight. To make 
a frozen stock, a colony on the plate was inoculated into sterile LB medium supplemented 
with appropriate antibiotics and incubated overnight. The overnight culture was treated 
as described in Section 2.7.  
2.12 PHA beads isolation and purification 
2.12.1 Cell harvest 
After 48 hours of culturing and PHA bead production at 25˚C (Section 2.6.1), cells were 
collected by centrifugation at 6,000×g for 20 minutes at 4˚C using a Sorvall RC-6+ 
(Thermo Scientific, USA). Before the centrifugation, 1ml of the cell culture was taken 
into centrifuge tubes for microscopy analysis (Section 2.13.1). The cell pellet was frozen 
at -20˚C overnight before completing a cell disruption procedure (Section 2.12.2). 
2.12.2 Mechanical cell disruption 
To extract PHA beads from E. coli cells, a Microfluidizer® (M110-P: Microfluidics, 
USA) was used. The frozen cell sediment (Section 2.12.1) was thawed at room 
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temperature and suspended completely in 0.5×lysis buffer, at 10% w/v concentration, 
using a homogeniser (MICCRA D-9: MICCRA, Germany). The mixture was then 
subjected to a mechanical cell disruption procedure with the Microfluidizer (Z type 
chamber) for 3 passes at 20,000 psi. The crude cell lysate was centrifuged at 9,000×g for 
30 minutes at 4˚C. The pellet was washed once with the lysis buffer and then the beads 
purified as described in Section 2.12.3. The composition of the lysis buffer is outlined 
below: 
 
0.5×Lysis buffer:  
Tris 25 mM 
EDTA 5 mM 
SDS 0.04% w/v 
pH adjusted to pH 9.5 using NaOH  
 
2.12.3 Purification of PHA beads  
PHA beads in the crude cell lysate (Section 2.12.2) were purified by the inclusion body 
purification method as described in Palmer & Wingfield (2012). PHA beads were re-
suspended in 2M urea wash buffer at 10 % w/v concentration. The suspension was mixed 
well and homogenised for one minute using a MICCRA D-9 then PHA beads were 
collected by centrifugation at 9,000×g for 30 minutes at 4ºC. This procedure was repeated 
three times. Subsequently, the pellet containing the PHA beads was re-suspended in 70% 
ethanol at 10% w/v and incubated at room temperature with shaking overnight. The 
composition of the urea wash buffer is outlined below: 
 
2 M Urea wash buffer:  
Tris 100 mM 
EDTA 5 mM 
Urea 2 M 
Triton X-100 2% v/v 
pH adjusted to pH 9.5 using NaOH  
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2.12.4 PHA beads storage 
After purification (Section 2.12.3), PHA beads were washed once with sterile Milli-Q 
water and then centrifuged at 9,000×g for 30 minutes at 4˚C. The PHA bead pellet was 
re-suspended in sterile Milli-Q water and stored at 15% w/v concentration at 4˚C for 
future use. 
2.13 PHA beads characterisation 
2.13.1 Detection of PHA beads in E. coli cells 
2.13.1.1 Nile-red staining 
The presence of PHA beads in cells was detected by a Nile-red staining method as 
previously described (Spiekermann et al., 1999). Cell culture (1 ml) (Section 2.12.1) was 
harvested by centrifugation at 6,000×g for 5 minutes, and the supernatant was carefully 
removed. The cell pellet was mixed with 10 µl of Nile-red solution (0.25 mg/ml in 
DMSO), followed by the addition of 1 ml of 50 mM potassium phosphate buffer (pH 7.5) 
and mixed thoroughly. The mixture was then incubated in a dark room at room 
temperature for 15 minutes. After the incubation, the cells were harvested by 
centrifugation at 6,000×g for 5 minutes and washed once with 1 ml of 50 mM potassium 
phosphate buffer. The cell pellet was re-suspended in 1 ml of 50 mM potassium phosphate 
buffer, and 10 µl spotted on a glass slide and covered by a coverslip. The slide was 
analysed by fluorescent microscopy (Section 2.13.1.2).  
 
50 mM potassium phosphate buffer:  
K2HPO4 (Alkaline) 50 mM 
KH2PO4 (Acidic) 50 mM 
pH of K2HPO4 adjusted to pH 7.5 using KH2PO4 
 
2.13.1.2 Fluorescence microscopy 
Fluorescent microscopy was used to detect PHA beads in E.coli cells after staining by 
Nile-red (Peters et al., 2007). The glass slide prepared in Section 2.13.1.1 was examined 
with an Olympus BX51 Fluorescence Light Microscope (Olympus, Japan) under 1,000× 
magnification with a U-MWIG2 filter unit (Ex. 520-550 nm; Em. 580 nm; Dichromatic 
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mirror 565 nm). Images were captured using MicroPublisher™ 5.0 RTV and analysed by 
Q-Capture Pro7 software (QImaging, Canada). 
2.13.2 Transmission and Scanning electron microscopy 
Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) 
images were taken at the Manawatu Microscopy and Imaging Centre (MMIC, Massey 
University, Palmerston North, New Zealand). The samples were prepared by centrifuging 
0.5 to 1 ml of sample (Section 2.12.1 and 2.12.4) in a microfuge tube, and a small pellet 
was sent to the MMIC. All subsequent processing on the samples was done by the MMIC. 
2.13.3 Particle size analysis 
The particle size distribution of PHA beads in the storage solution (Section 2.12.4) was 
measured by laser diffraction using a Mastersizer 3000 (Malvern Instruments, UK). The 
Mastersizer 3000 was equipped with an Hydro small volume sample dispersion unit and 
a dispersion unit controller (Malvern Instruments, UK). The particle refractive index of 
the PHA beads and the dispersion refractive index of water were set to 1.50 and 1.33, 
respectively. The particle absorption index of PHA beads was set to 0.01. The obscuration 
factor was set between 5-15% and aimed at 10%. The dispersion unit controller was set 
to 2,000 rpm. The particle size analysis was based on the Mie scattering model. 
2.14 General methods for protein analysis 
2.14.1 Determination of protein profile 
2.14.1.1 Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
2.14.1.1.1 SDS-PAGE gel preparation 
Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
in a vertical slab gel to evaluate and characterise protein samples. Each gel consisted of 
two layers with a separating gel (10% w/v polyacrylamide, pH 8.9) at the bottom and a 
stacking gel (4% w/v polyacrylamide, pH 6.8) on the top. The gel was made in Mini 
PROTEAN® glass plates (Bio-Rad Laboratories, USA, 1.0 mm thick gel). The separating 
gel solution was prepared and a few milligrams of Na2SO3 was added to help remove O2 
from the solution. The polymerisation was initiated by adding 30 µl of 40% w/v 
ammonium persulfate (APS) solution and 28 µl of N, N, N’, N’–tetramethylethyl-
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endiamin (TEMED) while mixing. The mixture was gently poured into the glass plates 
and a layer of isopropanol immediately added to the top of the gel. The gel was left for 
approximately one hour to complete the polymerisation. Once the gel had set, the 
isopropanol was removed and the gel washed once with Milli-Q water and drained using 
a paper towel. The composition of the separating gel (10% w/v) is outlined below: 
 
3.5×Bis-tris gel buffer:  
Bis-tris 1.25 M 
pH adjusted to pH 6.5 using HCl  
 
Separating gel (10% w/v): (For four gels) 
3.5×Bis-tris gel buffer 11.44 ml 
30% Acrylamide 13.32 ml 
Milli-Q water 15.24 ml 
 
Ammonium persulfate (40% w/v), APS:  
APS 4 g 
Milli-Q water Make to 10 ml 
 
The stacking gel solution was prepared and a few milligrams of Na2SO3 added to help 
remove O2 from the solution. While mixing, 17 µl of 40% w/v APS and 19 µl of TEMED 
were added to initiate polymerisation. The solution was gently poured onto the separating 
gel. A plastic comb was immediately inserted into the glass plates to form wells. The gel 
was left for approximately 30 minutes to complete the polymerisation. The composition 
of stacking gel (4% w/v) is outlined below: 
 
Stacking gel (4% w/v):  
3.5×Bis-tris gel buffer 2.9 ml 
30% Acrylamide 1.5 ml 
Milli-Q water 5.6 ml 
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2.14.1.1.2 Protein sample preparation for SDS-PAGE and electrophoresis 
conditions 
SDS-PAGE sample preparation used 30 µl of a solution containing 33-50 µg (wet weight) 
of whole cell or PHA beads. Two volumes of protein solution were mixed with one 
volume of 3×SDS denaturing buffer in a microfuge tube and incubated on a heating block 
at 95ºC for 15 minutes. The denatured protein sample was then centrifuged at 17,000×g 
for 5 minutes to collect the polyester beads before loading onto the gel. GangNam-
STAIN™ prestained protein ladder (iNtRON Biotechnology, Korea) was also loaded 
onto the gel and used for estimating the molecular weight of proteins on the gel. Running 
buffer was added to the electrophoresis tank. The electrophoresis conditions were electric 
current at a fixed 1,000 mA and voltage at 150 V until the loading dye had reached the 
end of the gel, which takes approximately 1 hour. The composition of 3×SDS denaturing 
buffer, 5×High molecular weight running buffer, and 200×Reducing agent are outlined 
below: 
 
3×SDS denaturing loading buffer:  
Tris 100 mM 
SDS 8.0 g 
EDTA 37.2 mg 
Glycerol 40 ml 
β-mercaptoethanol 20 ml 
Bromothymol blue 10.0 mg 
Milli-Q water Make to 100 ml 
pH adjusted to pH6.8 using HCl  
 
5×High molecular weight running buffer:  
MOPS 250 mM 
Tris 250 mM 
SDS 0.5 w/v 
EDTA 5 mM 
 
200×Reducing agent:  
Sodium bisulfite 1 M 
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Running buffer:  
5x High molecular weight running buffer 100 ml 
200x Reducing agent 2.5 ml 
Milli-Q water Make to 500 ml 
 
Protein marker Molecular weights (kDa) 
Gangnam-STAIN prestained protein ladder 235, 170, 130, 93, 72, 53, 41, 30, 22, 18, 14, 9 
Note: Molecular weights are in Bis-Tris 10 % MOPS buffer condition 
 
2.14.1.1.3 Protein staining with Coomassie blue and destaining 
The SDS-PAGE gel was carefully removed from the glass plates and stained with 
Coomassie brilliant blue staining solution for 15 minutes on a tilt shaker. After staining, 
the gel was washed with distilled water and then destained using destaining solution until 
protein bands were visible and the background stain was removed. The GEL-DOC 2000 
(Bio-Rad Laboratories, USA) and Image Lab software (Bio-Rad Laboratories, USA) 
were used to obtain and to analyse the gel image. 
 
Coomassie brilliant blue staining solution:  
Coomassie blue R-250 4 g 
Ethanol 450 ml 
Acetic acid 90 ml 
Distilled water 460 ml 
 
Destaining solution:  
Ethanol 600 ml 
Acetic acid 200 ml 
Distilled water 1,200 ml 
 
2.14.1.1.4 Densitometry 
Densitometry was used to determine the percentage of the fusion (PhaC derived) protein 
on the PHA beads from the total proteins in the bead suspension. Each SDS-PAGE gel 
image was analysed using Image Lab software (Bio-Rad Laboratories, USA). 
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2.14.2 Determination of protein concentration 
2.14.2.1 Gel densitometry 
Densitometry of SDS-PAGE gels was used to quantify the protein on the surface of PHA 
beads based on a serially diluted bovine serum albumin as the standard. PHA bead 
suspension was prepared at 5 µg/µl (0.5% w/v) bead concentration in a microfuge tube 
and eventually 3.33 µg/µl concentration after addition of 3×SDS denaturing loading 
buffer (Section 2.14.1.1.2). Bovine serum albumin (BSA: Thermo Fisher Scientific, 
USA) was prepared at 75 ng/µl then 50 ng/µl after addition of the loading buffer. Into the 
well of SDS-PAGE gel, BSA was loaded from 50-500 ng. PHA beads were loaded from 
10-40 µg of PHA beads into the well. The sample preparation and conditions of SDS-
PAGE were followed as described in Section 2.14.1.1.2. The amount of protein displayed 
on the surface of PHA beads was determined from a standard curve prepared from known 
BSA protein amounts shown on the gel. Similarly, the quantity of human IgG was 
determined on the SDS-PAGE gel using serially diluted human IgG (Equitech-Bio, USA) 
as a standard. Human IgG was prepared at 375 ng/µl then 250 ng/µl after addition of 
3×SDS denaturing loading buffer. The quantity of human IgG bound per unit of protein 
was determined from a standard curve prepared from 250-2,500 ng of human IgG on the 
SDS-PAGE gel. 
2.14.2.2 Bradford assay 
Protein concentration in a suspension was determined using the Bradford assay method. 
10 µl of standard or sample were prepared in a flat bottom well microtitre plate (Greiner 
Bio-One, Austria). A known concentration of serially diluted bovine serum albumin 
(BSA) or IgG (Equitech-Bio, USA) was used as the standard for the assay. Into each well 
containing 10 µl of standard or sample, 200 µl of filtered Bradford reagent was added. 
The plate was then incubated in the dark at room temperature for 5 minutes for colour 
development. After the incubation, the absorbance was measured at λ=595 nm using 
ELx808iu ultra microtiter plate reader (BIO-TEK Instruments Inc., USA). Protein 
concentration in the sample was determined from a standard curve. For the standard curve, 
BSA was prepared at 0.05-0.4 mg/ml, and IgG was prepared at 0.05-0.8 mg/ml.  
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2.14.2.3 Bicinchoninic acid (BCA) assay 
The total protein concentration in PHA bead suspension was determined using BCA assay. 
The Pierse™ BCA protein assay kit (Thermo Fisher Scientific, USA) was used according 
to the manufacturer’s instructions. A known concentration of BSA was used as the 
standard for this assay. PHA bead suspension was prepared to 2.5-10% w/v slurry. 60 µl 
of standard or sample was prepared in a microfuge tube, and then 480 µl of working 
solution was added. The tube was incubated at 37ºC for 30 minutes on an orbital rotator. 
After the incubation, the tube was centrifuged at 17,000×g for 5 minutes to pellet PHA 
beads. The supernatant fluid (200 µl) was transferred to a flat bottom well microtitre plate 
(Greiner Bio-One, Austria) and the absorbance was measured at λ=562nm by ELx808iu 
ultra microtiter plate reader (BIO-TEK Instruments Inc., USA). Protein concentration in 
the sample was determined from a standard curve prepared with known concentrations of 
BSA ranging from 0.125-2.0 mg/ml. 
2.15 Assessment of the activity of fusion protein displayed on PHA beads 
Determination of the activity of fusion protein displayed on the surface of PHA beads is 
described in Section 2.17.2. 
2.16 Preparation of PHA beads encapsulated in alginate microspheres 
2.16.1 Alginate solution preparation 
Medium viscosity sodium alginate (Section 2.3) solution was prepared at 2.5% w/v in 
sterile Milli-Q water. Dried sodium alginate was mixed with sterile Milli-Q water in a 
sterile beaker and stirred with a magnetic stirrer. The alginate solution was heated and 
stirred at 80ºC until the dried alginate was fully dissolved. Once it had completely 
dissolved, the heat was turned off and the mixture stirred overnight at room temperature 
to ensure complete re-hydration. The alginate solution was then stored at 4ºC for future 
use. Alginate solution was equilibrated to room temperature before using for alginate 
sphere production. 
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2.16.2 Internal gelation 
PHA beads encapsulated in alginate microspheres were produced by the water-in-oil 
(w/o) emulsion technique with internal gelation as described by Silva et al. (2005). 
Alginate solution prepared in Section 2.16.1 was mixed with a 15% w/v PHA bead 
suspension to produce the alginate-PHA bead mixture. Into this mixture, CaCO3 (May & 
Baker, UK) solution (100 mg/ml) was also added to give final concentrations of each 
component in the mixture of 2% w/v alginate, 2% w/v PHA beads and 40 mM CaCO3. 
For making blank alginate microspheres, an equal volume of sterile Milli-Q water was 
added instead of PHA bead suspension. The mixture was homogenised for 1 minute with 
a blade homogeniser (MSE, UK). The mixture was then dispersed into paraffin liquid 
(Paraffin liquid, water white, general purpose grade, Thermo Fisher Scientific, USA) 
containing Span 80 (Span 80 viscosity 1,000-2,000 mPa.s at 20ºC), a lipophilic surfactant, 
at 1% v/v by stirring at a preselected speed (Table 4) using a homogeniser equipped with 
blades (MSE, UK). The stirring speed of the homogeniser was monitored using a light 
tachometer (461895: EXTECH, USA). The w/o ratio was kept constant at 30/70 ratio (30 
ml water phase and 70 ml oil phase, in total 100ml) throughout this study. After 
emulsifying for 15 minutes, glacial acetic acid was added at 2.5 molar ratio of acid/Ca2+  
into the emulsion to reduce the pH in the water phase. An additional 15 minutes stirring 
was completed to ensure gelation. The oil dispersed alginate microspheres were recovered 
by washing with 100 mM acetate buffer (pH 5.5) and centrifuging by Centrifuge 5702 
(Eppendorf, Germany) at 2,000×g for 15 minutes. The washing was continued until no 
more oil was detected under an optical microscope. After the acetate buffer washing, the 
microspheres were washed twice with sterile Milli-Q water. The microspheres were then 
dispersed in Milli-Q water and incubated at 4ºC overnight with tilt shaking to equilibrate 
the suspension. The microspheres were then collected by centrifugation at 2,000×g for 15 
minutes and dispersed again in sterile Milli-Q water at 50% w/v and kept at 4ºC for future 
use. The schematic procedure of preparing alginate microspheres by w/o emulsion with 
internal gelation is shown in Figure 8, and the production parameters are summarised in 
Table 4: 
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Figure 8: Schematic image of alginate microspheres preparation by water-in-oil emulsion method 
with internal gelation. 
 
Table 4: Summary of formulation parameters in water-in-oil emulsion with internal gelation 
method. 
Production parameters  
Oil phase Paraffin liquid 
Water phase Alginate, PHA beads and CaCO3 mixture 
Emulsifier 1% v/v Span80 in paraffin liquid 
Duration 15 minutes emulsification, 15 minutes 
gelation 
Stirring speed 250-450 rpm (Section 3.1) 
400 rpm (Section 3.2) 
w/o ratio 30/70 
Acid/Ca2+ 2.5 molar ratio 
Washing buffer solution 100 mM Acetate buffer (pH 5.5) 
Storage solution Milli-Q water 
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2.16.3 Double gelation 
The PHA beads displaying IgG binding domain encapsulated in alginate microspheres, 
prepared with internal gelation (Section 2.16.2), were subjected to an additional gelation 
in CaCl2 cross-linking solution (Figure 9). Briefly, the 50% w/v suspension of alginate 
microspheres prepared with internal gelation were dispersed into 40 mM CaCl2 cross-
linking solution at a ratio of 1:1. The final concentration of CaCl2 in the crosslinking 
solution was 20 mM after the addition of the microsphere suspension. The dispersion was 
then incubated with a magnetic stirrer at 300 rpm for 15 minutes at room temperature. 
After the incubation, the microspheres were collected by centrifugation at 2,000×g for 15 
minutes. The pellet containing the microspheres was washed with sterile Milli-Q water 
for three times then dispersed in sterile Milli-Q water at 50% w/v and kept at 4ºC for 
future use. 
 
 
Figure 9: Schematic image of alginate microspheres preparation by double gelation. 
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2.16.4 External gelation 
A simple extrusion dropping method was applied to produce PHA beads encapsulated in 
alginate millispheres (Zhao et al., 2015). Alginate solution was mixed with a PHA bead 
suspension at a range of concentrations (Section 3.3). For making blank alginate 
millispheres, the same volume of sterile Milli-Q water was added instead of the PHA 
bead suspension. The alginate-PHA bead mixture was prepared in a 50 ml syringe (BD 
Plastipak, USA), then C-FLEX® Tubing L/S 14 (Masterflex, Germany) equipped with 
23 G needle (TERUMO, Japan) was attached to the syringe. A peristaltic pump (BT300-
2J pump, LongerPump, China) was used with the pumping speed of 5 rpm and the mixture 
added dropwise into a CaCl2 cross-linking solution. The needle tip was set to 3 cm above 
the surface of the solution and perpendicular to the solution. The solution was stirred at 
300 rpm with a magnetic stirrer. After all the alginate-PHA bead mixture had been added 
to the solution, millispheres were stirred for an additional hour before collection. The 
millispheres were washed three times with sterile Milli-Q water then stored hydrated in 
Milli-Q water at 4ºC for future use. A schematic image of alginate millisphere production 
is shown below (Figure 10). 
 
Figure 10: Schematic image of alginate millisphere preparation by a simple extrusion dripping 
method with external gelation. 
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2.17 Characterisation of PHA beads encapsulated in alginate microspheres and 
millispheres 
2.17.1 Morphology analysis 
2.17.1.1 Microscopic analysis of microspheres 
Phase contrast microscopy (Leica, Germany) was used to observe the structure of alginate 
and PHA beads encapsulated in alginate microspheres. In the meantime, the same frame 
position was also analysed by fluorescence for the presence of PHA beads in the alginate 
microspheres using N 2.1 unit (Ex. 515-560 nm; Em. 590 nm; Dichromatic mirror 580 
nm). The image was captured using a Leica DFC500 (Germany) and analysed by LAS 
AF Lite software (Leica, Germany). PHA beads in alginate microspheres were stained as 
previously described in Section 2.13.1 using Milli-Q water for washing instead of 50 mM 
potassium phosphate buffer. 
2.17.1.2 Scanning electron microscopy 
PHA beads encapsulated in alginate microspheres were collected by centrifugation at 
2,000×g for 5 minutes in a microfuge tube. The supernatant was removed, and the pellet 
was mixed with absolute ethanol to dehydrate the pellet. The sample was then collected 
at 2,000×g for 5 minutes. The pellet was frozen at -80ºC then lyophilised. Millispheres 
were collected by filtration using Whatman 542 filter paper (Whatman, UK) and treated 
with absolute ethanol to dehydrate. The dehydrated millispheres were frozen at -80ºC 
then lyophilised. The sample was then processed at the MMIC as described in Section 
2.13.2. 
2.17.1.3 Particle size analysis 
2.17.1.3.1 Microspheres 
The particle size of alginate and PHA beads encapsulated in alginate microspheres was 
analysed by Mastersizer 3000 (Malvern instruments, UK) as also described for PHA 
beads in Section 2.13.3. The particle refractive index was set to 1.78, and the absorption 
index was set to 0.005, as given by optimal property optimizer in the Mastersizer software 
(Malvern instruments, UK). The dispersion refractive index was set to 1.35. The 
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obscuration was set between 5-15% and aimed at 10%. The dispersion unit was set to 
1,500 rpm. The particle size analysis was based on the Mie scattering model. 
2.17.1.3.2 Millispheres 
The particle size (mm, diameter) of alginate millispheres produced by the simple 
extrusion dropping method (Section 2.16.4) was determined by measuring the diameter 
of 30 randomly picked spheres using a ruler (H-101C, SHINWA, Japan) as the standard.  
2.17.1.4 Encapsulation efficiency 
To determine the encapsulation efficiency of PHA beads in alginate microspheres, the 
combination of solubilising alginate microspheres, BCA assay for protein quantification 
(Section 2.14.2.3), and densitometry on SDS-PAGE gel for determining the proportion 
of protein (PhaC derived) on PHA beads (Section 2.14.1.1.4) were used. Microsphere 
suspension (300-500 µl) was collected in a microfuge tube by centrifugation at 6,000×g 
for 5 minutes, the supernatant discarded and 1,000 µl of solubilising buffer was added to 
the tube. The suspension was mixed well by vortex-mixing and centrifuged at 17,000×g 
for 5 minutes. The extracted PHA bead pellet was washed once with the solubilising 
buffer and twice with Milli-Q water or any buffer solution in the test. Finally, the PHA 
bead pellet was re-suspended at 10% w/v concentration. The PHA bead suspension was 
then tested by BCA assay for protein quantity and SDS-PAGE for protein proportion of 
PhaC derived protein on PHA beads. The encapsulation efficiency of PHA beads in 
alginate microspheres was determined by the following equation: 
 !!	(%) = '(()*+, × )%./.) × 012134)56,	7839: × ; < ÷ (>56,	7839: × 056,	7839:)? × 100 
 
Where EE(%) is the encapsulation efficiency, PBCA is the protein amount of BCA assay 
(mg), P%SDS is the protein proportion of the extracted PHA beads (%), PPHA beads is the 
amount of fusion protein on PHA beads (mg/mg), v is the volume used in microsphere 
solubilisation from stock suspension (ml), Vtotal is the total volume of the microsphere 
stock suspension (ml), CPHA beads is the theoretical concentration of initial PHA beads in 
stock bead suspension (mg/ml), and VPHA beads is the total volume of initial PHA bead 
stock suspension used (ml). 
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Solubilising buffer (TBS+EDTA):  
Tris 50 mM 
NaCl 150 mM 
EDTA 50 mM 
pH adjusted to pH 7.4 by HCl  
 
For the millispheres prepared with external gelation (millimetre size), the NaCl 
concentration was 300 mM and EDTA was 100 mM. Millispheres were weighed and 
added to the solubilising buffer in a microfuge tube and incubated with orbital agitation 
for 1 hour at room temperature. The quantification of PHA beads in millispheres was 
followed as described above and the following equation was used: 
 )BC	DEFGH	IEJ	K	LM	NOPPOHIℎEJE	(NK/K) = S)*+, × )%./.)56,	7839: T ÷ UVW44W:XY8Z8 
 
Where PBCA is the protein amount from BCA assay (mg), P%SDS is the protein proportion 
of the extracted PHA beads (%), and  PPHA beads is the amount of fusion protein on PHA 
beads (mg/mg), and Mmillisphere is the wet weight (g) of PHA beads encapsulated in the 
alginate millispheres (excess water removed, Section 2.17.2.3). 
2.17.2 Functional assessment 
2.17.2.1 IgG binding testing of PHA beads encapsulated in alginate microspheres 
2.17.2.1.1 Batch IgG binding test 
An IgG binding capacity test was conducted to assess the IgG binding capacity of the ZZ 
domain on the surface of free PHA and the PHA beads encapsulated in alginate 
microspheres in batch conditions (Jahns et al., 2013) (Figure 11A). Approximately 50 mg 
of PHA beads and 300 µl of 50% w/v PHA beads encapsulated in alginate microspheres 
were collected in a microfuge tube. Samples were washed once with TBS (50 mM Tris-
Cl and 50 mM NaCl, pH7.4) and centrifuged for 5 minutes at 6,000×g. After the initial 
wash, PHA beads encapsulated alginate microspheres were added to 1 ml TBS buffer and 
incubated at room temperature for 1 hour with orbital rotational agitation (to equilibrate 
to temperature and in the buffer) before addition of the IgG sample. The supernatant was 
carefully removed. All samples were dispersed in 1 ml of 3 mg/ml of human IgG 
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(Equitech-Bio, USA) in TBS and incubated at 25ºC for 30 minutes with orbital agitation. 
After incubation, the samples were collected by centrifugation for 5 minutes at 6,000×g, 
and the unbound IgG fraction in the supernatant was collected into a new tube. The pellets 
containing bound IgG were washed three times with TBS by pipetting and collected by 
centrifugation for 5 minutes at 6,000×g between each wash. Bound IgG on PHA beads 
and PHA beads encapsulated in alginate microspheres was eluted by the addition of 100 
mM glycine (pH2.5) and incubation at 25ºC with orbital rotational agitation for 5 minutes. 
PHA beads and PHA beads encapsulated in alginate microspheres were centrifuged at 
17,000×g and 6,000×g for 5 minutes, respectively, and then supernatant containing eluted 
IgG was collected into a new tube. The low pH supernatant was neutralised by the 
addition of 1 M K2HPO4 at 1:10 ratio, e.g. 100 µl of supernatant with 10 µl of K2HPO4 
solution. The collected samples (unbound and eluted IgG fractions) were analysed by the 
Bradford assay as described in Section 2.14.2.2. 
2.17.2.1.2 Column IgG binding test 
IgG binding capacity of PHA beads encapsulated in alginate microspheres in column 
conditions was analysed with a Pierce™ Spin Cups Paper Filter column, and followed 
the manufacturer’s instructions (Thermo Fisher Scientific, USA) (Figure 11B). The 
column was washed once with TBS. 50 μl of  alginate microspheres suspension (50% 
w/v) was added to the column and washed with TBS. The column was centrifuged at 
1,000×g for 5 minutes. Then, the alginate microspheres were re-suspended in TBS and 
incubated for 1 hour at 25°C with orbital rotational agitation. The microspheres in the 
column were washed with TBS three times. Human IgG in TBS (300 μl of 3 mg/ml) was 
added to the column and mixed well with the microspheres in the column by pipetting up 
and down, and then the columns incubated for 30 minutes at 25°C with orbital rotational 
agitation. The column was centrifuged at 1,000×g for 5 minutes and the flow through 
collected in a separate microfuge tube to analyse the unbound IgG. TBS (300 μl) was 
added to the column containing the microspheres and the column washed three times with 
TBS. Bound IgG was eluted by adding 300 μl of 100 mM glycine (pH2.5) and incubating 
at 25°C for 5 minutes. The column was transferred to a new microfuge tube containing 
30 μl of K2HPO4 solution, and the eluted fraction was collected by 1,000×g for 5 minutes. 
The elution was repeated three times, and the collected samples (unbound and eluted IgG 
fractions) were analysed by the Bradford assay as described in Section 2.14.2.2. 
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Figure 11: Schematic overview of batch (A) and column (B) IgG binding assay. 
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2.17.2.2 Enzyme activity assay of PHA beads encapsulated in alginate 
microspheres 
Enzyme activity of free PHA beads displaying OpdA and the PHA beads encapsulated in 
alginate microspheres were assayed as described previously (Blatchford et al., 2012). The 
amount of protein on the surface of the free  and the encapsulated PHA beads were 
measured by SDS-PAGE gel densitometry, and 100 µg of the fusion protein on PhaC 
protein was used in each test. Coumaphos (O, O-diethyl O-3-chloro-4-methyl-2-oxo-2H-
chromen-7-yl phophorothioate, Sigma-Aldrich, USA) was used as the substrate. The 
assay was conducted in 50 mM HEPES buffer at pH 8.0 containing 20% v/v methanol 
with 200 µM Coumaphos in a 3 ml cuvette. The enzyme activity was monitored for 4 
hours by the increase of fluorescence intensity at a wavelength of Ex. 355 nm, and Em. 
460 nm, using FluoroMax®-4 (HORIBA, Japan) equipped with Thermo Neslab RTE7 
circulating chiller (Thermo, USA). The temperature was set at 25°C, and a small magnetic 
stirrer was added to the cuvette and stirred at level 3 on FluoroMax®-4 while monitoring. 
2.17.2.3 Adsorption equilibrium test of PHA beads encapsulated in alginate 
millispheres 
Batch adsorption equilibrium kinetic and isotherm test of blank alginate millispheres and 
PHA beads encapsulated in alginate millispheres were carried out at approximately 25ºC 
(a temperature controlled room) in an aluminium foil covered 50 ml flask shaking at 100 
rpm. Millispheres were prepared by removing excess water using Whatman 542 filter 
paper (Whatman, UK) until no watermarks were visible on the blotting paper. The 
millispheres were measured in wet weight in this test. The test was done in triplicate for 
each millisphere type. 
2.17.2.3.1 Adsorption kinetic test 
Millispheres (0.2g) and 20 ml of Nile red solution prepared at 70 ng/ml in Milli-Q water 
containing 10 % v/v DMSO were added to an aluminium foil covered conical flask. The 
flask was covered with aluminium foil cap. Samples were taken at preselected time 
intervals (1, 2, 4, 8, 12, 18, and 24 hours) then the residual concentration of Nile red in 
the solution was measured (Section 2.17.2.3.3) 
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2.17.2.3.2 Adsorption isotherm test 
0.2 g millispheres and 20 ml of Nile red solution (serially diluted) were added to an 
aluminium foil covered conical flask. The concentration of Nile red prepared in Milli-Q 
water containing 10% v/v DMSO was serially diluted to cover the range from 10-100 
ng/ml. The flask was covered with aluminium foil cap. The flask was incubated for 24 
hours as adsorption was assumed to reach equilibrium. After 24 hours contact time, the 
sample was analysed for residual Nile red concentration (Section 2.17.2.3.3). 
2.17.2.3.3 Analysis of residual Nile red 
Residual concentration of Nile red in the solution was measured by fluorescent intensity 
induced by Nile red reacting with a lipophilic substance. 20 µl of sample was withdrawn 
from the flask to a non-binding flat bottom black well microtiter plate (Greiner Bio-One, 
Austria). 200 µl of filtered 2% v/v Tween-20 in Milli-Q water was added to the plate. The 
plate was incubated in the dark for 15 minutes. Then, the fluorescence intensity in the 
plate was analysed at the wavelength of Ex. 544 nm, and Em. 612 nm, using FLUOstar 
galaxy (BMG labtechnologies, Germany). Milli-Q water containing 10% v/v DMSO was 
used as the blank. The concentration of Nile red in the solution was determined by the 
standard curve prepared from 7.5-120 ng/ml Nile red solution containing 10% v/v DMSO. 
The amount of Nile red in the solution at equilibrium, qe, was calculated using the 
following equation: 
!" = (%& − %") × *+  
Where Ci and Ce are the initial and equilibrium Nile red concentration in the solution 
(ng/ml), respectively. V is the volume of the solution (ml), and m is the wet weight of 
adsorbent used (mg).  
2.17.2.3.4 Quality control test 
Nile red solution in an aluminium foil covered flask without beads (blank) was also 
prepared to assess the interference between Nile red in the solution and glassware. The 
experimental conditions were as described in Section 2.17.2.3.1 and Section 2.17.2.3.2. 
The residual concentration of Nile red in the solution was analysed as described in Section 
2.17.2.3.3. All tests were conducted in triplicate.  
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2.18 Statistical analysis 
Experiments were done in triplicate (n=3) and were presented as means±standard 
deviation. The mean difference was analysed by one-way ANOVA (Minitab® version 17, 
Minitab Inc., USA) to determine statistical significance, and the difference is considered 
significant when p<0.05. 
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Chapter 3: Results 
3.1 PHA beads displaying IgG binding domain (ZZ) encapsulated in alginate 
microspheres 
3.1.1 Preparation of PHA beads displaying IgG binding domain (ZZ) 
3.1.1.1 In vivo production of PHA beads 
To produce alginate microspheres encapsulating PHA beads (PHA bead-alginate 
microspheres) and to assess their functionality, the following plasmids constructed in 
previous studies were selected, pPolyC (Hay et al., 2017) encoding PhaC and pET-14b 
zz(-)phaC (Brockelbank et al., 2006) encoding IgG binding ZZ domain fused at N-
terminus of PhaC. Both plasmids were confirmed by DNA sequencing (Section 2.10.3) 
before being used to transform a production strain of BL21 (DE3) E. coli harbouring 
plasmid pMCS69 (Amara & Rehm, 2003). pMCS69 plasmid encodes PhaA and PhaB 
from C. necator that are required for PHA precursor substrate synthesis. After the 
confirmation, plasmids were used to transform the production strain and plated on LB 
agar containing 100 µg/ml ampicillin and 50 µg/ml chloramphenicol for selection of 
transformants (Section 2.11). The recombinant strains were cultivated for in vivo PHA 
beads production under beads accumulating conditions (Section 2.6.1). The production E. 
coli strain transformed with pET14b expression vector was used as the negative control 
for the PHA beads production. 
The presence of PHA beads in the E. coli cells was confirmed by Nile red staining 
(Section 2.13.1.1) and visualised using fluorescence microscopy (Section 2.13.1.2). The 
intracellular accumulation of PHA beads was observed as fluorescence (Figure 12), 
therefore indicating the activity of PHA synthase under the PHA bead accumulation 
conditions. Further confirmation was done using TEM analysis on PHA bead 
accumulating E.coli cells (Figure 13). The TEM images showed the accumulation of 
white circular PHA beads in E.coli cells harbouring pPolyC and pET-14b zz(-)phaC 
plasmids (Figure 13B and C) while no intracellular accumulation was detected in E.coli 
cells harbouring pET14b plasmid (Figure 13A). 
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Figure 12: Fluorescence microscopy images of PHA beads produced in recombinant E.coli cells. 
A: BL21 (DE3) E.coli+pMCS69 (BL21_69) harbouring pET14b (negative control); B: 
BL21_69+pPolyC; C: BL21_69+pET-14b zz(-)phaC. 
 
 
Figure 13: TEM analysis of recombinant E.coli cells accumulating PHA beads, and isolated and 
purified PHA beads. A: BL21 (DE3) E.coli+pMCS69 (BL21_69)+pET14b (negative control); B: 
BL21_69+pPolyC; C: BL21_69+pET-14b zz(-)phaC; D: PhaC PHA beads, E: ZZC PHA beads. 
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3.1.1.2 Characterisation of PHA beads displaying the IgG binding domain 
The E.coli cells containing PHA beads were subjected to mechanical cell disruption 
(Section 2.12.2). The morphology of PHA beads isolated from cells was assessed by TEM 
and SEM analyses (Section 2.13.2). TEM images confirmed that PHA beads were 
successfully isolated from E. coli cells (Figure 13D and E), and further observation by 
SEM images showed that spherical or slightly irregular shaped beads were isolated from 
typical rod-shaped E. coli cells (Figure 14).  
 
 
Figure 14: SEM analysis of recombinant E.coli cells accumulating PHA beads, and isolated and 
purified PHA beads. A: BL21 (DE3) E.coli+pMCS69 (BL21_69)+pPolyC; B: PhaC PHA beads 
(WT) ; C: ZZC PHA beads (ZZCYC). 
 
The particle size distribution of the PHA beads as a stock solution (Milli-Q water) was 
analysed by the laser diffraction method using a Mastersizer 3000 (Section 2.13.3). The 
particle size was reported as bead diameters. Particle size distributions of both PhaC (wild 
type) and ZZC PHA beads showed two major peak distributions (Figure 15). The first 
peak of both PHA bead types was observed at 0.56 µm, and the second peak was observed 
at 7.17 µm and 3.78 µm, respectively. Moreover, the median particle size (D50) of PhaC 
and ZZC PHA beads was 6.23 µm and 2.17 µm, respectively (Table 10, Appendix I). 
However, the particle size of the single PHA beads was shown to be less than 1 µm from 
TEM and SEM images (Figure 13 and Figure 14). This indicated that the first peak can 
probably be attributed to a single PHA bead or possibly small bead aggregates, and the 
second peak can probably be attributed to larger aggregates of the beads. The SPAN factor 
indicates the width of the distribution that can be calculated using the following equation: ,-./	123456 = 789:7;97<9 . Due to the broader particle size distribution, ZZC PHA beads 
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showed higher SPAN factor than that of PhaC PHA beads. However, ZZC PHA beads 
had a higher specific surface area due to the higher volume density in smaller particle 
sizes (specific surface of PhaC and ZZC PHA beads were 2,211 and 6,085 m²/kg, 
respectively) (Table 10, Appendix I).  
 
 
Figure 15: Particle size distribution of PhaC and ZZC PHA beads in water. 
 
The protein profile of the fusion protein on the PHA beads was analysed by SDS-PAGE 
(Section 2.14.1), and the protein was quantified by densitometry on SDS-PAGE gel using 
BSA as the protein standard (Section 2.14.2.1). The theoretical molecular weight of 
recombinant fusion protein was calculated using the ProtParam tool in the ExPASy 
Proteomics Server (http://www.expasy.org/). The protein profile of whole cell lysate 
showed dominant protein bands observed at the theoretical molecular weight of 67 kDa 
for PhaC protein and 79 kDa for ZZC protein while E.coli transformed with pET14b 
showed no dominant protein band (Figure 16). Therefore, this indicated fusion proteins 
were overproduced in E.coli cells transformed with pPolyC and pET14b-zz(-) phaC 
plasmid, respectively. Densitometry analysis (Section 2.14.1.1.4) after isolation and 
purification procedure (Section 2.12) showed that the PhaC derived protein in the total 
protein from each suspension accounted for 36.9 % in pPolyC PHA bead, and for 26.2 % 
in the ZZC PHA bead. Protein quantification of the fusion protein on the wet weight PHA 
bead was 5.4±0.2 mg/g for PhaC PHA beads and 2.1±0.3 mg/g for ZZC PHA beads 
(Table 10, Appendix I). 
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Figure 16: SDS-PAGE protein profile analysis of whole-cell proteins from E.coli cells 
accumulating PHA beads, and isolated and purified PHA beads. Lane M, molecular weight ladder 
(GangNam-STAIN prestained protein ladder); lane 1, BL21 (DE3) E.coli strain+pMCS69 
(BL21_69) harbouring pET14b (negative control); lane 2, BL21_69+pPolyC; lane 3, 
BL21_69+pET14b-zz(-)phaC; lane 4, PhaC PHA beads (67 kDa); lane5, ZZC PHA beads (79.34 
kDa). 
 
3.1.1.3 Functional assessment of PHA beads displaying IgG binding domain 
The activity of the IgG binding domain (ZZ) displayed on the surface of PHA beads was 
confirmed before the beads were encapsulated in alginate microspheres. The binding 
capacity of the IgG binding domain was determined by an IgG binding assay (Section 
2.17.2.1.1) which utilised the following equation: =>?	@ABCAB>	32D23A4E =(F""G	HIJ:KLMNOLG	HIJ)PQNR"&L	STNOLR	NL	PUV	M"SGW	. The protein quantification of unbound and eluted fractions was 
completed using by the Bradford assay (Section 2.14.2.2). The IgG binding capacity of 
ZZC PHA beads was significantly higher at 3.95 fold than PhaC PHA beads (p<0.05). 
This indicated that IgG showed a binding affinity towards the IgG binding domain (ZZ) 
on the PHA beads. However, it also showed non-specific binding to the negative control 
PhaC PHA beads, which do not display the IgG binding domain (Figure 17A).  
Unbound and eluted fractions from the functional assessment of the IgG binding domain 
(ZZ) were analysed by SDS-PAGE (Section 2.14.1.1) to check the purity of the IgG from 
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the eluted fractions. SDS-PAGE gel image showed two bands at approximately 50 and 
25 kDa, which corresponded to the molecular weight of heavy and light chains of IgG, 
respectively (Figure 17B). The eluted fraction from ZZC PHA beads showed a greater 
band intensity than that of the eluted fraction from PhaC PHA beads, indicating that PHA 
beads displaying IgG binding domain were capable of purifying more IgG in comparison 
to the negative control (PhaC PHA beads). 
 
 
Figure 17: IgG purification performance of PHA beads displaying IgG binding domain. A, 
Comparative IgG binding capacity analysis of PhaC and ZZC PHA beads. PHA beads were 
incubated in 3 mg/ml human IgG in TBS at 25°C with orbital rotational agitation.* Indicates the 
statistically significant difference (p<0.05). B, Protein profile of unbound and eluted fractions of 
IgG binding test on PhaC and ZZC PHA beads. PHA beads were incubated in 3 mg/ml human 
IgG in TBS, pH 7.4 and eluted by 100 mM Glycine, pH2.5, at 25°C. The molecular weight of 
IgG heavy chain and light chain are 50 and 25 kDa, respectively. Lane M, molecular weight ladder 
(GangNam-STAIN prestained protein ladder); lane 1, Human IgG; lane 2, Unbound IgG of 
pPolyC PHA beads; lane 3, Unbound IgG of ZZC PHA beads; lane 4, Eluted IgG from pPolyC 
PHA beads; lane 5, Eluted IgG from ZZC PHA beads. 
 
3.1.2 IgG binding domain displaying PHA beads encapsulated in alginate 
microspheres 
3.1.2.1 Characterisation of the microspheres 
The PHA beads encapsulated in alginate microspheres (namely, PHA bead-alginate 
microspheres) were prepared initially by the water-in-oil (w/o) emulsion with internal 
gelation method (2.16.2), then a further gelation completed on the microspheres (Section 
2.16.3). The morphology of the alginate microspheres was assessed using phase contrast 
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microscopy (Section 2.17.1.1). The alginate microspheres without PHA beads (negative 
control) were clear spheres while both PhaC and ZZC PHA bead-alginate microspheres 
showed particulates enclosed within (Figure 18A, B, and C). For further confirmation that 
PHA beads were encapsulated in the alginate microspheres, the microspheres were 
stained using Nile red and observed under fluorescence microscopy (Section 2.17.1.1). 
Red fluorescence at the positions corresponding to the microspheres in the phase contrast 
images indicated the presence of PHA beads (Figure 18). This showed that the 
encapsulation of PHA beads within alginate microspheres by w/o emulsion with internal 
gelation followed by an additional gelation step (double gelation) was successful. In 
addition, no aggregation of the microspheres was observed. Further morphological 
analysis by SEM showed that the blank alginate microspheres had a smooth surface while 
the surface of PHA bead-alginate microspheres was rough (Figure 19). 
 
Figure 18: Microscopic images of alginate microspheres encapsulating PHA beads prepared with 
double gelation. A-C: phase contrast microscopic images; A: blank alginate microspheres; B: 2% 
w/v PhaC PHA bead-alginate microspheres; C: ZZC PHA bead-alginate microspheres. D and E: 
fluorescence microscopic images of corresponding alginate microspheres encapsulated PHA 
beads; D: 2% w/v PhaC PHA bead-alginate microspheres; E: ZZC PHA bead-alginate 
microspheres. 
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Figure 19: SEM analysis of lyophilised blank alginate microspheres and PHA bead-alginate 
microspheres prepared with double gelation. The microspheres were prepared with w/o 
emulsion/internal gelation with additional gelation. A, Blank alginate microspheres; B, PhaC 
PHA bead-alginate microspheres; C, ZZC PHA bead-alginate microspheres 
 
According to the manufacturer’s product description, Pierce™ Spin Cups Paper Filter 
column has pore sizes less than 10 µm. Therefore, the aim was to produce alginate 
microspheres above this pore size so they would be suitable for retention on these spin 
columns. Alginate microspheres were prepared from w/o emulsions using stirring speeds 
of 250, 350 and 450 rpm. The particle size distribution (diameter) of alginate 
microspheres prepared in these different stirring speeds was measured by laser diffraction 
(Section 2.17.1.3.1). A comparison of median particle size values (D50) showed the 
microspheres prepared at 250 rpm were 1.34-1.48 times larger in diameter than those 
prepared at 350 rpm and 2.06-2.28 times larger than those prepared at 450 rpm. Similarly, 
microspheres prepared at 350 rpm were 1.52-1.55 times larger than those prepared at 450 
rpm (Table 12, Appendix II). A comparison of the particle size diameter difference 
between microspheres prepared with only internal gelation, and microspheres prepared 
with internal gelation followed by an additional gelation step was also analysed. 
According to the median particle size value (D50), the extra gelation step resulted in a 
reduction in particle size of 33-56% for blank alginate microspheres, 52-71% for PhaC 
PHA bead-alginate microspheres, and 58-75% for ZZC PHA bead-alginate microspheres. 
Moreover, the microspheres prepared at a lower stirring speed demonstrated a larger 
particle size reduction than the alginate microspheres prepared with a higher stirring speed. 
For example, the reduction of particle size based on the median particle size (D50) for 
blank alginate microspheres prepared at 250, 350, and 450 rpm was 56, 45, and 33 %, 
respectively. The particle size distribution was compared in water (control), TBS (50 mM 
Tris, 50 mM NaCl, pH7.4), and 100 mM glycine (pH2.5), and showed the largest particle 
size in TBS and followed by 100 mM glycine (Figure 20 and Table 12, Appendix II). 
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These results showed that alginate microspheres react differently when dispersed in 
different solutions. 
 
Figure 20: Summary of particle size distribution of blank alginate and PHA bead-alginate 
microsperes prepared at 350 rpm. The particle size of microspheres was measured in water, TBS 
(pH7.4), and 100 mM glycine (pH2.5). I: Internal gelation, I+E: double gelation. 
 
The encapsulation efficiency of PHA beads in alginate microspheres was assessed by 
examining the PhaC derived protein (PhaC or ZZC) displayed on the PHA beads. The 
combination of extracting PHA beads by solubilising the alginate microspheres, total 
protein quantification of the extracted PHA bead fraction, and protein profiling by SDS-
PAGE was conducted (Section 2.17.1.4). The initial PhaC derived protein proportion 
from the total protein in the stock suspensions for PhaC, and ZZC PHA beads before 
encapsulating in alginate microspheres was 36.9% and 26.6%, respectively (Table 10, 
Appendix I). After encapsulation in alginate microspheres prepared with internal gelation, 
the protein proportion was increased by 2.8% for PhaC PHA beads and 3.1% for ZZC 
PHA beads. The encapsulation efficiency of alginate microspheres prepared in the 
internal gelation phase was slightly higher in PhaC PHA beads than ZZC PHA beads, but 
both beads showed high encapsulation efficiency (98.4±0.5% and 92.6±2.6%, 
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Alginate microspheres PhaC PHA bead-alginate microspheres
ZZC PHA bead-alginate microspheres Sample (350rpm) D(10) D(50) D(90) SPAN Uniformity
Alginate microspheres
I - H2O 87.5 138 220 0.96 0.296
I+E - H2O 46.3 76.3 125 1.037 0.323
I+E - TBS 76 114 173 0.851 0.263
I+E - Glycine 66.5 99.6 151 0.846 0.262
PhaC PHA bead-alginate microspheres
I - H2O 95.9 163 289 1.184 0.367
I+E - H2O 38.8 67.2 117 1.159 0.359
I+E - TBS 70.5 109 170 0.913 0.282
I+E - Glycine 60 95.1 154 0.985 0.304
ZZC PHA bead-alginate microspheres
I - H2O 117 197 332 1.092 0.334
I+E - H2O 39.5 69.8 123 1.192 0.368
I+E - TBS 72.6 113 177 0.926 0.286
I+E - Glycine 62.1 100 163 1.007 0.313
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respectively). The additional gelation on the internally gelled microspheres showed an 
increase in the proportion of PhaC derived proteins by 4.1% for PhaC PHA beads and 
2.7% for ZZC PHA beads compared to the alginate microspheres prepared with internal 
gelation only. In total, the proportion of PhaC derived proteins after double gelation 
resulted in an increase by 6.9% for PhaC PHA beads and 5.8% for ZZC PHA beads from 
the initial protein proportion in the stock suspension. However, the encapsulation 
efficiency was significantly reduced after the additional gelation step, compared to the 
microspheres prepared with internal gelation only, with encapsulation efficiency reduced 
by 34% and 26.1% for PhaC PHA bead-alginate microspheres and ZZC PHA bead-
alginate microspheres, respectively (Table 5). 
 
Table 5: The encapsulation efficiency of PhaC and ZZC PHA beads in alginate microspheres. 
  Internal gelation only Double gelation 
PHA 
bead 
types 
Initial PhaC 
proportion 
(%)* 
PhaC 
proportion 
(%)* 
Encapsulation 
efficiency (%) 
PhaC 
proportion 
(%)* 
Encapsulation 
efficiency (%) 
PhaC 36.9 39.7 98.4±0.5 43.8 64.4±1.0 
ZZC 26.6 29.7 92.6±2.6 32.4 66.5±1.9 
Note: * The protein proportion obtained from densitometry on SDS-PAGE gel 
 
3.1.2.2 Functional assessment of the microspheres: IgG binding capacity 
The IgG binding assay was conducted to assess the IgG binding capacity of the PHA 
bead-alginate microspheres (Section 2.17.2.1). The IgG binding capacity of the alginate 
microspheres in the batch test is shown in Figure 21A. All the alginate microsphere types 
(the blank, PhaC PHA bead- and ZZC PHA bead-alginate microspheres) demonstrated a 
similar binding capacity level with no significant differences (p>0.05). Similarly, the 
alginate microspheres tested in the column test showed similar binding capacity among 
all the type of alginate microspheres tested (p>0.05) (Figure 21B). In comparison with 
the IgG binding capacity of the alginate microspheres in the column test, the binding 
capacity of the batch test was approximately half of the column test (approximately 2.5 
µg/mg versus 5.0 µg/mg.). To avoid interference by the residual IgG in the elution result, 
the IgG concentration in the supernatant (batch) and flow through liquid (column) was 
measured prior to the elution phase and confirmed at negligible concentration levels 
(approximately 1% of initial IgG concentration). The elution procedure was completed 
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three times to ensure the release of bound IgG from the microspheres. Nevertheless, both 
batch and column test conditions resulted in very low, and almost no, IgG eluted (Figure 
21A and B). Therefore, the results of the IgG binding assay showed that alginate 
microspheres had a binding affinity with IgG, however, the bound IgG could not be eluted. 
 
Figure 21: Comparative interaction of IgG with blank alginate and PHA bead-alginate 
microspheres in batch (A) and column (B) test. Microspheres were incubated in 3 mg/ml human 
IgG in TBS (pH7.4) for 30 minutes at 25°C with orbital rotational agitation. Elution was done 
three times and for 5 minutes each with 100mM Glycine (pH2.5). The test was done in triplicate 
and mean ± standard deviation is reported. N.S indicates no significant difference. 
 
To confirm IgG had bound to the alginate microspheres in these tests, protein profiling of 
the alginate microspheres by SDS-PAGE after binding and elution phase was conducted 
(Section 2.14.1). Similar to the previous confirmation, the alginate microspheres were 
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washed until the residual IgG concentration in the supernatant in batch and flow through 
liquid from the column was reduced to negligible levels (1% of initial concentration) by 
Bradford assay (Section 2.14.2.2). After the confirmation, the microspheres were 
solubilised using the solubilising buffer, and SDS-PAGE was used to analyse the protein 
profile of the solubilised alginate gel matrix solutions and the extracted PHA bead 
suspensions (Figure 22). 
Figure 22: Schematic procedure of sampling of solubilised alginate microspheres and analysis for 
protein profiling. 
After the binding phase, the blank alginate microspheres (negative control) showed the 
presence of IgG in the solution of solubilised alginate gel matrix (Figure 23, lane 4). The 
solubilised alginate gel matrix solutions of PHA bead-alginate microspheres also showed 
the presence of IgG (Figure 23, lane 5 for PhaC and lane 7 for ZZC) after the binding 
phase. The protein profile of the extracted PHA beads from the alginate microspheres 
showed that IgG was bound to the PhaC and ZZC proteins displayed on the surface of 
PHA beads (Figure 23 lanes 6 and 8, respectively), indicating IgG was capable of binding 
to the PhaC derived proteins of the encapsulated PHA beads in alginate microspheres. 
Similarly, IgG was observed in the alginate microspheres after the elution phase as shown 
on the SDS-PAGE gel after the elution phase (Figure 23, lanes 9-13). The presence of 
two protein bands of heavy and light chain of IgG indicated IgG was not eluted after the 
triplicate elution by 100 mM glycine (pH2.5). 
Binding Phase Elution Phase
Solubilised 
alginate gel 
matrix solution
Extracted 
PHA bead 
suspension
Solubilised the alginate microspheres 
using Solubilising buffer
SDS-PAGE Protein Profiling
PHA bead-alginate 
microspheres after 
Binding phase
PHA bead-alginate 
microspheres after 
Elution phase
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Figure 23: Protein profile of IgG bound to blank alginate and PHA bead-alginate microspheres in 
batch (A) and column (B) test. Blank alginate microspheres and PHA bead-alginate microspheres 
were incubated with 3 mg/ml human IgG in TBS, pH7.4, for 30 minutes at 25ºC. The blank 
alginate and PHA bead-alginate microspheres pellets were solubilised using a solubilising buffer 
(50 mM Tris-Cl, 150 mM NaCl, and 50 mM EDTA, pH7.4). Solubilised alginate gel matrix 
solutions and extracted PHA beads suspensions after binding and elution phase were analysed for 
the protein profile by SDS-PAGE. Lane M, molecular weight ladder (GangNam-STAIN 
prestained protein ladder); lane 1, IgG; lane 2, PhaC PHA beads; lane3, ZZC PHA beads; lanes 
4-8 solubilised alginate gel matrix solutions and extracted PHA beads suspension (Binding 
Phase); lane 4, blank alginate microspheres; lane 5 alginate gel matrix solution of PhaC PHA 
bead-alginate microspheres; lane 6, extracted PhaC PHA beads with bound IgG; lane 7, alginate 
gel matrix solution of ZZC PHA bead-alginate microspheres; lane 8, extracted ZZC PHA beads 
with bound IgG; lane 9-13, solubilised alginate gel matrix solution and extracted PHA beads 
suspension (Elution Phase); lane 9, blank alginate microspheres; lane 10, algiante gel matrix 
solution of PhaC PHA bead-alginate microspheres; lane 11, extracted PhaC PHA beads with 
bound IgG; lane 12, alginate gel matrix solution of ZZC PHA bead-alginate microspheres; lane 
13, extracted ZZC PHA beads with bound IgG. 
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The IgG binding capacity assay showed no significant differences between the types of 
alginate microspheres in both batch and column test conditions (Figure 21). Therefore, 
the effect of alginate encapsulation on the IgG binding performance of PhaC derived 
proteins (PhaC or ZZC) on PHA beads was determined by comparison of the amout of 
IgG bound to the PhaC derived proteins on free PHA beads and extracted PHA beads. 
Densitometry on the SDS-PAGE gel was used to quantify the amount of IgG bound to 
the PhaC derived proteins on the PHA beads (Section 2.14.2.1). The standard curve using 
BSA (50-500ng) and IgG (250-2,500 ng) produced an excellent correlation coefficient 
that allowed the quantification of proteins on the gel (Figure 43, Appendix III).  
After incubation with the IgG solution (Binding phase), the encapsulated PHA beads in 
alginate microspheres were extracted and analysed for the amount of bound IgG on the 
PhaC derived proteins on PHA beads by SDS-PAGE densitometry (Section 2.14.2.1). 
The bound IgG on the PhaC derived proteins on PHA beads was shown to increase 
significantly in all the type of PHA bead-alginate microspheres in both batch and column 
test conditions when compared with the free PHA beads (Figure 24). The amount of IgG 
bound on PhaC protein on PhaC PHA bead-alginate microspheres was significantly 
higher than free PhaC PHA beads in batch and column test, increasing by 4.09 fold and 
4.78 fold, respectively. The ZZC PHA bead-alginate microspheres also showed an 
increase in the amount of IgG bound to ZZC protein compared with the free ZZC PHA 
beads by 2.35 fold and 2.16 fold, in the batch and column tests respectively. Since ZZC 
PHA beads have IgG binding domains (ZZ), the amount of IgG bound to their PhaC 
derived protein was expected to be higher for ZZC PHA beads than PhaC PHA beads; it 
was 3.97 fold higher in the batch test and 3.11 fold higher in the column test. The 
comparison of the amount of IgG bound on the same type of PhaC derived proteins on 
PHA beads in alginate microspheres showed similar value (p>0.05) between batch and 
column test conditions. 
After elution in 100 mM glycine (pH 2.5) three times, the encapsulated PHA beads in 
alginate microspheres were extracted and analysed by SDS-PAGE gel densitometry as 
previously conducted (Figure 22, Section 2.14.2.1). The amount of bound IgG on the free 
ZZC PHA beads showed a significant reduction (p<0.05) after the elution phase, 
indicating the bound IgG was eluted (Figure 24; ZZC). However, all the types of PHA 
bead-alginate microspheres resulted in significantly increased (p<0.05) in the amounts of 
bound IgG on the PhaC derived protein on PHA beads after the elution phase (Figure 24). 
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The amount of bound IgG in batch and column test conditions increased by 1.57 and 1.75 
fold, respectively for the PhaC PHA bead-alginate microspheres, and by 1.25 and 1.43 
fold, respectively for the ZZC PHA bead-alginate microspheres. There were no 
significant differences in the amount of bound IgG on the PhaC derived protein on PHA 
beads in alginate microspheres between the batch and column test after the elution phase 
(p>0.05). 
 
Figure 24: Comparative analysis of the amount of IgG bound to the PhaC derived proteins on free 
PHA beads and PHA bead-alginate microspheres in batch and column test. The IgG binding 
capacity was obtained by SDS-PAGE gel densitometry. PhaC and ZZC refer to PHA bead type, 
and PhaC-ALG and ZZC-ALG refer to their respective PHA beads encapsulated in alginate 
microspheres. The blue bar represents mg of IgG bound per mg of PhaC derived protein after 
incubation in 3 mg/ml in TBS (pH7.4) for 30 minutes at 25°C. The red bar represents mg of IgG 
bound per mg of PhaC derived protein after elution by 100 mM Glycine (pH2.5) for 5 minutes 
with agitation at 25°C. The elution results of PHA beads and PHA beads encapsulated in alginate 
microspheres were obtained after single and triple elution procedures, respectively. The test was 
done in triplicate and mean ± standard deviation is reported. * indicates a statistically significant 
difference (p<0.05). N.S indicates no significant difference. 
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3.2 PHA beads displaying OpdA encapsulated in alginate microspheres 
3.2.1 PHA beads displaying OpdA 
3.2.1.1 In vivo Production of PHA beads: PHA beads displaying OpdA 
To produce alginate microspheres encapsulating PHA beads displaying an enzyme, the 
following previously constructed plasmids were selected: pPolyC (Hay et al., 2017) and 
pET-14b PhaC-linker-OpdA (Blatchford et al., 2012). pPolyC plasmid encodes PhaC 
with a linker fused to the C-terminus of PhaC, and pET-14b PhaC-linker-OpdA encodes 
OpdA fused to the C-terminus of PhaC via a linker. The pET14b expression vector was 
used as the negative control for the PHA beads production in vivo. The plasmids were 
confirmed by DNA sequencing (Section 2.10.3) and used to transform the production 
strain of BL21 (DE3) E.coli cells harbouring pMCS69 (Section 2.11). After the selection 
on LB agar containing ampicillin and chloramphenicol (Section 2.11), the transformants 
were cultivated under PHA bead accumulating conditions to produce PHA beads in vivo 
(Section 2.6.1). 
As the routine for confirming PHA bead accumulation in the production E. coli strain, 
cells were stained with Nile red (Section 2.13.1.1) and visualised using fluorescence 
microscopy (Section 2.13.1.2). The fluorescence indicated the production of PHA beads 
in vivo and hence the activity of PHA synthase (Figure 25). Further confirmation was 
provided by TEM analysis (Section 2.13.2). In comparison to the PHA bead production 
negative control (pET14b), PHA beads were observed in the cytoplasm of E. coli cells 
transformed with pPolyC and pET-14b PhaC-linker-OpdA (Figure 26). 
 
 
Figure 25: Fluorescence microscopy images of PHA beads produced in recombinant E.coli cells. 
A: BL21 (DE3) E.coli+pMCS69 (BL21_69) harbouring pET14b (negative control); B: 
BL21_69+pPolyC; C: BL21_69+pET-14b PhaC-OpdA. 
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Figure 26: TEM analysis images of recombinant E.coli cells accumulating PHA beads, and 
isolated and purified PHA beads. A: BL21 (DE3) E.coli+pMCS69 (BL21_69) harbouring 
pET14b (negative control); B: BL21_69+pPolyC; C: BL21_69+pET-14b PhaC-OpdA; D: PhaC 
PHA beads; E: PhaC-OpdA PHA beads. 
 
3.2.1.2 Characterisation of PHA beads displaying OpdA 
PHA beads were isolated from E. coli cells by mechanical cell disruption (Section 2.12.2) 
and their characteristics were assessed. The morphology of the isolated PHA beads was 
observed by TEM and SEM analyses (Section 2.13.2). The TEM images showed the PHA 
beads were separate from the bacterial cells, indicating successful isolation from the 
E.coli cells (Figure 26). Further observation by SEM showed that the isolated PHA beads 
were spherical or slightly irregular shaped spheres (Figure 27). 
 
Figure 27: SEM analysis images of recombinant E.coli cells accumulating PHA beads, and 
isolated and purified PHA beads. A: BL21 (DE3) E.coli+pMCS69 harbouring pET-14b phaC-
OpdA; B: PhaC PHA beads (WT); C: PhaC-OpdA PHA beads (phaC-opdA). 
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The particle size distribution of PHA beads in the stock suspension was analysed by laser 
diffraction (Section 2.13.3). Particle size distribution of PhaC and PhaC-OpdA PHA 
beads showed a maxima at 4.89 µm and 13.56 µm, respectively (Figure 28). The median 
particle size (D50) was 6.92 and 13.2 µm, respectively (Table 11, Appendix I). PhaC 
PHA beads demonstrated a broader distribution than PhaC-OpdA PHA beads, as shown 
by the higher SPAN factor value, however, these beads have approximately 1.8 times 
higher specific surface area than PhaC-OpdA PHA beads (as the majority of the beads 
were smaller). According to the TEM and SEM images (Figure 26 and Figure 27), the 
particle size could be estimated to be smaller than 1 µm. Therefore, the particle size 
distribution result demonstrated that these PHA beads were most likely aggregated in the 
stock suspension. 
 
  
Figure 28: Particle size distribution of PhaC and PhaC-OpdA PHA beads in water. 
 
The protein profile of fusion protein displayed on PHA beads was analysed by SDS-
PAGE (Section 2.14.1.1) and the amount of the protein on the bead was quantified by 
densitometry on SDS-PAGE gel using BSA as the standard (Section 2.14.2.1). The 
protein profile of the whole cell lysate on the SDS-PAGE gel showed dominant protein 
bands in E. coli cells transformed with pPolyC and pET-14b PhaC-linker-OpdA. The 
protein bands corresponded to the theoretical molecular weight of 67 kDa for PhaC 
protein and 104 kDa for PhaC-OpdA protein (Figure 29). Therefore, the fusion protein 
was overproduced in these transformants. The purity of fusion protein in the isolated PHA 
bead suspensions (stock suspension) was analysed by densitometry (Section 2.14.1.1.4) 
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and showed that the PhaC derived protein accounted for 40.4% of the total protein in 
PhaC PHA bead fraction and 46.0% for PhaC-OpdA PHA bead fraction. The quantity of 
fusion protein on the PHA bead was 5.61±0.02 mg/g for PhaC PHA beads and 14.2±0.4 
mg/g for PhaC-OpdA PHA beads based on wet weight (Table 11, Appendix I). 
 
 
Figure 29: SDS-PAGE protein profile analysis of whole cell proteins from E.coli cells 
accumulating PHA beads, and isolated and purified PHA beads. Lane M, molecular weight ladder 
(GangNam-STAIN prestained protein ladder); lane 1, BL21 (DE3) E.coli strain+pMCS69 
(BL21_69) harbouring pET14b (negative control); lane 2, BL21_69+pPolyC; lane 3, 
BL21_69+pET-14b PhaC-OpdA; lane 4, PhaC PHA beads; lane5, PhaC-OpdA PHA beads. 
 
3.2.2 PHA beads displaying OpdA in encapsulated alginate microspheres 
3.2.2.1 Characterisation of the microspheres 
The PHA beads encapsulated in alginate microspheres (PHA bead-alginate microspheres) 
were prepared by a water-in-oil (w/o) emulsion with internal gelation (Section 2.16.2). 
The morphology of the alginate microspheres was assessed by phase contrast microscopy 
(Section 2.17.1.1). The PHA bead-alginate microspheres were observed as small 
particulates in the alginate microspheres while blank alginate microspheres were clear 
and transparent (Figure 30). The presence of PHA beads in the alginate microspheres was 
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confirmed by staining the microspheres with Nile red (Section 2.13.1.1) and visualised 
using phase contrast and fluorescence microscopy (Section 2.17.1.1). The fluorescence 
indicated the presence of PHA beads, and the position of the fluorescence corresponded 
to the position of alginate microspheres in the phase contrast images in both PhaC PHA 
beads (Figure 30B and D) and PhaC-OpdA PHA bead-alginate microspheres (Figure 30C 
and E). Therefore, PHA beads were successfully encapsulated in alginate microspheres 
by the w/o emulsion with internal gelation. In addition, the microspheres were well 
dispersed and spherical, and no aggregation of the spheres was observed. Additional 
morphological analysis by SEM demonstrated that the blank alginate microspheres were 
spherical in shape, however, the surface texture was different. The negative control (blank 
alginate microspheres) had a smooth surface while PHA bead-alginate microspheres had 
a rough surface (Figure 31). 
 
 
Figure 30: Microscopic images of alginate microspheres encapsulating PHA beads prepared with 
internal gelation. A-C: Phase contrast microscopic images; A: blank alginate microspheres; B: 
PhaC-alginate microspheres; C: PhaC-OpdA-alginate microspheres. D and E: fluorescence 
microscopic images of corresponded alginate microspheres encapsulating PHA beads; D: PhaC-
alginate microspheres; E: PhaC-OpdA-alginate microspheres. 
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Figure 31: SEM analysis images of lyophilised blank alginate microspheres and PHA bead-
alginate microspheres prepared with internal gelation. A, blank alginate microspheres; B, PhaC-
alginate microspheres; C, PhaC-OpdA-alginate microspheres 
 
The particle size distribution of the alginate microspheres in the stock solution was 
measured by laser diffraction (Section 2.17.1.3.1). The volume density graph showed that 
the peak of the blank alginate microspheres was 86.4 µm, PhaC PHA bead-alginate 
microspheres was 144 µm, and PhaC-OpdA PHA bead-alginate microspheres was 163 
µm (Figure 32). These values were close to the median size of the particle size distribution 
(Table 13, Appendix II). The distribution of the microspheres was narrower for the blank 
alginate microspheres than alginate microspheres encapsulating PHA beads, indicating 
the blank alginate microspheres were prepared in a more uniform fashion than PHA bead-
alginate microspheres. 
 
 
Figure 32: Particle size distribution analysis of blank alginate microspheres and PHA bead-
alginate microspheres in water. 
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The encapsulation efficiency of PHA beads in alginate microspheres was determined 
using the combination of PHA beads extraction from alginate microspheres by 
solubilising the microspheres, the total protein quantification by the BCA assay, and the 
protein profiling of PhaC derived protein in the suspension by SDS-PAGE (Section 
2.17.1.4). The encapsulation efficiency of PHA beads in alginate microspheres is 
summarised in Table 6. The encapsulation efficiency of PhaC and PhaC-OpdA PHA 
beads was 88.2±0.04% and 88.5±2.0%, respectively, after the w/o emulsion with internal 
gelation preparation. Interestingly, the proportion of PhaC derived protein (PhaC or 
PhaC-OpdA) on PHA beads was increased by 4.6% for PhaC PHA beads and 8.5% for 
PhaC-OpdA PHA beads in the bead fraction after extraction from microspheres. 
 
Table 6: The encapsulation efficiency of PhaC and PhaC-OpdA PHA beads in alginate 
microspheres. 
PHA bead types Initial PhaC derived 
protein proportion 
(%)* 
Final PhaC derived 
protein proportion 
(%)* 
Encapsulation 
Efficiency (%) 
PhaC 40.4 45.0 88.2±0.04 
PhaC-OpdA 46.0 54.5 88.5±2.0 
Note: * Protein proportion obtained from densitometry on SDS-PAGE gel 
 
3.2.2.2 Functional assessment: Enzyme activity 
The enzymatic activity of PHA beads displaying OdpA in the free and the encapsulated 
state was monitored by the increase in fluorescence intensity created by the liberation of 
the product by the enzyme activity (Section 2.17.2.2). Figure 33 shows the transition of 
fluorescence intensity over 4 hours. The enzyme negative controls, including free PhaC 
PHA beads, blank alginate microspheres, and PhaC PHA bead-alginate microspheres, 
showed no change in the level of fluorescence intensity throughout 4 hours monitoring. 
The enzyme positive control, the free PhaC-OpdA PHA beads, showed a gradual increase 
in the fluorescence intensity as soon as the PHA beads were added into the solution 
containing the substrate. It was observed that the rate of activity steadily increased from 
0-2 hours, and then gradually decreased from 2 hours to the end of the measurement 
period. For PhaC-OpdA PHA bead-alginate microspheres, there was a significant 
reduction in the catalytic activity of OpdA when the PHA bead was encapsulated within 
alginate microspheres. The difference in fluorescence intensity level between the free and 
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the encapsulated state reached approximately 7.5 fold higher in the free PHA beads for 
approximately 1 hour then reached a maximum difference (8.19 fold) after 1.8 hours 
incubation. The difference gradually decreased from around 2 hours of incubation then 
reached 5.83 fold at the end of monitoring. The state of PHA bead-alginate microspheres 
in HEPES buffer (pH8.0) containing 20% v/v methanol during the monitoring process 
was observed by phase contrast microscopy and fluorescence microscopy (Section 
2.17.1.1) over 6 hours. This showed that the structure of alginate microspheres was 
retained with PHA beads remaining enclosed within the alginate microspheres throughout 
the observation (Figure 34). 
 
 
Figure 33: Enzyme kinetic curve of Coumaphos hydrolysis by free PHA beads and PHA bead-
alginate microspheres. 100 µg of protein on the beads was used. Controls were PhaC PHA beads, 
blank alginate microspheres, and PhaC PHA bead-alginate microspheres as negative control and 
PhaC-OpdA PHA beads as positive control. Beads and microspheres were incubated in 50mM 
HEPES buffer (pH8.0) with 20% methanol containing 200µM Coumaphos. The sample was 
measured in a cuvette (3.5 mL) with a magnetic stirrer and monitored over 4 hours.  
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Figure 34: Phase contrast and fluorescence microscopy images of alginate microspheres in the testing condition over 6 hours. The microspheres were stained 
with Nile red. The testing condition was 50 mM HEPES buffer (pH 8.0) with 20% v/v methanol at 25ºC with stirring by a magnetic stirrer at 300 rpm. The 
black bar represents 200 µm. 
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3.3 PHA beads encapsulated in alginate millispheres for removal of a lipophilic 
substance removal from aqueous solution 
3.3.1 PHA beads encapsulated in alginate millispheres 
3.3.1.1 Characterisation of the millispheres 
To produce PHA beads encapsulated in alginate millispheres (namely, PHA bead-alginate 
millispheres) for Nile red adsorption, a simple extrusion dropping method with external 
gelation was employed (Section 2.16.4). The method used CaCl2 as the cross-linking 
solution. Alginate millispheres are shown in Figure 35. The blank alginate millispheres 
were pale grey and transparent whereas PHA bead-alginate millispheres were white and 
opaque. Further image analysis by SEM (Figure 36) showed that lyophilised PHA bead-
alginate millispheres had a rough surface. The higher magnification image of the 
transection of a millisphere showed that the inner structure of the alginate matrix was 
rough, and tunnel-like structures could be observed. In the tunnel-like structures, PHA 
beads encapsulated in the alginate matrix can be seen, indicating successful 
immobilisation of the PHA beads in alginate millispheres. The millispheres were 
characterised by the diameter, wet weight, and PHA bead content. The characteristics of 
the millispheres are summarised in Table 7. The blank alginate millispheres were slightly 
smaller than PHA bead-alginate millispheres throughout all the parameters. The calcium 
concentration in the preparation influenced the particle size with increased particle size 
associated with lower concentration of calcium ion in the cross-linking solution. The 
alginate concentration also influenced the particle size as a lower concentration of 
alginate produced smaller millispheres. Meanwhile, the particle size showed no 
significant differences with the amount of PHA beads used in the preparation. The PHA 
bead amount per gram of alginate millispheres was measured by quantifying the amount 
of fusion protein on the PHA beads (Section 2.17.1.4). The PHA bead-alginate 
millispheres prepared with different concentrations of calcium ion (25-100 mM) showed 
a slight difference in the amount of PHA bead encapsulated however there was no 
significant difference among them. The concentration of PHA bead used in the 
preparation (0.5-1.5 %w/v PHA beads) directly correlated with the PHA bead amount per 
the weight of millispheres. The PHA bead-millispheres prepared with 1 %w/v alginate 
was a similar value to the millispheres prepared with 1.5 %w/v PHA beads due to smaller 
and lighter particles. 
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Figure 35: A representative image of blank alginate beads and PHA bead-alginate millispheres. 
A: Blank alginate millispheres; B: 1% w/v PHA bead-alginate millispheres. Both millispheres 
were formulated in 2% w/v alginate with 50mM CaCl2 cross-linking solution. 
 
 
Figure 36: SEM analysis images of a lyophilised PHA bead-alginate millisphere. A: A whole 
view of a PHA bead-alginate millisphere (2% w/v alginate, 1% PHA beads, and 50 mM Ca2+), B: 
High magnification image of inner structure of transection of the PHA bead-alginate millisphere. 
The arrow indicates the immobilised PHA beads inside the alginate matrix. 
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Table 7: Summary of blank alginate and PHA bead-alginate millisphere characteristics. 
 Particle size in 
diameter±SD 
(mm) 
Wet weight±SE 
(mg) 
PHA beads per 
gram of 
millispheres±SD 
(mg per g) 
Alginate millispheres 
Alginate 2%w/v; Ca2+ 25mM 2.70.1 8.2±0.1 - 
Alginate 2%w/v; Ca2+ 50mM * 2.5±0.1 8.1±0.1 - 
Alginate 2%w/v; Ca2+ 100mM 2.3±0.2 6.6±0.1 - 
Alginate 1%w/v; Ca2+ 50mM 2.0±0.2 4.0±0.1 - 
PHA beads encapsulated in alginate millispheres 
Alginate 2%w/v; PHA beads 
1%w/v;  Ca2+ 25mM 
2.8±0.1 8.6±0.1 19.2±0.8 
Alginate 2%w/v; PHA beads 
1%w/v; Ca2+ 50mM* 
2.8±0.2 8.0±0.1 17.4±0.5 
Alginate 2%w/v; PHA beads 
1%w/v; Ca2+ 100mM 
2.5±0.1 6.1±0.03 18.6±0.5 
Alginate 2%w/v; PHA beads 
0.5%w/v; Ca2+ 50mM 
2.7±0.2 7.5±0.02 9.1±0.9 
Alginate 2%w/v; PHA beads 
1.5%w/v; Ca2+ 50mM 
2.7±0.1 7.5±0.1 27.0±1.0 
Alginate 1%w/v; PHA beads 
1%w/v; Ca2+ 50mM 
2.2±0.1 4.2±0.1 27.4±1.9 
Note: SD, standard deviation; SE, standard error of mean;*, the standard preparation  
 
3.3.2 Functional assessment: Adsorption  
3.3.2.1 Adsorption kinetics 
To investigate the mechanism of adsorption of PHA bead-alginate millispheres, they were 
prepared with different parameters, and the difference in the adsorption kinetic 
performance among these parameters was analysed (Section 2.17.2.3.1). In this 
investigation, the parameters were calcium ion concentration ranging from 25-100 mM, 
the amount of PHA beads ranging from 0.5-1.5 % w/v, and alginate concentration ranging 
from 1-2 % w/v. The PHA bead-alginate millispheres prepared with 2% w/v alginate, 1% 
w/v PHA beads, and 50 mM calcium ion was used as the standard preparation. The 
interaction between Nile red and the glassware was measured at each selected sampling 
time in the 24 hours incubation. The Nile red concentration reduced in the first hour of 
incubation, however, the concentration was close to the initial concentration and stayed 
at a constant level during the incubation (Figure 44, Appendix IV). 
The adsorption kinetics of PHA bead-alginate millispheres prepared with different 
concentrations of calcium ion in the cross-linking solution is shown in Figure 37. The 
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blank alginate millispheres prepared with 25-100 mM calcium ion showed no significant 
transition over the 24 hours incubation. The trend of increasing capacity to adsorb the dye 
was observed in all the type of PHA bead-alginate millispheres as soon as they were added 
to the Nile red solution. The rate of increase in adsorption capacity was higher in 
millispheres prepared with higher concentrations of calcium ion. The equilibrium 
adsorption capacity was at 3.10 ng/mg, 3.61 ng/mg (standard preparation), and 4.39 
ng/mg for 25, 50, and 100 mM calcium ion, respectively, and the equilibrium point was 
observed after approximately 15-18 hours incubation. The adsorption kinetic of PHA 
bead-alginate millispheres prepared with different amounts of PHA beads is shown in 
Figure 38. The blank alginate beads showed no increase in adsorption capacity over the 
24 hours incubation. The adsorption of Nile red was observed, and the rate of increase in 
adsorption capacity was higher in beads prepared using a higher amount of PHA beads. 
The equilibrium was observed at 2.7 ng/mg after 15 hours for 0.5%w/v PHA beads with 
a slight increasing trend for 1.5% w/v PHA beads after 24 hours incubation. However, 
this was within the standard deviation. Therefore, the beads prepared with 1.5%w/v PHA 
beads was assumed to reach the adsorption equilibrium at 18-24 hours incubation. The 
adsorption capacity was also calculated based on the amount of PHA beads used in the 
preparation between 0.5-1.5% w/v PHA beads instead of millisphere weight. The 
adsorption equilibrium point of 0.5, 1.0, and 1.5 % w/v PHA beads was 299, 207.5, and 
159.3 ng/mg of PHA beads, respectively. The adsorption kinetic of PHA bead-alginate 
millispheres prepared with different concentrations of alginate is shown in Figure 39. The 
alginate concentration did not influence the adsorption capacity as shown by the negative 
controls. With the millispheres encapsulating PHA beads, the rate of increase was higher 
in millispheres prepared with the lower concentration of alginate. In addition, the 
adsorption equilibrium point of the millispheres prepared with 1% w/v alginate was 4.09 
ng/mg after 12-15 hours incubation which was higher and faster than the standard 
preparation (3.61 ng/mg after 15-18 hours). 
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Figure 37: Equilibrium Nile red adsorbed as a function of time using different concentrations of 
calcium in the preparation of millispheres. The concentration of CaCl2 used in the crosslinking 
solution: 25mM, 50mM or 100mM; Alginate: 2.0% w/v; PHA beads: 0%, as negative control and 
1.0% w/v; initial concentration of Nile red solution containing 10% v/v DMSO: 70 ng/ml; 
incubation; 25°C with 100rpm shaking for 24 hours. The measurement was done in triplicate and 
mean ± standard deviation is reported. 
 
  
Figure 38: Equilibrium Nile red adsorbed as a function of time using different amount of PHA 
beads in the preparation of millispheres. The amount of PHA beads used: 0.5, 1.0 or 1.5% w/v; 
Alginate: 2.0% w/v; CaCl2 concentration: 50 mM; initial concentration of Nile red solution 
containing 10% v/v DMSO: 70 ngml-1; incubation: 25°C with 100rpm shaking for 24 hours. The 
measurement was done in triplicate and mean ± standard deviation is reported. 
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Figure 39: Equilibrium Nile red adsorbed as a function of time using different concentrations of 
alginate in the preparation of millispheres. Alginate concentration: 1.0 or 2.0%w/v; CaCl2 
concentration: 50mM ; PHA beads: 0%, as negative control and 1.0% w/v;  initial concentration 
of Nile red solution containing 10% v/v DMSO: 70ngml-1; incubation: 25°C with 100rpm shaking 
for 24 hours. The measurement was done in triplicate and mean ± standard deviation is reported. 
 
The process of Nile red removal from the aqueous solution was analysed by pseudo-first 
order and pseudo-second order kinetic models. The pseudo-first order model of Lagergren 
is expressed as: 
!"#(%& − %() = !"#%& − +,2.303 1 
where qe and qt are the amount of Nile red adsorbed to the alginate bead at equilibrium 
and at time (t), respectively (ng/mg). k1 is the rate of constant of first-order adsorption (h-
1). A straight line was plotted by log (qe-qt) versus t to determine the rate constant (k1) 
and the correlation coefficient (R2). The plotted straight line from the pseudo-first order 
kinetic model is shown in Figure 40. 
The pseudo-second order kinetic model is expressed as: 1%( = 1+3%&3 + 1%& 1 
where k2 is the rate constant of second order adsorption (ng/mgml), qe and qt are the 
maximum adsorption capacity and at time (t), respectively. A straight line was plotted by 
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t/qt versus t to determine the rate constant (k2) and correlation coefficient (R2). The plotted 
line of the pseudo-second order kinetic model is shown in Figure 40. From the value 
obtained, the initial sorption rate (V0, ng/mgh) was calculated by the following equation: 
56 = +3%&3 
 
 
Figure 40: Adsorption kinetic data for PHA bead-alginate millispheres fitted to linear form of 
pseudo-first order and pseudo-second order kinetic models. 
 
The summary of the calculated experimental data by pseudo-first and pseudo-second 
order kinetic models is summarised in Table 8. The calculations were also applied to the 
blank alginate millispheres. The results showed that the data did not match the pseudo-
first order kinetic model, and poor correlation coefficient values in all the parameters in 
both order kinetic models, indicating the millispheres did not function for adsorbing Nile 
red. For the PHA bead-alginate millispheres, the values of adsorption capacity (qe) 
calculated by the pseudo-first order was less than the values observed in experimental 
data by 0.1-1.5 ng/mg while more in the pseudo-second order by 0.5-0.7 ng/mg. The 
correlation coefficient (R2) for the pseudo-first order was between 0.849-0.917 and was 
0.992-0.999 for the pseudo-second order. The results of the pseudo-second order kinetic 
model clearly fitted the experimental data plotted in the adsorption kinetic tests. These 
results suggested that the adsorption system obeys the pseudo-second order kinetic model. 
As shown in the initial sorption rate (V0) values obtained by the pseudo-second order 
kinetic model, the rate of adsorption was faster for higher concentrations of calcium ions, 
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more PHA beads, and lower concentrations of alginate used in the preparation of 
millispheres. 
Table 8: Summary of pseudo-first and pseudo-second order kinetic model of blank alginate and 
PHA encapsulated in alginate millispheres. 
 Pseudo-first order  Pseudo-second order 
 k1 
(h-1) 
qe 
(ng/mg) 
R2  V0 
(ng/mgh) 
k2 
(ng/mgml) 
qe 
(ng/mg) 
R2 
Blank alginate millispheres 
Alginate 2%w/v;25mM Ca2+ 0.0723 5.372 0.754  0.0449 0.671 0.259 0.771 
Alginate 2%w/v;50mM Ca2+  0.00346 2.014 0.026  0.0146 0.0324 0.671 0.021 
Alginate 2%w/v;100mM Ca2+  n/a* n/a* n/a*  -0.0322 -4.83 0.0816 0.864 
Alginate 1%w/v;50mM Ca2+ n/a* n/a* n/a*  0.0918 4.16 0.149 0.937 
PHA beads encapsulated in alginate millispheres 
Alginate 2%w/v; PHA beads 
1%w/v; 25mM Ca2+ 
0.0682 2.799 0.917  0.798 0.0554 3.791 0.997 
Alginate 2%w/v; PHA beads 
1%w/v; 50mM Ca2+ 
0.0725 2.949 0.886  1.091 0.0591 4.296 0.997 
Alginate 2%w/v; PHA beads 
1%w/v; 100mM Ca2+ 
0.0751 3.179 0.849  1.562 0.0596 5.118 0.995 
Alginate 2%w/v; PHA beads 
0.5%w/v; 50mM Ca2+ 
0.0643 2.583 0.884  0.637 0.0542 3.426 0.992 
Alginate 2%w/v; PHA beads 
1.5%w/v;50mM Ca2+ 
0.076 3.215 0.882  1.483 0.0597 4.985 0.998 
Alginate 1%w/v; PHA beads 
1%w/v; 50mM Ca2+ 
0.0854 2.579 0.877  1.916 0.0922 4.56 0.999 
* Unable to calculate due to mathematical error 
 
3.3.2.2 Adsorption isotherm 
To analyse the interactive behaviour of PHA bead-alginate millispheres with Nile red in 
the aqueous solution, the adsorption isotherm test in Nile red solution ranging from 10-
100 ng/ml Nile red concentration was conducted (Section 2.17.2.3.2). Initially, the 
interaction between glassware and Nile red in the solution was analysed in the blank flask 
containing the reagent solution after 24 hours incubation (Section 2.17.2.3.4). This 
confirmed that there was no interaction between the glassware and the Nile red (Figure 
45, Appendix IV). In this test, the standard preparation which was prepared with 2% w/v 
alginate, 1% w/v PHA beads and gelated by 50 mM calcium ion, was compared with the 
blank alginate millispheres. Figure 41 shows the adsorption isotherm of blank alginate 
millispheres and PHA bead-alginate millispheres. It was observed that the adsorption of 
Nile red occurred in PHA bead-alginate millispheres, and the degree of adsorption 
increased as the initial concentration of Nile red in the solution increased. Meanwhile, 
there was no adsorption observed in the blank alginate millispheres. 
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Figure 41: Adsorption isotherm of blank alginate millispheres and PHA bead-alginate 
millispheres. Millispheres: 0.2g; Nile red concentration: 10-100ngml-1; pH: pH 6.7. The 
measurement was done in triplicate and means ± standard deviation is reported. 
 
To quantify the adsorption capacity of blank alginate millispheres and PHA bead-alginate 
millispheres for Nile red adsorption from the aqueous solution, two most commonly used 
isotherm models were employed in this study, namely the Freundlich and Langmuir 
isotherm model. The Freundlich isotherm model can be represented by the following 
equation: 
%& = 789&,/; 
Where qe is the solid phase concentration at equilibrium (ng/mg), Ce is the aqueous phase 
concentration at equilibrium (ng/ml), KF is an indicator of the adsorption capacity, and 
1/n represents the adsorption intensity. The results obtained from the experiment were 
analysed by plotting linear line produced by qe versus Ce. The following equation for the 
Freundlich isotherm formula was used: 
log %& = log78 + 1? log 9& 
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 The Langmuir isotherm model can be represented by the following equation: 
%& = %@A9&1 + A9& 
Where qe is the equilibrium adsorption of solid phase (ng/mg), Ce is the equilibrium 
concentration of the aqueous phase (ng/ml), qm is the maximum adsorption capacity 
(ng/mg), and b is the Langmuir isotherm constant (ml/ng). The linear equation of the 
above formula to plot qe versus Ce was: 1%& = B 1A%@C 19& + 1%@ 
The linearised isotherm calculated by the Freundlich and Langmuir isotherm linear 
formulae are shown in Figure 42, and the resulting values were summarised in Table 9. 
 
 
Figure 42: Adsorption isotherm data for blank alginate millispheres and PHA bead-alginate 
millispheres fitted to linear form of the Freundlich and Langmuir adsorption isotherm models.  
 
Table 9: Summary of adsorption isotherm calculated by the Freundlich and Langmuir isotherm 
models. 
 Frundlich Langmuir 
 KF 
(ng/mg(ng/ml)n) 1/n R
2 qm (ng/mg) b (ml/ng) R2 
Alginate 
millispheres 0.023 1.874 0.501 0.234 0.052 0.227 
PHA bead-alginate 
millispheres 0.040 0.882 0.995 -6.566 -0.007 0.984 
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According to the Freundlich isotherm result, the adsorption capacity of PHA bead-
alginate millispheres was slightly higher than the blank alginate millispheres, however, 
the adsorption intensity value was lower than the negative control. In contrast, the 
Langmuir isotherm result showed that the adsorption capacity of the PHA bead-alginate 
millispheres exhibited much lower value in comparison with the negative control. 
However, it must be noted that the correlation coefficient of the blank alginate 
millispheres for both isotherm models showed poor correlations (R2=0.501 for Freundlich 
and R2=0.227 for Langmuir). This indicated that the blank alginate millispheres fitted 
neither isotherm model. Furthermore, based on the correlation coefficient, PHA bead-
alginate millispheres showed a better fit to the Freundlich isotherm model than the 
Langmuir isotherm model (R2=0.995 for Freundlich and R2=0.984 for Langmuir). 
Moreover, the value obtained from the Langmuir isotherm model showed negative values. 
This indicated the isotherm model did not fit the adsorption performance of PHA bead-
alginate millispheres. 
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Chapter 4: Discussion 
4.1 Preparation of PHA beads for alginate encapsulation 
Previous studies have demonstrated the successful production of genetically engineered 
PHA beads displaying a range of functionalised proteins on their surface (Grage et al., 
2009; Parlane et al., 2017). This study aimed to produce alginate microspheres 
encapsulating the functionalised PHA beads and to evaluate the difference in functional 
activity of the protein on the PHA beads in the free and the encapsulated state. It was 
hypothesised that the fusion protein on PHA beads retains functional activity in the 
alginate microspheres, and the encapsulation within the alginate gel matrix will influence 
the level of the activity. In this study, PHA beads displaying ZZ domain (IgG binding 
domain) and OpdA (organophosphate hydrolase) were selected for encapsulating in 
alginate microspheres.  
As shown in the fluorescence microscopy images (Figure 12 and Figure 25) and the TEM 
images (Figure 13 and Figure 26), E. coli cells transformed with the respective plasmids 
were shown to contain PHA beads, indicating the activation of PHA synthase (PhaC) that 
catalyses the synthesis of the PHA to mediate the bead formation (Rehm, 2007). 
Furthermore, SDS-PAGE gel confirmed the overproduction of the fusion protein 
displayed on the PHA bead, and the predominant band corresponded to the expected 
theoretical molecular weight (Figure 16 and Figure 29). Other protein bands were still 
present after PHA bead isolation and purification procedures, and these may be a part of 
commonly found co-purified proteins such as ATPase, Elongation factor-Tu and outer 
membrane proteins (OmpF and OmpA) (Bäckström et al., 2007). The particle size of the 
PHA beads measured using laser diffraction showed that particle size was larger than the 
general particle size of a single PHA bead (50-500 nm in diameter) (Grage et al., 2009). 
Therefore, the particle size distribution results in this study of 1-100 µm in diameter 
indicated that PHA beads were aggregated. This observation was also seen in a previous 
study (Reyes et al., 2016). The aggregation was probably due to non-specific 
intermolecular and hydrophobic interactions. In addition, due to the small particle size of 
the PHA beads, material factors (size, shape, and surface charge) and environmental 
factors (temperature, gravity force, pH and ionic strength of solution) may cause the 
formation of the aggregates (Zhang, 2014). As shown in Figure 17 and Figure 33, the 
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functional activity of the fusion proteins on the surface of PHA beads was confirmed 
before producing PHA beads encapsulated in alginate microspheres. 
4.2 PHA beads encapsulated in alginate microspheres 
4.2.1 Internal gelation 
The PHA beads displaying the ZZ domain (an IgG binding domain) or OpdA were 
encapsulated in alginate microspheres using a water-in-oil (w/o) emulsion with internal 
gelation in which calcium crosslinking is induced by the calcium ion release from 
insoluble calcium (CaCO3) by pH reduction (Poncelet, 2001). This method produces 
micron-sized alginate spheres (Fundueanu et al., 1999). This is considered the most 
favourable particle size for the functional tests in this study because small particle sizes 
give higher specific surface area and reduce the distance between the functional proteins 
displayed on PHA beads and its substrate (Doherty Speirs et al., 1995; Hussain et al., 
2015). For the IgG binding test using alginate microspheres encapsulating ZZC PHA 
beads, the microspheres were subjected to an additional gelation (double gelation) 
(Section 4.2.2). The alginate microspheres encapsulating OpdA PHA beads were 
prepared with internal gelation only. 
4.2.1.1 Morphology of PHA beads encapsulated in alginate microspheres 
The alginate microspheres prepared by the w/o emulsion with internal gelation produced 
micron-sized and spherical-shaped microspheres as expected. The morphology was easily 
distinguishable between blank and PHA bead-alginate microspheres using a phase 
contrast microscope, as there were particulates enclosed in the alginate microspheres, 
while blank alginate microspheres were transparent (Figure 30). The presence of PHA 
beads in the alginate microspheres was readily confirmed by Nile red staining 
(Spiekermann et al., 1999). SEM image analysis showed both blank and PHA bead-
microspheres were spherical, discrete, and distinct with a solid dense structure (Figure 
31). For the PHA bead-alginate microspheres, the surface texture was seen as very rough, 
and PHA beads were seen exposed on the outer surface of the microsphere. There were 
no apparent morphological differences between microspheres prepared with internal 
gelation only and double gelation (Figure 19 and Figure 36). The rough surface 
morphology in SEM images may be due to the sample preparation method, which used 
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ethanol to dehydrate the alginate microspheres, and the intrinsic structure of the PHA 
bead polymer core resisted further shrinkage of the microspheres during lyophilisation.  
4.2.1.2 Particle size distribution of alginate microspheres: Internal gelation 
As expected, the particle size distribution of alginate microspheres prepared by the w/o 
emulsion with internal gelation was relatively uniform (a unimodal distribution with no 
secondary peaks) (Figure 32). This observation was commonly observed in previous 
studies using this method (Silva et al., 2006; Wang et al., 2011; Lupo et al., 2014). The 
diameter distribution of alginate microspheres prepared by this method depends on the 
droplet size in the dispersed phase of the emulsion. The size of the droplet is determined 
by a balance between dispersive force and the surface tension force that emulsify the 
mixture and cause merging of droplets, respectively (Reis et al., 2006; Ching et al., 2017). 
In the present study, a lipophilic surfactant, Span80, was used to reduce the interfacial 
tension between the dispersed (water) phase droplets and paraffin oil in the continuous 
(oil) phase, promoting an increase in stability of the w/o emulsion (Ching et al., 2017). 
Therefore, the particle size distribution in this study generated relatively uniform particle 
sizes of microspheres when prepared using the same parameters.  
A change in the stirring speed, hence dispersive force, influenced the particle size 
distribution of the alginate microspheres prepared at 250, 350, and 450 rpm (Table 12, 
Appendix II). This observation agrees with previous studies (Perumal, 2001; Silva et al., 
2006) that demonstrated higher stirring speed decreased the particle size. However, it has 
also been reported that using higher stirring speed increased particle size distribution, 
causing higher heterogeneity of the batch (Silva et al., 2005; Mokhtari et al., 2017). In 
the w/o emulsion, shear stress is higher at the tip of the propeller than at the centre, 
creating a difference in energy distribution. The higher stirring speed modifies the random 
droplet coalescence, and consequently gives rise to an increase in particle size distribution 
(Silva et al., 2006). However, in this study, the particle size distribution of microspheres 
prepared with different stirring speeds gave no significant difference in SPAN factor 
(which represents the spread of the particle size distribution). The broader size 
distribution has been observed at higher stirring speeds (higher than 600 rpm) than used 
in the present study (Silva et al., 2005). Therefore, the lack of heterogeneity may be due 
to the stirring speeds selected (250, 350, and 450 rpm). Simultaneously, the interfacial 
tension reduction induced by emulsifiers (Reis et al., 2006) as well as physical properties 
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of materials, such as viscosity of water phase and oil phase (Hudson et al., 2003; De 
Bruyn et al., 2014), might have contributed to the stability of the emulsion and helped to 
avoid the coalescence of the droplets. 
4.2.1.3 Encapsulation efficiency 
The encapsulation efficiency of PHA beads in alginate microspheres was determined by 
quantifying the amount of fusion protein on the PHA beads in combination with protein 
profiling by SDS-PAGE. The results showed the microspheres prepared with w/o 
emulsion with internal gelation had a high encapsulation efficiency. The microspheres 
prepared for an IgG binding test (PhaC and ZZC PHA beads) had an encapsulation 
efficiency of more than 92 % meanwhile microspheres prepared for the enzyme test 
(PhaC and PhaC-OpdA PHA beads) demonstrated more than 88 % encapsulation 
efficiency. The loss of encapsulated material, leading to a reduced encapsulation 
efficiency, is often due to the diffusion of encapsulated materials out through the porous 
gel structure created by the release of CO2 during the solubilisation of CaCO3 in the 
internal gelation reaction (Silva et al., 2005; Lee & Mooney, 2012). The high 
encapsulation efficiency in this study might be attributed to the particle size of the PHA 
beads. The bead particle size could be larger than the pore size of the alginate gel matrix, 
preventing leakage of the PHA beads out from the microspheres. Moreover, this may also 
explain the increase in the proportion of PhaC derived protein on the PHA beads observed 
after the PHA beads were extracted from the microspheres (Table 5 and Table 6). The 
non-immobilised proteins, such as bacterial membrane proteins, diffused out of the 
microspheres while the PHA beads remained within the alginate microspheres. Therefore, 
this highlights the advantage of protein immobilisation on PHA beads as they can retain 
protein at relatively high levels within alginate microspheres. 
In this study, the high encapsulation efficiency of proteins on PHA beads was obtained 
using an acidic acetate buffer as the recovery medium from the emulsion in the washing 
cycle as previously reported (Silva et al., 2005). The reduction in pH influences the degree 
of ionisation of proteins that promote interactions between proteins and the alginate 
polymer of opposite charge (Dumitriu & Chornet, 1998). The acetate buffer was pH 5.5 
so alginate remained in a polyanionic state (pKa of M and G residual are 3.38 and 3.65, 
respectively) (Ching et al., 2017). The theoretical isoelectric point (pI) of PhaC, ZZC, 
and PhaC-opdA proteins given by ExPASy pI/Mw tool is 6.09, 5.75, and 6.47 
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respectively, therefore, the proteins were considered to be positively charged in the acidic 
conditions. The positively charged proteins may contribute to the high encapsulation 
efficiency by forming an electrostatic interaction with the alginate polymer throughout 
the washing procedure. Moreover, microsphere recovery using an acetate buffer was 
considered to maintain the solubilisation of the remaining CaCO3 in microspheres, thus 
contributing to the gel strength of the microspheres (Silva et al., 2005). 
4.2.2 Double gelation: Microsphere preparation with internal gelation followed by 
additional gelation 
The original design of preparing the ZZ domain-displaying PHA beads encapsulated in 
alginate microspheres aimed to use only internal gelation and to analyse the IgG binding 
capacity of this in packed bed column utilising the porous structure of the resulting 
alginate microspheres. However, the microspheres showed not enough mechanical 
strength to be retained in the column even at a low centrifugation, had low PHA bead 
density per unit volume, and showed very poor mass transport (Data not shown). 
Therefore, the additional gelation step was conducted to provide higher mechanical 
strength by creating more interaction between calcium ions and alginate (Donati & 
Paoletti, 2009), and to increase the PHA bead density per unit volume by condensing the 
microsphere. However, increased alginate gel network leads to a greater resistance to 
liquid mass transport (Amsden & Turner, 1999). Therefore, a conventional affinity 
chromatography protocol was employed in the column test instead of the packed bed 
column chromatography in this study. 
4.2.2.1 Morphology and particle size distribution: Double gelation 
There were no distinctive differences in the morphology between microspheres prepared 
with double gelation and internal gelation only. Instead, the fluorescence images 
suggested the PHA beads within alginate microspheres prepared with double gelation 
were more dense (Figure 18D, E and Figure 30D, E), indicating the additional gelation 
influenced the structural characteristic of microspheres. The result from laser diffraction 
supports this as it showed the additional gelation resulted in a reduction in particle size of 
50-70%. It was observed that the percentage reduction in diameter of alginate 
microspheres was higher for microspheres prepared at lower stirring speed in the internal 
gelation step (Table 12, Appendix II). This was probably due to the addition of extra 
calcium ions inducing gel shrinkage by increasing the degree of cross-linkage between 
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the free G residual of alginate polymer and calcium ion (Martinsen et al., 1989). Also, 
the larger microspheres produced by a slower stirring speed provide more interior space 
for calcium ion to react the free G residual and therefore capable of a higher degree of 
shrinkage than smaller microspheres. Surprisingly, in contrast to the previous study that 
used CaCl2 solution for the microsphere recovery medium from w/o emulsion (Poncelet 
et al., 1992), the median particle size decreased, and the particle size distribution 
remained unimodal in this study (Figure 20). Previous studies reported CaCl2 washing 
causes the loss of water molecules from microspheres that induces gel shrinkage, but also 
induces adhesion between microspheres results in their aggregation by forming a new 
hydrogen bond between hydroxyl groups of alginate polymers. As a result, there will be 
an increase in median size (Poncelet et al., 1995; Fundueanu et al., 1999; Chai et al., 
2004). However, in this study, increase in median particle size was not observed. 
Therefore, the results suggest additional gelation after a full recovery process from the 
emulsion allows the alginate microspheres to remain discrete with a unimodal particle 
distribution. 
4.2.2.2 Encapsulation efficiency after additional gelation (double gelation) 
The encapsulation efficiency of microspheres prepared with double gelation was reduced 
by 34 % for PhaC PHA beads and 26.1 % for ZZC PHA beads compared with internal 
gelation only. The significant loss of encapsulated material by the additional gelation has 
also been demonstrated in the microsphere recovery from a w/o emulsion and may be due 
to the release of encapsulated PHA beads into the CaCl2 solution (Ostberg et al., 1993; 
Silva et al., 2005). However, as expected, the double gelation microspheres produced 
denser PHA beads within the microspheres than microspheres prepared with only internal 
gelation as suggested by the fluorescent microscopy results (Figure 18 and Figure 30). 
Although this is qualitative data, it could indicate that external pressure created by the 
addition of calcium ion and alginate polymer interaction (Donati & Paoletti, 2009), and 
the relatively large pore size created by internal gelation (Liu et al., 2002), released PHA 
beads into the cross-linking solution, resulting in lowering the encapsulation efficiency. 
4.2.2.3 Effect of different solutions 
The particle size distribution of alginate microspheres prepared for the IgG binding test 
was measured in water, TBS (50 mM Tris, 50 mM NaCl, pH7.4) and 100 mM glycine 
(pH2.5) solutions. The results confirmed that there was a change in particle size in the 
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buffer solution tested (Figure 20 and Table 12, Appendix II). As expected, the degree of 
swelling was higher in TBS than glycine buffer because of its ionic strength and neutral 
pH (Matyash et al., 2014). Unexpectedly, the alginate microspheres in glycine (pH 2.5) 
showed larger particle sizes than in water even though the microsphere size is known to 
decrease at low pH (Lee et al., 1997; Darrabie et al., 2006; Soni et al., 2010). Therefore, 
it indicated that glycine buffer induced swelling of microspheres even at low pH. The 
smaller particle sizes observed in water could be due to the loss of water molecules from 
the microspheres, which accompanied ion diffusion to the external solution in low 
osmolarity (Martinsen et al., 1989). 
The laser diffraction results showed alginate microspheres prepared with double gelation 
at 250-450 rpm produced particle sizes >10 µm in all of the preparations. This is bigger 
than the pore size of the porous support of the test column (Pierce™ Spin Cups Paper 
Filter column (Section 2.17.2.1.2)). The particle size is an important factor as smaller 
particles provides higher specific surface area and more efficient exchange of components 
in and out of the microsphere (Paques, 2015). In this study, there were two reasons to 
choose the alginate microspheres prepared at 350 rpm to use for the following IgG 
binding capacity test. These are: (1) to avoid the potential leakage through the porous 
support of the column by small alginate microspheres with particle sizes prepared at 450 
rpm and (2) to give high efficiency of substrate exchange due to generating the smallest 
diameter particle possible. 
4.2.3 IgG binding test 
4.2.3.1 IgG binding assay to PHA bead-alginate microspheres 
IgG binding capacity of PHA bead-alginate microspheres was assessed by an IgG binding 
assay in batch and column test conditions using purified human IgG. It was found that 
there was no significant difference in the IgG binding capacity between blank alginate 
microspheres, PhaC PHA bead-alginate microspheres, and ZZC PHA bead-alginate 
microspheres (Figure 21). These results indicated that IgG binds non-specifically to the 
alginate microspheres. In addition, the elution fraction analysis showed almost no IgG, 
indicating the bound IgG was not eluted from the microspheres. SDS-PAGE confirmed 
IgG was present in the microspheres before and after the elution phase. Also, the extracted 
PHA beads still contained bound IgG to the PhaC derived proteins after elution showing 
that the pH reduction by 100 mM glycine (pH 2.5) did not cause elution of IgG in the 
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microspheres (Figure 23). A previous study has shown that IgG can diffuse into alginate 
microspheres (Mørch et al., 2006), and another study has demonstrated the 
immobilisation of IgG in alginate microspheres in a pH neutral solution via electrostatic 
interaction with calcium ions (Chen et al., 2013). Therefore, these studies may help 
explain the results in this study that no significant difference in the level of IgG binding 
capacity found between all the types of alginate microspheres. Alginate microspheres 
have been reported to be responsive to external stimuli such as the pH and ionic strength 
of the buffer solution (Lee et al., 1997; Ching et al., 2017). Previous studies demonstrated 
encapsulation of protein in alginate microspheres for oral delivery purposes and showed 
that the cumulative release of the encapsulated material was limited in low pH medium 
(Martins et al., 2007; Isiklan et al., 2011; Zhang et al., 2011). This is attributed to 
shrinkage of the alginate microspheres and the reduction of pore size of the alginate gel 
matrix (Gombotz & Wee, 2012). In the present study, particle size reduction was also 
observed (Figure 20). Therefore, the low pH of 100 mM glycine (pH 2.5) may have 
caused the particle size and pore size reduction, which in turn inhibited the movement of 
IgG out from the alginate microspheres. A difference in IgG binding capacity between 
batch and column test condition was found, however, this was due to the degree of liquid 
removal before the microspheres were weighed. 
4.2.3.2 IgG binding test to the PhaC derived proteins on PHA beads in alginate 
microspheres 
As discussed above, the IgG binding capacity assay in batch and column conditions did 
not show a significant difference between blank alginate microspheres and PHA bead-
alginate microspheres (Figure 21). However, SDS-PAGE confirmed the presence of IgG 
in the alginate microspheres and the IgG was bound to both PhaC derived proteins (PhaC 
or ZZC) on PHA beads in alginate microspheres (Figure 23). Therefore, the effect of 
alginate encapsulation on the amount of IgG bound to the PhaC derived proteins on PHA 
beads was investigated by quantifying bound IgG on the protein of the extracted PHA 
beads from alginate microspheres using SDS-PAGE gel densitometry (Figure 43, 
Appendix III). In comparison with IgG binding capacity value obtained from a previously 
described IgG binding assay (Jahns et al., 2013), the SDS-PAGE gel densitometry of free 
PHA beads resulted in similar values (Figure 17 and Figure 24), indicating the feasibility 
of testing the IgG binding capacity using this method. The amount of IgG bound to the 
PhaC derived protein on the PHA beads encapsulated in alginate microspheres was 
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significantly higher than on the corresponding free bead state in both test conditions 
(batch and column). However, there was very little difference in the amount of IgG bound 
to the PhaC derived proteins in the different test conditions (p>0.05). Since ZZ domain-
displaying PHA beads have IgG binding sites (ZZ), the amount of bound IgG was much 
higher than that of PhaC PHA beads, even after alginate encapsulation. These results 
indicate that the IgG binding domain displayed on PHA beads within an alginate hydrogel 
matrix was capable of binding IgG, and the alginate encapsulation enhanced the binding 
ability of the PhaC derived protein on PHA beads with IgG. Further studies are needed to 
investigate why the amount of bound IgG to the PhaC derived protein on PHA beads in 
alginate microspheres was enhanced, however, the protocol in the IgG binding assay 
might explain the difference in the binding performance. According to the conventional 
protocol for analysing IgG binding capacity of PHA beads as described in Jahns et al. 
(2013), free PHA beads were collected by centrifugation and were re-suspended by 
pipetting. At each step, PHA beads in the test may form aggregates, which significantly 
reduce the specific surface area of the functionalised PHA beads. In contrast, the 
encapsulated PHA beads are entrapped and immobilised in the alginate gel matrix of 
microspheres, which effectively prevented aggregation of PHA beads. Therefore, it could 
be considered that the specific surface area of PHA beads was more easily retained than 
with the free PHA beads. 
As expected, the free PHA beads showed a reduction in bound IgG after elution indicating 
the IgG was eluted successfully (Figure 24, ZZC). Interestingly, the amount of IgG bound 
on the PhaC derived proteins of the encapsulated PHA beads of both encapsulated PhaC 
and ZZC PHA beads was significantly higher after the elution phase than after the binding 
phase (Figure 24). This indicates that the bound IgG after the binding phase was not eluted, 
however, IgG binding to the protein on PHA beads was enhanced. From the observation 
of particle size reduction in low pH (Figure 20) and lack of IgG elution after triplicate 
elution phase (Figure 21), the following explanations for this are suggested. The alginate 
microspheres were dispersed in the low pH medium, reducing particle size and pore size 
of microspheres, thus inhibiting movement of IgG out from the microspheres and leading 
to entrapment of IgG within the microspheres. Subsequently, the physical distance 
between IgG and the protein displayed on the PHA beads was decreased and the reduction 
in particle size possibly increased the inner pressure of the alginate microsphere, assisting 
binding of IgG towards the protein on PHA beads. Alternatively, it may simply be that 
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the PhaC derived proteins on the encapsulated PHA beads were exposed to IgG for a 
longer time in the microspheres. Further studies are needed to investigate these 
possibilities.  
4.2.4 Enzyme activity 
The fluorescence intensity created by the liberated  chlorferon from Coumaphos was used 
as a measure of the catalytic activity of the encapsulated OpdA displayed on the PHA 
beads in alginate microspheres. The result showed there was no change in the level of 
fluorescence intensity for the negative controls, including free PhaC PHA beads, blank 
alginate microspheres, and PhaC PHA bead-alginate microspheres. These results 
confirmed that the alginate gel matrix and PHA beads lacking the OpdA do not possess 
functionality in the catalytic reaction of the substrate. As expected, the free PhaC-OdpA 
PHA beads showed a gradual increase in the fluorescence intensity as soon as the PHA 
beads were introduced in the solution containing the substrate. This indicates the OpdA 
on the PHA beads functioned. The PhaC-OdpA PHA bead-alginate microspheres also 
showed an increase in fluorescence intensity, thus the catalytic activity of the 
encapsulated PHA beads displaying OpdA in the alginate microsphere gel matrix was 
confirmed. However, the rate of the activity of the encapsulated PhaC-OdpA PHA beads 
was significantly reduced compared to the free PhaC-OdpA PHA beads. Therefore, the 
catalytic activity of OpdA on the PHA beads was restricted by the alginate encapsulation. 
In previous studies, this phenomenon has also been reported, and they suggested that there 
might be limitations in mass transfer of substrate into the microspheres in order to reach 
the active site of the enzyme (Blandino et al., 2003; Rehman et al., 2013; Nawaz et al., 
2015). In addition to this, the substrate in this study, Coumaphos, is a hydrophobic 
compound (Sanchez-Bayo & Goka, 2014) while its hydrolysis products, chlorferon and 
diethylthiophosphate (DETP), have higher water solubility and have been shown to 
diffuse into alginate hydrogel (Ha et al., 2008). Therefore, these chemical properties 
might also influence the rate of diffusion into the hydrophilic microenvironment inside 
the alginate microspheres, and limit the exchange of substrate into the alginate 
microspheres.  
The catalytic activity observed in this test could be attributed to PHA beads released from 
the microspheres. To exclude this possibility, the Nile red-stained PHA bead-alginate 
microspheres were monitored by phase contrast and fluorescence microscopy to observe 
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the microspheres structure and the position of PHA beads in the test conditions (Figure 
34). The images showed that the microspheres structure was maintained and the PHA 
beads remained enclosed in the microspheres throughout the incubation. This qualitative 
data suggests a catalytic reaction occurred as a result of PHA beads encapsulated in 
alginate microspheres, and highlighted the advantage of immobilising the enzyme on a 
solid material (in this case, PHA beads) to prevent the spontaneous leakage of the enzyme 
through the porous structure of alginate microspheres, similar to that demonstrated by 
Zhao et al. (2015). 
4.3 PHA beads encapsulated in alginate millisphere for lipophilic substance 
removal from aqueous solution 
The core of the PHA beads is composed of hydrophobic polymers (Grage et al., 2009). 
Using this property, a lipophilic fluorescent dye, Nile red, has been used to confirm the 
presence of hydrophobic polymers in the cytoplasm of bacterial cells (Spiekermann et al., 
1999). In addition, a biomimetic adsorbent produced from PHB has been shown to adsorb 
lipophilic organic pollutants from an aqueous solution (Zhang et al., 2010b). Therefore, 
the hydrophobic polymer core of PHA beads has the potential to function as the reservoir 
for lipophilic substances. In this study, the aim was to produce PHA beads encapsulated 
in alginate millispheres and to assess their ability to remove a lipophilic substance from 
an aqueous solution, using Nile red as a model lipophilic substance. It was hypothesised 
that PHA beads encapsulated in alginate millispheres are capable of adsorbing lipophilic 
substances from aqueous solutions and that the preparation parameters would influence 
the degree of adsorption.  
4.3.1 Morphology of PHA bead-alginate millispheres 
A simple extrusion dripping method was employed to add PHA beads and alginate 
mixtures into a CaCl2 cross-linking solution to produce PHA beads encapsulated in 
alginate millispheres (PHA bead-alginate millispheres) by external gelation. The PHA 
bead-alginate millispheres were produced using different concentrations of alginate, PHA 
beads, and calcium ions, and evaluated for their adsorption performance. The blank 
alginate millispheres and PHA bead-alginate millispheres have a smooth surface, and the 
difference between them was distinguished easily by the white colour of the PHA beads 
within the alginate millispheres (Figure 35). In addition, the lyophilised PHA bead-
alginate particle showed the core of a millisphere forms a tunnel-like structure, and PHA 
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beads were observed being immobilised on the wall of the tunnel (Figure 36). These 
observations suggested successful encapsulation of the PHA beads into alginate 
millispheres by the external gelation method.  
4.3.2 Effect of calcium ion concentration 
The particle size of the alginate millispheres was influenced significantly by the 
concentration of calcium ion used in the cross-linking solution, indicating calcium ion is 
critical in particle preparation (Daemi & Barikani, 2012). The adsorption kinetics of the 
blank alginate millispheres showed no adsorption capacity over the 24 hours incubation, 
indicating calcium ion is not the factor responsible for adsorption of Nile red from the 
solution. In contrast, PHA bead-alginate millispheres showed a gradual increase in the 
adsorption capacity, indicating the adsorption of Nile red from the solution occurred in 
the millisphere encapsulating PHA beads. Moreover, the adsorption rate was higher in 
the millisphere prepared with a higher concentration of calcium ions, thus the calcium ion 
concentration in the millisphere preparation contributes to the degree of adsorption 
performance. The alginate gel produced by external gelation causes a heterogeneous 
gelling profile with a denser gel network on the surface of the millisphere (Ching et al., 
2017). Moreover, the concentration of calcium ion influences the degree of the gel 
network with less diffusion of solute to the core of the particle in high concentration of 
calcium ion due to the denser peripheral gel matrix (Radovich, 1985). Therefore, the 
higher adsorption capacity observed in higher concentration of calcium ion was 
considered to be due to smaller particle size which provides more specific surface area 
(Wang & Shadman, 2013).  
4.3.3 Effect of alginate concentration 
The diameter of alginate millispheres, prepared with lower alginate concentration (1% 
w/v alginate) was smaller than those prepared with a higher concentration (2% w/v 
alginate) (Table 7), as observed in previous studies (Chan et al., 2009; Bhujbal et al., 
2014; Davarcı et al., 2017). This was attributed to a higher alginate concentration as 
higher viscosity requires a higher flow rate, thus pressure, to cut the droplet (Bhujbal et 
al., 2014). Therefore, under a constant flow rate in this study, a droplet formed on the end 
of a needle will be larger in a more viscous solution, which in turn leads to an increase in 
resultant particle size. In addition to this, it has been shown that a droplet formed from a 
lower concentration of alginate is prone to shrink more than higher concentration of 
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alginate upon gelation (Chan et al., 2009). Nile red was not adsorbed by the blank alginate 
microspheres. Meanwhile, the PHA bead-alginate millispheres did show adsorption of 
Nile red from the solution, and the rate of adsorption was higher in millispheres prepared 
from a lower alginate concentration. This showed that millispheres generated from a 
different alginate concentrations influence Nile red adsorption from the solution. As 
previous studies have reported, lower concentrations of alginate produced less dense and 
smaller alginate particle size (Klemenz et al., 2003; Salsac et al., 2009; Stewart et al., 
2009). The higher specific surface area and lower polymer density of the gel matrix in 
smaller alginate millispheres could account for the higher adsorption capacity in the PHA 
bead-alginate millispheres prepared with 1% w/v alginate. 
4.3.4 Effect of PHA bead concentration  
The concentration of PHA beads used in the preparation influenced the extent of Nile red 
adsorption. As expected, higher concentrations of PHA beads in the millispheres 
increased the rate and amount of Nile red adsorption owing to more adsorption sites 
(Zulfikar et al., 2016). However, the adsorption capacity of PHA beads for Nile red was 
inversely correlated to the concentration of PHA beads used in the preparation when the 
adsorption capacity was calculated based on the amount of PHA beads weight instead of 
millisphere weight. This may be due to the distribution of PHA beads within the alginate 
millispheres. At high concentration of PHA beads, PHA beads were distributed at high 
density within alginate millispheres, providing more adsorption sites for Nile red. 
However, adsorption predominately occurred at the peripheral area of the millispheres, 
thus the adsorption sites of PHA beads at the centre of millispheres were not saturated. 
Meanwhile, lower concentrations of PHA beads would have space to allow Nile red to 
penetrate through the alginate gel matrix and reach the adsorption sites of PHA beads at 
the centre of the millisphere. In addition to this, the lower adsorption in higher 
concentration of PHA beads may have been due to steric hindrance of Nile red molecule 
that hindered full penetration of the molecule into the core of millispheres (Aljeboree et 
al., 2017). 
4.3.5 Adsorption Kinetics 
The adsorption of Nile red from the aqueous solution was time dependent. Based on the 
adsorption kinetic data obtained from different parameters in the preparation of alginate 
millispheres, the data was modelled to determine if it followed pseudo-first or pseudo-
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second order kinetics (Zhou et al., 2015; Li et al., 2017). Based on the correlation 
coefficient (R2) value, the pseudo-second order kinetic model fitted better than pseudo-
first order kinetic model. In addition, the theoretical adsorption capacity (qe) from pseudo-
second order kinetic model was closer to the experimental adsorption capacity value, 
confirming the validity of the model. Furthermore, the initial adsorption rate (V0) seemed 
to follow the rate of adsorption capacity curve. Therefore, the model suggests the 
adsorption rate depends on the availability of active sites of PHA bead-alginate 
millisphere rather than the concentration of Nile red in the solution. Moreover, the 
adsorption mechanism suggested was chemisorption that relates to valent forces through 
sharing or exchanging electrons between the adsorbent (PHA bead-alginate millisphere) 
and adsorbate (Nile red) (Rudzinski & Plazinski, 2009). However, it is known that Nile 
red interacts with polymers by hydrophobic interaction (Riahi et al., 2017), which is 
considered as a physisorption mechanism (Holzer et al., 2017). Therefore, further study 
is needed to elucidate the exact mechanism of the adsorption. 
4.3.6 Adsorption Isotherm 
The adsorption isotherm of Nile red in water containing 10% v/v DMSO at 25°C, and pH 
6.7 showed that as the initial concentration of Nile red increased, the amount of Nile red 
adsorbed on PHA bead-alginate millisphere also increased. This may be attributed to an 
increase in contact between the active site of PHA beads in the alginate millisphere and 
Nile red in the solution (Hu et al., 2017; Riahi et al., 2017). However, no maximum 
adsorption value for PHA bead-alginate millispheres was obtained in the isotherm 
experiment (Figure 41). This could be attributed to the low concentration of Nile red in 
the solution (due to its poor water solubility), thus adsorption saturation did not occur 
(Greenspan & Fowler, 1985; Kurniasih et al., 2015); this was also seen in other studies 
for the adsorption of lipophilic substances from aqueous solutions (Ru et al., 2007; Liu et 
al., 2009). The adsorption capacity of blank alginate millispheres and PHA bead-alginate 
millispheres was evaluated using Freundlich and Langmuir isotherm model. The former 
assumes that the adsorption occurs on a heterogeneous surface by multilayer adsorption 
and the latter assumes that adsorption occurs on a homogeneous surface by monolayer 
adsorption (Ngah & Fatinathan, 2008; Peretz et al., 2015; Zhou et al., 2015). Based on 
the coefficient correlation value for blank alginate millispheres, both models showed poor 
correlation (Table 9). Therefore, the blank alginate millispheres fit neither isotherm 
model, indicating the gel matrix of alginate millisphere do not adsorb Nile red from the 
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solution in any way, and this is consistent with the observation above (Figure 41). For the 
PHA bead-alginate millispheres, the adsorption was better evaluated by the Freundlich 
than the Langmuir isotherm model, based on the higher coefficient correlation 
(Freundlich R2=0.995, Langmuir R2=0.984). Therefore, this indicated that the adsorption 
behaviour of PHA bead-alginate millispheres occurs on a heterogeneous surface by 
multilayer adsorption. A Freundlich isotherm parameter “n” shows the adsorption 
intensity, thus the favourability of the adsorption (Ngah & Fatinathan, 2008). If the value 
is n<1, it indicates that the adsorption intensity was favourable over the range of 
concentrations in the study, while n>1 indicates adsorption is favourable in higher 
adsorbate concentrations than lower concentrations (Nomanbhay & Palanisamy, 2005). 
The results showed the n-value is n>1, therefore, it indicated that the adsorption of PHA 
bead-alginate millisphere is favourable in a high concentration of Nile red in the solution.  
4.4 Summary 
This study aimed to encapsulate PHA beads within an alginate hydrogel matrix by 
ionotropic gelation methods and assess the functionality of the hybrid material.  
PHA beads displaying IgG binding domain (ZZ) were encapsulated in alginate 
microspheres prepared by w/o emulsion with internal gelation. The microspheres were 
subjected to subsequent additional gelation to give higher mechanical strength. The 
additional gelation caused significant reduction of the encapsulation efficiency 
(approximately 30%) compared to internal gelation alone. IgG binding capacity of the 
microspheres was tested. Due to non-specific binding of IgG to the alginate microspheres, 
there was no difference found between negative controls (blank and PhaC PHA bead-
alginate microspheres) and ZZC PHA bead-alginate microspheres. Also, no IgG could be 
obtained after elution. However, the amount of IgG bound on the PhaC derived proteins 
(PhaC or ZZC) on PHA beads analysed by SDS-PAGE gel densitometry showed that 
alginate encapsulation enhanced binding of IgG to the PhaC derived protein on the 
encapsulated PHA beads. 
PHA beads displaying OpdA were encapsulated in alginate microspheres by w/o 
emulsion with internal gelation. The encapsulation efficiency of PHA beads was high at 
over 90 %. The enzymatic activity of OpdA on the encapsulated PHA beads was 
measured by the increase in fluorescence intensity caused by the liberation of enzymatic 
product. The results showed that alginate encapsulation significantly reduced the activity 
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of the enzyme displayed on the PHA beads. This was probably due to the alginate limiting 
mass transfer of the substrate to the active site of the enzyme. However, this system had 
an advantage that leakage of the enzyme through the porous structure of the alginate 
hydrogel matrix was inhibited by the particle size of the PHA beads. 
Alginate millispheres encapsulating PHA beads were produced by a simple extrusion 
dripping method with external gelation in a CaCl2 cross-linking solution. PHA bead-
alginate millispheres were prepared with different concentrations of alginate, calcium ion, 
and PHA beads. The former two parameters directly influenced the particle size of the 
millispheres. Lower alginate concentration and higher calcium ion concentration 
produced smaller millispheres, which provided higher specific surface area, resulting in 
higher adsorption capacity. More PHA beads in the preparation of millispheres adsorbed 
more Nile red. However, when adsorption was calculated based on the PHA bead weight, 
fewer PHA beads used in the preparation adsorbed more Nile red. This was presumably 
because the adsorption sites at the peripheral region of the millisphere were quickly 
saturated with the higher concentrations of PHA beads, while Nile red had easier access 
to the core of the millisphere with fewer PHA beads. The adsorption kinetic and isotherm 
were evaluated. According to the coefficient correlation (R2) values, PHA bead-alginate 
millispheres fit a pseudo-second order kinetic model and the Freundlich isotherm model. 
4.5 Future directions 
4.5.1 ZZC PHA bead-alginate microspheres 
In this study, the amount of IgG binding to the protein displayed on the surface of PHA 
beads was enhanced by encapsulation within alginate microspheres. However, from the 
materials point of view, it is strongly recommended to use an alternative polymer to 
encapsulate the PHA beads displaying the IgG binding domain for an IgG purification 
application. This is because alginate microspheres are prone to change their structure due 
to changes in external stimuli, such as pH and ionic strength in the solution (Matyash et 
al., 2014). Moreover, the elution buffer (100 mM glycine (pH2.5)) is prone to cause 
proton hydrolysis of alginate polymer (Haug et al., 1963). Then, the subsequent 
dispersion of the alginate microspheres in a neutral pH solution causes the alginate to 
dissolve, destroying the microsphere’s structure (Mørch et al., 2007), thus reducing the 
reusability of the microspheres. Furthermore, alginate microspheres resulted in non-
specific interaction with IgG in the present study, and previous studies have used alginate 
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for several protein purifications based on its direct interactions with proteins (Jain et al., 
2006). Based on these results, alginate is not recommended for encapsulating material for 
application in protein purification utilising the protein displayed on PHA beads. Therefore, 
the PHA beads displaying IgG binding domain should be encapsulated with a 
physiologically inert hydrogel with a high mechanical strength. Also, it is important to 
consider the porosity of the scaffold to ensure sufficient mass transfer of solute through 
the matrix, which would, in turn, result in higher IgG binding. This would also ensure 
higher efficiency in eluting bound IgG from the protein immobilised on the encapsulated 
PHA beads. However, the pore size has to be small enough to hold the bead within the 
hydrogel matrix. 
4.5.2 PhaC-OpdA PHA bead-alginate microspheres 
In this study, the enzymatic activity of PhaC-OpdA PHA beads encapsulated in alginate 
microspheres was only shown by the increase in fluorescence intensity due to the 
liberation of enzymatic product. The enzyme kinetic data should be quantitatively 
estimated using an equation. For instance, use a Lineweaver-Burk plot to analyse the 
Michaelis-Menten equation to obtain the catalytic constant (kcat), Michaelis-Menten 
constant (KM) and second order rate constant (kcat/KM) (Al-Mayah, 2012). In addition, this 
study only tested one condition. As previous studies have shown, the main advantage of 
alginate encapsulation is an enhancement of enzyme stability (Zhu et al., 2005). Therefore, 
a future experiment should examine the stability of the enzyme activity in a wide range 
of different conditions (pH or temperature). 
The limited exchange of solute (mass transfer) into alginate microspheres could be 
improved by blending alginate with other polymers to alter the structural properties of 
alginate hydrogel. For instance, a previous study has shown that that blending poly(vinyl-
alcohol) in alginate formed porous microspheres that enhanced mass transfer of solute. 
Moreover, the microspheres encapsulating lipase enhanced its activity in the hydrolysis 
of olive oil in comparison to free lipase (De Queiroz et al., 2006). In addition, a study has 
shown that density of encapsulated material within alginate hydrogel influences the 
effective diffusion of substrate (Ha et al., 2008). Therefore, increasing enzyme activity 
by optimisation of PHA bead load in alginate microspheres should be investigated in 
future studies. 
112 
 
This study has provided qualitative data suggesting protein immobilised on PHA beads 
may inhibit spontaneous leakage of the functional protein owing to the particle size of 
PHA beads. Therefore, another possible application for the enzyme-displaying PHA 
beads encapsulated in alginate hydrogel, is in a fixed-bed reactor. As a previous study 
showed, alginate encapsulation of enzyme immobilised on chemically reduced graphene 
oxide greatly inhibited leakage of enzyme while it retained its activity within a broad 
range of conditions (pH and temperature) (Zhao et al., 2015). As shown in the present 
study, the particle size of PHA beads may inhibit the potential leakage of the enzyme 
immobilised on the PHA beads from the alginate matrix. This may be similar to the study 
mentioned above, therefore, it would be interesting to test the potential application in a 
column to model a continuous fixed-bed enzyme catalytic reaction. 
4.5.3 PHA bead-alginate millispheres for lipophilic substance removal 
To gain an in-depth understand of the adsorption mechanisms of the alginate encapsulated 
PHA beads, further studies are required. In this study, it was demonstrated that different 
parameters in the preparation of the PHA bead-alginate millispheres resulted in different 
adsorption performances. However, the effects of the various conditions, such as 
temperature, pH, initial concentration of adsorbate (in the case of this study, Nile red), 
and initial dose of adsorbent should be investigated to elucidate the dynamic behaviour 
of adsorption. Furthermore, Brunauer–Emmett–Teller (BET) analysis should be applied 
to determine the surface area and pore size using nitrogen adsorption test (Park et al., 
2007).  
The present study has concluded that adsorption was chemisorption due to higher 
correlation coefficient in pseudo-second order kinetics. To confirm this, the data should 
be further analysed using the intra-particle diffusion equation and investigated using 
Fourier transform infrared spectroscopy (FT-IR) to read the spectra of interaction 
between adsorbent and adsorbate before and after the adsorption test (Vijayakumar et al., 
2012). 
In this study, two commonly used isotherm models, the Freundlich and Langmuir 
isotherm models, were used to analyse the adsorption isotherm. This concluded that the 
date in this study fits better to the Freundlich isotherm model than the Langmuir isotherm 
model according to the correlation coefficient obtained from plotting of linear equations 
of both models. In addition to this, several isotherm models have been used in this 
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particular topic. For example, a linear isotherm model has been used in a study which had 
a similar adsorption curve pattern to the present study (linear adsorption curve) due to the 
solubility of adsorbate in their study (Liu et al., 2009). Thus, the model may suggest other 
adsorption mechanisms based on the data in this study. 
Due to the hydrophobic nature of the lipophilic substance, the diffusion behaviour of the 
lipophilic substance across the hydrophilic alginate inner microenvironment is of 
particular interest. This is because the diffusion behaviour may influence the degree of 
adsorption to the PHA beads in alginate millispheres.  
In this study, the adsorption capacity of free PHA beads was not characterised. Therefore, 
the effect of alginate encapsulation on the adsorption performance could not be 
determined. This was due to difficulties in controlling the rate of adsorption by the free 
PHA beads, and the interaction of the adsorbate (Nile red) with plastic wares used in this 
study. High performance liquid chromatography (HPLC) could be used to analyse the 
concentration of residual adsorbate as described in Zhang et al. (2010b).  
Nile red was used as the model adsorbate in this study. This lipophilic substance has been 
shown to be a promising substance for testing interactions with the polymer core of PHA 
beads (Peters et al., 2007). The next stage of utilising the hydrophobic nature of the inner 
core is testing with other lipophilic substances. This may include organic pollutants as 
well as lipophilic substances used for medical or pharmaceutical applications. Therefore, 
this has the potential to widen the application of PHA beads as a carrier in drug delivery 
systems. 
Alginate has been used for water treatment applications utilising the property of chelating 
with heavy metal ions (Pandey et al., 2007). In addition to this, previous studies showed 
that alginate encapsulation of activated carbon had the property of dual adsorption of 
heavy metal ions and organic pollutants (Park et al., 2007). Therefore, PHA bead-alginate 
millispheres should be applicable for dual adsorption ability as well and future studies 
could investigate this. 
4.5.4 PHA bead-alginate hybrid material fabrication 
Future work also involves optimisation of hybrid material fabrication methods. This is 
because the properties of alginate hydrogel are highly variable depending on the source 
of alginate, which has varying chemical compositions and monomer sequences, and the 
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type of cross-linker used. For example, alginate with higher G-block content would 
produce hydrogels with stronger mechanical properties with high porosity. Divalent 
cations with higher affinity for alginate polymers, such as barium ions, would also 
enhance the mechanical properties.  
The structure of alginate microspheres prepared with internal gelation could also be 
improved by using calcium carbonate nanoparticles (15-40 nm) instead of ultrafine 
calcium carbonate particle (micron-size) (Paques et al., 2014a). Calcium carbonate 
nanoparticles would reduce the spatial variations of calcium concentrations within an 
alginate droplet, and the smaller particle size would give a faster reaction when the gelling 
agent is added. Therefore, the hydrogel prepared with calcium carbonate nanoparticle 
would produce a more homogeneous gel network than that produced with ultrafine 
calcium carbonate particles.  
An alternative preparation method of alginate microspheres is the use of devices for 
modified extrusion techniques, such as electrostatic atomization and impinging aerosol 
method (Ching et al., 2017). These techniques produce alginate microspheres with a 
uniform particle size and eliminate the extensive washing procedures required in w/o 
emulsion microsphere production. In addition, they avoid exposure of encapsulated 
materials in alginate microspheres to acid during the process of dissolving calcium 
carbonate in the internal gelation method. 
A study has demonstrated coating alginate microspheres by poly(L-histidine) through 
electrostatic interaction between the negatively charged alginate polymer and the 
positively charged poly-histidine (Wang et al., 2005). Previously, poly-histidine tag fused 
at N-terminus of PhaC was constructed, and PHA beads displaying poly-histidine tag 
were produced (Lee, 2011). During the preparation of alginate microspheres, the charge 
differences may give a positive effect, especially in encapsulation efficiency.  
4.5.5 Applications 
Potential applications of the hybrid material of PHA beads and alginate are mainly in the 
biomedical and pharmaceutical fields. For instance, oral administration of drugs and 
vaccine delivery are of particular interest. Alginates have been employed as an 
encapsulating carrier material in drug delivery system owing to its favourable properties. 
They can provide the controlled release of drugs at specific destinations (Lee & Mooney, 
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2012). Also, oral administration of vaccines encapsulated in alginate microspheres has 
elicited protective immune responses (Bowersock et al., 1996). PHA beads have also 
been demonstrated as carriers of drugs, enzymes, and vaccines. Therefore, alginate 
encapsulation of functionalised PHA beads could be used as a novel formulation for drug 
delivery systems. Future studies could aim to include animal and human trials of hybrid 
materials designed to control the release of encapsulated drugs or enzymes on PHA beads.  
4.6 Conclusion 
This study has developed novel hybrid materials of PHA beads with alginate and assessed 
their functionality. The results demonstrated that the functional proteins displayed on 
PHA beads retained their function within the alginate hydrogel matrix. In comparison to 
their free state PHA beads, alginate encapsulation enhanced the binding capacity of an 
IgG binding domain (ZZ), but reduced the activity of OpdA. Therefore, the effect of 
alginate encapsulation depended on the function of the proteins on the surface of the PHA 
beads, and its substrate. The hydrophobic core of PHA beads within alginate millispheres 
acted as an adsorbent for Nile red in aqueous solution. The preparation parameters 
influenced the adsorption capacity of the millispheres. Alginate concentration and 
calcium concentration directly influenced the particle size of resultant PHA bead-
millispheres, thus generating differences in the specific surface area. Although a higher 
concentration of PHA bead provide more adsorption sites, the adsorption capacity was 
higher when fewer PHA beads were used in the preparation, when it was based on the 
weight of PHA beads. The rate of adsorption was found to obey pseudo-second order 
kinetics and the equilibrium data were fitted to the Freundlich isotherm model. This study 
has shown the effect of alginate encapsulation on the functionality of PHA beads within 
the hydrogel matrix, however, further studies on optimisation of fabrication methods and 
formulations and characterisation of the hybrid material are required. PHA beads have 
been shown to be a versatile platform to display various functional proteins on their 
surface, and the number of functional proteins that can be immobilised on PHA beads is 
likely to increase. In addition to this, the hydrophobic core of PHA beads also has a vast 
potential as a reservoir for lipophilic substances. Therefore, further studies on the 
production of hybrid materials of PHA beads with polymer materials including alginate 
should be conducted to maximise the function of PHA beads and widen their applications. 
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Chapter 6: Appendices 
Appendix I 
Table 10: Summary of PHA bead characteristics used for IgG binding domain assay in stock 
suspension. 
 Protein Profile  Particle size distribution3 
PHA 
bead 
Types 
Protein on PHA 
beads (mg/g)1 
PhaC 
derived 
protein 
proportion 
(%)2 
 
D 
(10) 
(μm) 
D 
(50) 
(μm) 
D 
(90) 
(μm) 
SPAN Uniformity 
Specific 
Surface 
Area 
(m²/kg) 
PhaC 5.4±0.2 36.9  0.818 6.23 18.0 2.764 0.957 2,211 
ZZC 2.1±0.3 26.2  0.392 2.17 12.6 5.646 2.493 6,085 
Note: 1 Protein quantified by SDS-PAGE gel densitometry. 2 Protein proportion obtained from densitometry 
on SDS-PAGE gel. 3 Results obtained from laser diffraction. 
 
Table 11: Summary of PHA bead characteristics used for enzyme activity assay in stock 
suspension. 
 Protein Profile  Particle size distribution3 
PHA 
bead 
Types 
Protein on 
PHA beads 
(mg/g)1 
PhaC derived 
protein 
proportion 
(%)2 
 D 
(10) 
(μm) 
D 
(50) 
(μm) 
D 
(90) 
(μm) 
SPAN Uniformity 
Specific 
Surface 
Area 
(m²/kg) 
PhaC 5.6±0.02 40.4  2.53 6.92 46.6 6.365 1.921 1,021 
PhaC-
OpdA 
14.2±0.4 46  5.15 13.2 33.9 2.167 0.914 559.5 
Note: 1 Protein quantified by SDS-PAGE gel densitometry. 2 Protein proportion obtained from densitometry 
on SDS-PAGE gel. 3 Results from laser diffraction. 
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Appendix II 
Table 12: Summary of particle size distribution of alginate microspheres in different production 
parameters and solutions. 
  Particle size distribution characteristics Particle size difference 
rpm Sample Name D (10) D (50) D (90) Span Uniformity D (10) D (50) D (90) 
 Alginate microspheres 
250 I-H2O 107 186 334 1.22 0.377 - - - 
 I+E-H2O 47.9 82.3 144 1.037 0.323 -55% -56% -57% 
 I+E-TBS 81.7 131 211 0.987 0.307 171% 159% 147% 
 I+E-Glycine 66.5 99.6 151 0.846 0.262 144% 131% 121% 
350 I-H2O 87.5 138 220 0.96 0.296 - - - 
 I+E-H2O 46.3 76.3 125 1.037 0.323 -47% -45% -43% 
 I+E-TBS 76 114 173 0.851 0.263 164% 149% 138% 
 I+E-Glycine 72.8 120 203 1.087 0.334 152% 146% 141% 
450 I-H2O 56.1 90.3 147 1.004 0.31 - - - 
 I+E-H2O 37.6 60.3 97.1 0.987 0.306 -33% -33% -34% 
 I+E-TBS 52.3 79.8 123 0.888 0.273 139% 132% 127% 
 I+E-Glycine 48.8 74.7 116 0.893 0.276 130% 124% 119% 
 PhaC PHA bead-alginate microspheres 
250 I-H2O 125 231 450 1.407 0.443 - - - 
 I+E-H2O 37.4 67.8 137 1.469 0.527 -70% -71% -70% 
 I+E-TBS 71.8 119 202 1.099 0.336 192% 176% 147% 
 I+E-Glycine 63.1 109 200 1.264 0.406 169% 161% 146% 
350 I-H2O 95.9 163 289 1.184 0.367 - - - 
 I+E-H2O 38.8 67.2 117 1.159 0.359 -60% -59% -60% 
 I+E-TBS 70.5 109 170 0.913 0.282 182% 162% 145% 
 I+E-Glycine 60 95.1 154 0.985 0.304 155% 142% 132% 
450 I-H2O 62.1 105 183 1.16 0.399 - - - 
 I+E-H2O 29.9 50.5 86 1.111 0.396 -52% -52% -53% 
 I+E-TBS 50 81.6 136 1.059 0.325 167% 162% 158% 
 I+E-Glycine 47 76.1 127 1.047 0.327 157% 151% 148% 
 ZZC PHA bead-alginate microspheres 
250 I-H2O 161 292 525 1.247 0.384 - - - 
 I+E-H2O 38 72.7 152 1.572 0.529 -76% -75% -71% 
 I+E-TBS 72.4 128 232 1.247 0.387 191% 176% 153% 
 I+E-Glycine 67.3 119 217 1.259 0.388 177% 164% 143% 
350 I-H2O 117 197 332 1.092 0.334 - - - 
 I+E-H2O 39.5 69.8 123 1.192 0.368 -66% -65% -63% 
 I+E-TBS 72.6 113 177 0.926 0.286 184% 162% 144% 
 I+E-Glycine 62.1 100 163 1.007 0.313 157% 143% 133% 
450 I-H2O 77.6 128 215 1.075 0.335 - - - 
 I+E-H2O 31.7 53.4 89.2 1.077 0.333 -59% -58% -59% 
 I+E-TBS 57.9 89.9 141 0.924 0.285 183% 168% 158% 
 I+E-Glycine 52.1 79.8 124 0.899 0.277 164% 149% 139% 
Note: “I” refers to microspheres produced by internal gelation and “I+E” refers to microspheres produced 
by internal gelation followed by additional gelation (double gelation). The percentage of I+E was compared 
with microspheres produced by internal gelation and I+E-TBS (50mM Tris and 50mM NaCl, pH7.4) and 
100 Mm Glycine (pH2.5) were compared with I+E-H2O 
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Table 13: Summary of particle size distribution of PHA bead-alginate microspheres in water. 
PHA bead Types D (10) (μm) 
D (50) 
(μm) 
D (90) 
(μm) SPAN Uniformity 
Specific Surface 
Area (m²/kg) 
Alginate microspheres 60 95.2 152 0.963 0.297 66.92 
PhaC PHA bead-alginate 
microspheres 78.9 151 294 1.425 0.448 63.19 
PhaC-OpdA PHA bead-
alginate microspheres 85 157 272 1.188 0.372 68.68 
Note: Results from laser diffraction. 
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Appendix III 
 
Figure 43: Quantification of bound IgG on the PhaC derived proteins by SDS-PAGE densitometry 
method. A: representative SDS-PAGE gel for quantifying bound IgG on PhaC derived protein on 
PHA beads by densitometry method, B: Summary of the amount of bound IgG on PhaC derived 
proteins after binding and elution phase and coefficient correlation of the densitometry test. PhaC 
indicates free PhaC PHA beads, ZZC indicates free ZZC PHA bead, PhaC-ALG indicates PhaC 
PHA bead-alginate microspheres, ZZC-ALG indicates ZZC PHA bead-alginate microspheres. 
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Bound IgG on PhaC derived 
protein (mg/mg)
R2 (BSA) R2 (IgG)
PhaC Binding 1.34±0.01 0.995 0.994
Elution 1.05±0.03 0.999 0.998
ZZC Binding 9.25±0.10 0.992 0.99
Elution 4.16±0.13 0.999 0.995
Batch test
PhaC-ALG Binding 5.49±0.23 0.996 0.997
Elution 8.64±0.87 0.999 0.998
ZZC-ALG Binding 21.77±0.21 0.991 0.995
Elution 27.30±1.59 0.992 0.994
Column test
PhaC-ALG Binding 6.40±0.43 0.995 0.993
Elution 11.21±1.87 0.996 0.997
ZZC-ALG Binding 19.96±1.70 0.991 0.984
Elution 28.65±1.96 0.975 0.977
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Appendix IV 
 
 
Figure 44: Quality control of Nile red solution in a flask over 24 hours incubation for adsorption 
kinetic test. The initial concentration of Nile red solution containing 10% v/v DMSO: 70 ng/ml; 
incubation: 25°C with 100rpm shaking for 24 hours. The measurement was done in triplicate and 
mean±standard deviation is reported. 
 
Figure 45: Quality control of Nile red solution in a flask after 24 hours incubation for adsorption 
isotherm test. The initial concentration of Nile red solution containing 10% v/v DMSO: 10-100 
ng/ml; incubation: 25°C with 100rpm shaking for 24 hours. The measurement was done in 
triplicate and mean±standard deviation is reported. 
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